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Abstract
Oocyte maturation has been the subject of extensive studies but there remains debate
as to the effect of steroid hormones on this process and the subsequent implications
for developmental competence. During oocyte maturation the establishment of the
correct maternal DNA methylation pattern is vital ifnormal embryo development is
to occur after fertilisation. Thus, any factors which perturb the process of DNA
methylation could have an impact on the acquisition of oocyte developmental
competence. This study investigates the effects of androgens and oestrogens on
oocyte maturation, with particular emphasis on DNA methylation.
Alterations in DNA methylation and the subsequent expression of imprinted genes
could be mediated through changes in ovarian expression of genes affecting the
methylation process, such as one of the Dnmt or Mbd genes. However, no
consistent, reproducible changes in expression levels ofDnmt or Mbd genes were
observed after the administration of exogenous gonadotrophins. Further analysis
found that exposure to raised steroid levels in culture had a significant effect on the
global DNA methylation levels of oocytes. Although, no alterations in gene
expression were previously identified this did not rule out the possibility that the
observed changes to DNA methylation levels were the result of an effect on Dnmt
proteins. To begin investigating this, the localisation of Dnmtlo was assessed after
exposure to high levels of androgens and oestrogens. Under physiological conditions
the Dnmtlo protein is present in the nucleus in growing oocytes and translocates to
the cytoplasm as maturation progresses. Steroid exposure was found to alter the
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localisation profile of Dnmtlo, making this a candidate mechanism by which the
global DNA methylation levels are influenced by raised androgens and oestrogens.
The mechanisms controlling genomic imprinting during oocyte and embryo
development are still being investigated. An increased understanding of genomic
imprinting during development has been achieved through analysis of the gametes,
embryos and offspring of mice with null mutations for Dnmt or Mbd genes.
Although, Mbd2~'~ mice have been reported to have a reduced litter size, the cause of
this maternal effect is currently unknown. This study did not find any significant
difference between maternal genotypes in the number of oocytes ovulated,
fertilisation rate or percentage of 2-cell embryos developing to the blastocyst stage
during IVF. Thus, the observed phenotype of small litter size may not be the result
of impaired oocyte maturation or early embryo development occurring in the absence
of Mbd2.
The increasing use of assisted reproductive techniques means that a full
understanding of the role of the environment on oocyte developmental competence is
vital. This thesis presents evidence that raising the concentration of androgens and
oestrogens can influence the process of DNA methylation during oocyte maturation.
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Although there have been extensive studies investigating the role of steroids on
follicular development and on aspects of oocyte maturation, the effects of these
hormones on the developmental competence of the oocyte are still under debate. The
importance of furthering our understanding of the mechanisms of oocyte maturation
and the factors that influence this becomes apparent when Assisted Reproductive
Techniques (ARTs) are considered. The use of these techniques is becoming
increasingly common but, as the relatively low success rates demonstrate, many
aspects of the technologies are yet to be fully investigated. One area of interest is
epigenetics, particularly genomic imprinting, with recent studies finding a correlation
between assisted conceptions and an increase in the incidence of normally rare
imprinting disorders. One of the major differences between embryos obtained from
either natural or assisted conceptions is in the steroidal environment both they, and
the gametes which gave rise to the embryos, were exposed to. This variation in
steroidal milieu may occur in vivo due to superovulation or be the result of in vitro
culture systems (Kajta, 1998). This study aims to investigate the effects of
androgens and oestrogens on mammalian oocyte maturation, with particular
emphasis on genomic imprinting. The term "androgens" is used within this thesis to
encompass the group of androgenic hormones that act through the classical androgen
receptors. Likewise, the term "oestrogens" is used to cover a range of oestrogenic
hormones that act through classical oestrogen receptors, including oestradiol and
oestrone. The research model utilised in this project is the murine system, with all
work referring to this species unless otherwise stated.
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1.2 PRIMORDIAL GERM CELLS (PGCs)
1.2.1 Localisation, Proliferation and Migration of PGCs
Early mouse embryos contain an initial population of PGCs which will go on to form
the oocytes and spermatozoa of the adult gonads. These PGCs are initially identified
near the posterior region of the primitive streak, from approximately embryonic day
7.5 (E7.5), by the presence of alkaline phosphatase activity (Chiquoine, 1954;
reviewed by Matsui & Okamura, 2005). They are localised within the extra¬
embryonic mesoderm resulting in them being separated from the embryonic somatic
cells and protected from many of their differentiation signals. As any epiblast cells
that are transplanted to the proximal epiblast are capable of forming PGCs, there may
not be a subset of cells which are pre-programmed to form the germ line. It may be
that germ cell determination is caused by local tissue signals (Figure 1.1) (Tarn &
Zhou, 1996; reviewed by Matsui & Okamura, 2005). Bone morphogenetic protein 4
(Bmp4) is proposed as one such local signal. Mice homozygous for a functional
mutation of Bmp4 (Bmp4~'~) do not have any PGCs while the heterozygote (Bmp4+/~)
has a smaller PGC founder population, demonstrating that Bmp4 is vital for the germ
cell determination (Lawson et al., 1999). PGCs undergo mitotic proliferation during
their migration to the gonadal ridge (reviewed by Molyneaux & Wylie, 2004). This
migration into the embryonic mesoderm and through the hindgut begins at E8.5, with
the binding of Kit ligand (KL) to the c-Kit receptor being involved in mediating the
required interactions between somatic and germ cells (Pesce et al., 1997). They
reach the undifferentiated gonadal ridge at E10.5-11.5 but proliferation continues
until E12.5-13.5 (reviewed by De Felici et al., 2005). The rate of this proliferation
seems to be determined by Pinl with a species specific number of divisions
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occurring (Atchison et al., 2003). From El2.5, the gonads become sexually
dimorphic and subsequently impose a sex determined fate on the PGCs residing
within the developing gonad (reviewed by McClaren, 2003). PGCs located in a
developing ovary cease to replicate by mitosis and enter meiosis to become oocytes
while those in the early testes enter mitotic arrest and are termed prospermatogonia
(Hilscher et cil., 1974; as reviewed by De Felici et al., 2005). In addition to factors
that control the migration and determination of the PGCs they are also dependent in
vivo on KL for survival, while in vitro studies also suggest a survival role for
leukaemia inhibitory factor (LIF), growth arrest-specific protein-6 (Gas-6) and
interleukin-4 (11-4) (Godin et al., 1991; Matsui et al., 1991; Matsubara et al., 1996;
Cooke et al., 1996). In culture, PGC proliferation is stimulated by tumour necrosis
factor-a (TNF-a), retinoic acid and cyclic adenosine monophosphate (cAMP)
although whether these factors carry out a similar role in vivo is yet to be determined
(Kawase et al., 1994; Koshimizu et al., 1995; De Felici et al., 1993). Around E13.5
there is increased apoptosis of male PGCs, while an increase in female germ cell
death occurs nearer E15.5 (Wang et al., 1998; Ratts et al., 1995; as reviewed by De
Felici et al., 2005). During these periods of germ cell reduction B-Cell
Leukemia/lymphoma 2 (Bcl-x) is responsible for protecting germ cells from
apoptosis whilst the presence of Bcl2-associated X protein (Bax) increases cell death
(Rucker et al., 2000).
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Figure 1.1:- Diagram illustrating the timecourse and main factors
involved in primordial germ cell formation and migration. Bax-
Bcl-2-associated X protein; Bcl-x- B-Cell Leukemia/lymphoma
2; Bmp4 - Bone morphogenetic protein-4; E - Embryonic day;
PGC - Primordial germ cell; Pinl - protein (peptidyl-prolyl
cis/trans isomerase) NIMA-interacting gene; TrkB - Tyrosine
Kinase B.
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1.3 FOLLICLE DEVELOPMENT (Figure 1.2)
1.3.1 Primordial Follicle Formation
Once located in the ovary, PGC clusters must be broken down: the oogonia interact
with surrounding somatic cells to form primordial follicles (reviewed by Skinner
2005). Each primordial follicle consists of a quiescent oocyte in meiotic arrest
surrounded by a layer of flattened granulosa cells (GCs). Oogonia which do not
successfully become part of a primordial follicle cannot survive. The exact timing of
primordial follicle formation is species-specific, occurring during fetal development
in primates while in rodents this process is underway around the time ofbirth. When
no oocytes are present in the female gonad the somatic cells tend to differentiate
towards a male phenotype, with structures reminiscent of seminiferous tubules or
Sertoli cells developing (Hashimoto et al., 1990, Mclaren, 1991; Guigon et al.,
2005). Although this suggests that the oocyte has an active role in determining
gonad differentiation, the study of mice lacking functional oestrogen receptors a and
P {ERafT1') and homozygous null mutants for the aromatase enzyme (ArKO_/~) mice
suggest that it is the action of oestrogen, rather than the presence of oocytes, which
maintains the normal ovarian somatic cell phenotype (Couse et al., 1999; Britt et al.,
2001; Britt & Findlay, 2003). Additionally, in the ovary of adult mice lacking the
deleted in azoospermia like gene (dazlthere is no evidence of differentiation
towards a testis phenotype, even though there are no oocytes present. Interestingly,
the ovarian somatic cells in these animals maintain their steroidogenic function
(McNeilly et al., 2000). It is largely accepted that the population of primordial
follicles represents the lifetime complement of female germ cells and is not
renewable, although, the possibility of ovarian stem cells renewing the oocyte
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population has been proposed (Johnson et al., 2004). Several factors have been
identified as playing important roles in oocyte survival and primordial follicle
formation. A member of the tyrosine kinase (Trk) receptor family, TrkB, has been
shown to effect germ cell and primordial follicle survival. If TrkB is inhibited at the
time when primordial follicles are forming there is extensive germ cell death (Spears
et al., 2003). The expression profile offactor in the germline-a (Figla) and the
phenotype of female mice with disrupted Figla expression {Figla'1') suggest a role for
this protein in oocyte survival and primordial follicle formation (Soyal et al., 2000).
No primordial follicles form in the ovaries of Figla'1' females and widespread oocyte
death is observed demonstrating a vital role of Figla in some aspect of germ cell
survival and follicle formation (Soyal et al., 2000). A similar role of FIGLA in the
human fetal ovary is suggested by the increase in FIGLA expression in parallel with
the time of primordial follicle formation (Bayne et al., 2004). The ovaries of Wnt4''~
females also lack primordial follicles and oocytes, suggesting that this gene may also
have a role in determining the early organisation of the ovary and perhaps follicle
development (Vainio et al., 1999).
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Figure 1.2:- Follicle development:- When the previously quiescent primordial follicle is
recruited to the growing pool the granulosa cells become cuboidal and oocyte growth is
initiated. During pre-antral development oocyte growth continues, granulosa cells proliferate
and thecal layers form. The development of the antrum marks the start of the antral phase of
development. As the antral cavity volume increases two sub-populations of granulosa cells
form with cumulus cells surrounding the oocyte and mural granulosa cells at the outer edge of
the antrum.
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1.3.2 Primordial Follicle Recruitment
Once primordial follicle formation is complete, follicles from the quiescent pool
begin to be recruited to form a population of growing follicles (reviewed by Fortune,
2003; Skinner, 2005). Follicles which are activated (or released from inhibition)
prior to puberty will die through atresia before they are fully developed. Once
puberty has been reached the growth of some follicles will be supported to the
Graafian stages and ovulation will occur; only a small proportion of the follicles
recruited to the growing pool will reach this stage, with the large majority becoming
atretic. Tight regulation of primordial follicle recruitment is vital as the loss of
follicles into the growing population results in diminishment of the follicular reserve
and therefore determines the reproductive lifespan of the female. When a primordial
follicle leaves the resting population and begins to grow, the earliest observable
change is the GCs becoming cuboidal in shape. This primary stage of pre-antral
follicular development is characterised by proliferation of GCs. Molecular analysis
demonstrates that these GCs express markers of proliferation, including proliferating
cell nuclear antigen (PCNA). It is possible that the transition from primordial to
primary follicle is mediated by activating factors or through a release of inhibition.
The spontaneous initiation of follicles into the growing population seen in cultured
ovaries is suggestive of an inhibitory factor acting in vivo. Anti-Mullerian hormone
(Amh) has an inhibitory effect on primordial follicle recruitment both in vitro and in
vivo (reviewed by Fortune, 2003 and Skinner, 2005), with Amh'1' ovaries becoming
depleted of primordial follicles more rapidly than in Amh+/+ animals (Durlinger et al.,
1999; 2002). Additionally, there are many factors which although capable of
influencing follicle recruitment in vitro there is as yet no evidence that they perform
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this function in vivo. KL or fibroblast growth factor (FGF) in culture cause a
reduction in the number of primordial follicles and an increase in pre-antral follicle
numbers within the rat ovary, with the implication that they stimulate the primordial
to primary transition (Parrott & Skinner, 1999; Nilsson et al., 2001; reviewed by
Skinner, 2005). This transition process is also seen to increase when LIF is added to
the culture, which may be mediated through its ability to increase KL levels (Nilsson
et al., 2002; reviewed by Skinner, 2005). Insulin also has a stimulatory effect on
primordial follicle transition and when added in combination with either LIF or KL
there is an additive effect (Nilsson et al., 2002; Parrot & Skinner 1999; Kezele et al.,
2002). Pre-antral follicle growth is not dependent on pituitary gonadotrophins,
although primary follicles have detectable levels of follicle stimulating hormone
receptor (FSHR) messenger ribonucleic acid (mRNA) this may not signify the
presence of active FSHR (O'Shaughnessy et al., 1996).
1.3.3 Pre-Antral Follicle Development
Once follicles have developed a second layer of GCs they are deemed to have
entered the secondary phase of pre-antral growth (reviewed by Fortune, 2003).
During this stage GC proliferation continues and the number of layers surrounding
the oocyte increases (Figure 1.2). Primary pre-antral follicles require the oocyte
specific growth differentiation factor 9 (Gdf-9) if they are to progress to the
secondary stage (Dong et al., 1996). Gdf-9 is expressed in all oocytes except those
quiescent oocytes in primordial follicles (McGrath et al., 1995). During mid to late
pre-antral stages, a layer of theca cells develops by recruiting surrounding somatic
cells. KL is involved in the development of this theca layer, but whether its role is
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recruitment or purely proliferation is undetermined (Parrott & Skinner, 1997; Parrott
& Skinner, 2000). These early stages of follicle growth and development are able to
occur independently of gonadotrophin stimulation, with luteinising hormone
receptors (LHRs) and FSHRs beginning to be synthesised on the theca and GCs
respectively during the late pre-antral stage (Camp et al., 1991).
In mice, the oocyte contained within a pre-antral follicle enters a phase of rapid
growth which is complete by the time the follicle reaches a diameter of
approximately 150pm and prior to antrum formation (Carabatsos et al., 1998). The
oocyte must also store mRNA and proteins that will be vital for later stages of oocyte
maturation, fertilisation and pre-implantation development. At this stage the oocyte
is not competent to resume meiosis when isolated from its follicular environment. At
least in vitro, oocyte growth is stimulated by KL acting through the c-Kit receptors
which are present on the oocyte (Packer et al., 1994). The oocyte also synthesises
and secretes glycoproteins which form the zona pellucida (ZP) around the oocyte
which prevents polyspermy and inappropriate implantation. The ZP consists of three
glycoproteins, ZP1, 2 and 3 which require other factors including figla if they are to
be correctly expressed (Epifano et al., 1995; Liang et al., 1997). The oocyte
maintains communication and receives chemical substrates from the surrounding
GCs via connexin (cx) -dependent gap junctions. Mice lacking functional cx37
(cx3T'~) have impaired oocyte-GC communication. This results in follicle
development arresting at the time of antrum formation and incomplete oocyte
maturation (Simon et al., 1997). Follicles of cx43~'' animals have follicle
development arrested even earlier, at the primary pre-antral stage, as it is required for
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gap junction formation between neighbouring GCs (Ackert et al., 2001). The
presence of gap junctions allows vital cross-talk to coordinate development between
the follicular cells and the oocyte (Eppig, 1991; Eppig, 2001; reviewed by Fair,
2003). The oocyte appears to have responsibility for determining the rate at which
the follicle grows: when the quiescent oocyte of a primordial follicle is removed and
replaced with a growing oocyte from a secondary pre-antral follicle (one with two
layers of GCs), the earlier stage follicular cells grow more rapidly than controls until
they match the developmental stage of the growing oocyte (Eppig et al., 2002;
reviewed by Matzuk et al., 2002).
1.3.4 Antral Follicles
The end of the pre-antral development phase is marked by the formation of a fluid
filled antral cavity between the GCs (Figure 1.2). Follicle growth continues in antral
follicles due to the combination of GC proliferation and GC secretion of follicular
fluid to increase the volume of the antral cavity. It is hypothesised that the antrum
may allow a greater number of GCs to be supported, by providing nutrient support
and hormonal stimulation in the absence of a blood supply (Rodgers et al., 2001).
The antrum also provides fluid which allows the efficient expulsion of the oocyte at
ovulation. However, analysis of antral size suggests the volume of follicular fluid is
in excess of that required purely for ovulation (Rodgers et al., 2001). The in vitro
and in vivo formation and maintenance of the antrum has been shown to be follicle
stimulating hormone (FSH) dependent (Halpin et al., 1986; Hartshorne et al., 1994;
Mitchell et al., 2002). Over the period of antrum formation there is a separation of
the GCs into two distinct populations, the mural GCs around the outer edge of the
36
antrum and the cumulus GCs which closely surround the oocyte. Cumulus cells will
be ovulated with the oocyte and aid its expulsion from the follicle and its entry to the
oviduct. The mural GCs have a role in follicular rupture at ovulation and undergo
luteolysis to form much of the corpus luteum (CL), along with theca cells. Despite
the presence of several locally derived factors, whose presence are beneficial to
antral follicle growth and development, there is an absolute requirement for the
pituitary gonadotrophins. Early stage (primary) follicles express the FSHR on the
GCs and although more developed antral follicles have increased expression of these
receptors, there is no change in their localisation (Camp et al., 1991). FSHR'1'
females are infertile with no mature follicles evident in the ovary (Dierich et al.,
1998). Insulin-like growth factor-1 deficient (Igf-1") mice have severely reduced
FSHR levels accompanied by arrested antral follicle development. This
demonstrates that FSHR expression is stimulated by GC Igf-1 and that a suboptimal
level of the FSHR is detrimental to follicular development (Zhou et al., 1997). The
acquisition of gonadotrophin dependence is a key selection stage in determining
which follicles will continue along the developmental pathway and potentially
ovulate. Follicles which do not have adequate levels of FSHR or are not exposed to
high enough levels of FSH will enter atresia and die. There is a positive feedback
role of FSH on the expression of both its own receptor and the aromatase receptor of
GCs, although FSHR is still present in hypogonadal mice with no circulating
gonadotrophins (Zhou et al., 1997; O'Shaughnessy et al., 1994). FHRs are found on
the theca cells of the follicle; later in development, in response to FSH, larger antral
follicles have an increase in theca FHR and expression on the mural GCs (Erickson
et al., 1979; Camp et al., 1991; Segaloff et al., 1990). Paracrine signals from antral
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stage oocytes are able to inhibit the expression of LHRs on both mural and cumulus
GCs in vitro. This suggests it is an oocyte specific secretion in vivo, possibly Gdf-9,
which prevents cumulus cells developing LHRs while the mural cells escape this
short-range inhibitory signal (Eppig et al., 1997; Elvin et al., 1999). FSH and
luteinising hormone (LH) are able to stimulate steroid production by the follicle;
with theca cells mainly synthesising androgens under the influence of LH and FSH
controlling GCs production of oestrogens (see Section 1.4). Antral stage oocytes are
capable of resuming meiosis and when removed from the follicle spontaneously re¬
enter meiosis. Under normal conditions the oocyte is held in meiotic arrest until the
ovulatory LH surge. If an oocyte is to remain in meiotic arrest it requires high cAMP
levels. It is predicted that GC control of oocyte cAMP levels is mediated through the
oocyte Gpr3 receptor; this receptor may mediate Gs protein activation which in turn
stimulates adenylyl cyclase synthesis of cAMP (Mehlmann et al., 2002; Kalinowski
et al., 2004; Mehlmann et al., 2004).
1.3.5 Pre-ovulatory Follicles
During antral development, the follicles are gonadotrophin-dependent and a cohort
containing several follicles will progress through antral development as long as there
is a sufficiently high circulating level of FSH. The steroidogenic ability of the
follicle increases with growth. This means that more developed follicles will
synthesise greater concentrations of both oestradiol and androgens than less mature
follicles. In addition to having local ovarian actions these steroids also pass into the
circulation. When oestradiol levels reach a high concentration it exerts a negative
feedback effect on FSH production in the pituitary, thus as oestradiol levels rise there
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is a concurrent reduction in FSH synthesis and the level reaching the growing
follicles. Increasing levels of inhibins also contribute to the reduction in FSH. This
reduction results in inadequate gonadotrophin support of the less mature and still
gonadotrophin-dependent follicles, which will then become atretic. It is through this
mechanism that a species specific number of follicles become dominant, undergo
pre-ovulatory development and ovulate. One feature of late antral development is
the FSH-induced formation of LHRs on the GCs of the follicle. As the binding of
FSH and LH to their appropriate receptors activates a common intracellular cAMP
pathway, the effects of the gonadotrophins in pre-ovulatory follicles are considered
to be additive. Thus, pre-ovulatory follicles are less dependent on FSH with their
growth and development also being supported by LH.
1.4 STEROIDOGENESIS
Cholesterol is imported from the circulation into the theca cells of the follicle: the
rate of importation and the level of the cholesterol side-chain cleavage enzyme
P450scc present in the theca determine the rate at which cholesterol enters the
steroidogenic pathway. Both of these factors are controlled by cAMP stimulated by
LH, the cAMP-mediated up-regulation of the steroid hydroxylases depends upon
steroidogenic factor 1 (SF-1). Cholesterol is moved to the inner mitochondrial
membrane, a process which requires steroidogenic acute regulatory (StAR) protein,
and then converted to pregnenolone (Kiriakidou et al., 1996; Christenson & Devoto,
2003). The subsequent conversion of pregnenolone to progesterone is followed by
the cytochrome P450cl7a mediated synthesis of androgens, principally
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androstenedione (Smyth et al., 1993). These androgens then cross into the GCs
where the androgen is aromatised to oestrogens, mainly oestradiol, by cytochrome
p450 aromatase (Figure 1.3) (as reviewed by Magoffin, 2005). As GCs lack
P450cl7a they are unable to synthesise androgen to act as a substrate for oestradiol
synthesis. The GCs are therefore dependent on theca-synthesised androgens, thus
any factors which act to regulate thecal androgen production also impact on GC
oestradiol output. Although the theca cells do not contain FSFIR, FSH has been
shown to increase both P450cl7a mRNA expression and LH-responsive androgen
synthesis. This suggests a mechanism whereby FSH causes stimulation of a GC
paracrine signal which acts upon the theca cells. One such paracrine factor is inhibin
A which is produced by GCs but acts to enhance LH-stimulated androgen production
(Smyth et al., 1993; reviewed by Wood & Strauss, 2002). FSH stimulates the
expression of the inhibin a-subunit and the activin/inhibin [3-subunits in cultured
GCs, suggesting that the levels of these subunits increase as a follicle develops
(Turner et al., 1989). This relationship whereby the same stimulant of oestrogen
synthesis by the GCs also causes paracrine signalling to increase androgen synthesis
in the theca ensures that adequate substrate for aromatisation is supplied.
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Figure 1.3:- Steroidogenic pathways. Androgens are synthesised in
the theca cells and then pass into the granulosa cell where they are
aromatised to oestrogens. LH-Luteinising hormone; FSH-Follicle
stimulating hormone
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1.4.1 Activins and Inhibins
Inhibin is a glycoprotein heterodimer made up of an a and a fl-subunit. There are
two forms of inhibin which have a common a-subunit but each has a different p-
subunit. Inhibin A contains (3A while the inhibin B heterodimer consists of a [IB
subunit. Activin is a homodimer of the inhibin P-subunits which can combine to
give the three forms of activin, A, B and AB. There is a complex interplay of both
the activins and inhibins on the steroidogenic processes of the GC and theca cells (as
reviewed by Wood & Strauss, 2002). The activins enhance the activity of aromatase
in the GC causing an increase in oestradiol output (Ying et al., 1986; Hillier & Miro,
1993). Activin also acts to limit the LH-stimulated production of androgens from the
theca and through this restriction of the substrate required for aromatisation will
ultimately limit oestradiol production. High activin levels mean that the influence of
FSH is enhanced, maintaining the follicle in an FSH-responsive state by increasing
FSHRs. Inhibins cause an increase in P450cl7a mRNA and LH-dependent androgen
synthesis in the theca cells. This increase in aromatase substrate will result in an
overall increase in GC oestradiol output, although in vitro inhibins have been shown
to decrease FSH-mediated oestradiol secretion of GCs (Ying et al., 1986).
Overall, smaller follicles produce activins but as they grow, and under the
stimulatory influence of FSH, inhibin production increases. Dominant follicles have
greater levels of the inhibins present, which in turn has a negative feedback effect on
the pituitary to reduce further FSH secretions. This reduction in FSH level causes
the smaller follicles within the ovary to express lower levels of PB subunit, reducing
both their activin and inhibin levels. It is this reduction of FSH which results in
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many subordinate follicles entering atresia as they are not sufficiently developed to
withstand this decrease in gonadotrophin level.
1.5 THE EFFECTS OF OVARIAN STEROIDS
The presence of the steroid receptors within the ovarian follicle and the phenotypes
of mice with homozygous null mutations of these receptors demonstrate the
importance of steroidal hormones in female reproduction (Table 1.1). The
examination of the roles of steroids within the ovary is complicated by the large
number of factors present and by their interdependence. Additionally, any disruption
of a steroid or its receptors has implications for the normal level and function ofboth
steroids and other signalling pathways within the ovarian system. One such example
is the ArKO mouse, where the disruption of aromatase prevents oestrogen synthesis,
but also causes raised androgen levels (Fisher et al., 1998; Britt et al., 2001).
Over the period of follicle growth and development the steroidal milieu alters in
response to gonadotrophins, activins and inhibins. Under normal physiological
conditions the follicular environment can initially be considered to be androgen
dominant, while during later stages of follicle development the ratio of steroids is
altered towards higher oestrogen.
43
Table 1.1:- Mouse models have been created which are lacking the steroid
receptors or a key steroidogenic enzyme, aromatase. The table illustrates the






Main ovarian phenotype Key References
ArKO Aromatase
No oestrogen production; elevated
serum gonadotrophins; infertile
due to disrupted follicle
development; ovarian morphology
deteriorates with age potentially
due to chronic exposure to high
levels of androgen and
gonadotrophins in addition to the
loss of oestrogen; evidence of
Sertoli cell-like structures
Fisher et al., 1998
Britt et al., 2001
ARKO Androgen
receptor
Fertile but have a smaller number
ofpups per litter; longer oestrous
cycle; produce fewer oocytes in
response to superovulation;
defective conformation of the
COCs; increased apoptosis of
granulosa cells;
Yeh et al., 2002
Hu et al., 2004
BERKO Oestrogen
receptor P




• 3 wks - morphologically
similar to wild type ovary
• 5 months - abundant
atretic follicles and few
healthy late antral follicles
or corpora lutea
• 2 years - no healthy
follicles




development at the pre-ovulatory
stage with haemorrhagic cysts;










reversed follicles - no oocyte but
Sertoli like cells present.




1.5.1 The Steroid Receptors
The steroids produced by the ovary have multiple actions; they feedback to the
pituitary to determine gonadotrophin secretion as well as having paracrine and
autocrine functions within the ovary. The androgen receptors expressed on GCs are
developmentally regulated; in both rats and marmosets the expression of androgen
receptors (ARs) is reduced as follicle development progresses, while in humans and
sheep there is an up-regulation of AR expression in the preovulatory follicles (Horie
et al., 1992; Tetsuka et al., 1995; Hillier et al., 1997; Szoltys & Slomczynska, 2000).
Analysis of mouse follicles found the AR was abundant in GCs of pre-antral and
early antral stages but was not present in more developed follicles. However, atretic
follicles maintain high levels of GC AR regardless of developmental stage (Cheng et
al., 2002). In both rat and mouse ovaries AR has also been localised to the oocyte,
with its expression mainly seen in the cytoplasm (Szoltys et al., 2003; Gill et al.,
2004). Recent analysis of ARKCF" female mice demonstrates they have reduced
fertility and produce fewer oocytes in response to superovulation than wild types (Hu
et al., 2004) (Table 1.1). Further analysis of the GCs during preovulatory follicle
development shows there is a higher rate of apoptosis in ovaries lacking AR (Hu et
al., 2004).
Assessing the role of oestrogen in follicle development and atresia is complicated by
the presence of the two oestrogen receptors in the mammalian ovary, ERa and ERp.
Each subtype of the ER has several splice variants and there are species-specific
variations in expression pattern. In rodent follicles ERp is localised to the GCs,
found in all stages of growing follicle, with levels increasing as development
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progresses (Sar & Welsch, 1999; Cheng et al., 2002). ERa is only found in the theca
and interstitial regions of the ovary, with none present in the GCs (Sar & Welsch,
1999; Schomberg et al., 1999). The mRNA for both ER subtypes is expressed in the
mouse oocyte (Hiroi et al., 1999). The differing localisation pattern of each receptor
and the distinct phenotypes of mice lacking ER|3 (BERKO) and ERa (ERKO) mice,
points to each receptor having a specific role within the follicle (Table 1.1).
1.5.2 Steroids and Maintenance of Ovarian Cell Phenotype
Although the reproductive tract of fetal female a(3ERKO_/~ animals differentiate
correctly, postnatal growth and development is severely impaired in the absence of
oestrogen signalling (Couse et al., 1999). The loss of oestrogen signalling results in
elevated serum LH levels which may be the cause of the precocious follicle
development observed in a(3ERK07" ovaries during prepubertal development (Couse
et al., 1999). In spite of the presence of primordial and growing follicles in ovaries
of adult apERKO7 animals there were structures reminiscent of the male
seminiferous tubules present (Couse et al., 1999). Within these regions there is
evidence of degenerating oocytes and differentiation of somatic cells towards the
male Sertoli cell phenotype. Thus, the presence of both ERa and ER(3 are required
for the normal ovarian phenotype to be maintained. Potentially, the actions of
oestrogen are required to ensure that oocyte and GC survival factors are transcribed
(Couse et al., 1999). A second model which demonstrates the importance of
oestrogen for maintenance of the ovarian phenotype is the ArKO7" mouse. These
mice do not synthesise oestrogen although they remain responsive to it. The ovaries
of these mice contain Sertoli-like cells and have raised expression of several genes
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linked with male gonad development, Sox-9, Sf-1 and three enzymes involved in
testosterone production (Britt et al., 2002; Britt et al., 2004). When exogenous
oestrogen was administered to the ArKCT" females, there was a reduction in the
Sertoli cell-like phenotype and a concurrent reduction in the genes associated with
the male phenotype (Britt et al., 2002; Britt et al., 2004).
1.5.3 Steroids and Primordial Follicle Recruitment
There is some data which supports a role for androgen in the recruitment of
primordial follicles to the growing pool, at least in the rhesus monkey. After
exogenous androgen administration, ovaries of treated rhesus monkeys contained a
significantly raised number of primary stage follicles, suggesting an androgen
stimulated increase in primordial follicle activation (Vendola et al., 1999a). The
increased number of small growing follicles did not translate into higher numbers of
late antral or pre-ovulatory follicles (Vendola et al., 1998). The observed up-
regulation of both IGF-1 and IGF-1 receptor (IGF-1R) in primordial follicles, after
androgen treatment, may be the mechanism through which this steroid mediates its
effect on follicle recruitment (Vendola et al., 1999a, b). A stimulatory role for
androgens in follicular recruitment is supported by analysis ofpolycystic ovarian
syndrome (PCOS) in humans. Women with PCOS have a significantly correlated
increase in both androgen levels and the number of growing follicles. This is
consistent with the hypothesis that androgens stimulate follicle growth (Hughesdon
et al., 1982; Jonard et al., 2003; Webber et al., 2003). However, the complexities of
this syndrome mean that the role of androgen in follicular recruitment can not be
conclusively determined using this model. In addition to the possibility that
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recruitment of primordial follicles is accelerated, the fact that PCOS ovaries could
contain more follicles to start with or that the rate of follicle development is impaired
are also credible.
Oestrogen may also have a role in the recruitment ofprimordial follicles, although its
function in this process may not be consistent throughout the postnatal life of a
female. The rate of recruitment of in vitro and in vivo assembled primordial follicles
differs, suggesting the presence of a factor in vivo which limits the initial entry of
follicles into the growing pool (Kezele & Skinner, 2003). Analysis of newborn rat
ovaries in the presence of exogenous oestradiol allowed the effects of this steroid on
primordial follicle formation and recruitment to be assessed. While the presence of
oestradiol did not appear to influence the formation of primordial follicles it did
inhibit the transition of primordial to primary follicles both in vitro and in vivo.
However, this effect was not replicated in ovaries from older rats suggesting that
oestrogens only control initial postnatal primordial follicle recruitment and that
another mechanism is responsible for subsequent primordial to primary transition
(Kezele & Skinner, 2003).
1.5.4 Steroids and Granulosa Cell Differentiation
Oestrogen is proposed as being involved in several mechanisms which determine
follicle growth and development. Much of oestrogen's influence on the follicle
occurs through its ability to augment FSH. The role of oestrogen within the ovary is
complicated by the presence of two forms of the receptor, ERa and ER(3, which
mediate differing responses to oestrogen. Female mice with homozygous null
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mutations for either of these ERs have differing ovarian phenotypes (Table 1.1),
demonstrating the differing effects of oestrogen depending on which receptor type is
prevalent.
BERKO7" females have a reduced response to superovulation suggesting these mice
are less able to respond to gonadotrophins (Couse et al., 2005). This is an interesting
observation, when it is considered that a key aspect in the differentiation of the GCs
is the appearance of LHRs, as these receptors are vital if the follicle is to respond to
the ovulatory LH surge. The GCs of BERKO7" follicles have significantly reduced
levels ofLHR mRNA (Couse et al., 2005). In addition to containing abnormal levels
of LHR, these GCs also have aberrant aromatase expression. Taken together these
results demonstrate that signalling through ER(3 is vital for normal differentiation of
the GCs in the pre-ovulatory follicle (Couse et al., 2005).
1.5.5 Steroids and Inter-Cell Signalling
Oestrogen also has a regulatory role in the formation and maintenance of inter-cell
signalling between GCs. As previously described (section 1.3.3), the gap junctions
are important for co-ordinated development of the oocyte and GCs (reviewed by
Gilchrist et al., 2004). They are vital in allowing the transport of signals and
nutrients to the avascular regions of the follicular compartment (Eppig, 1991;
reviewed by Eppig, 2001). This role becomes increasingly important with follicular
growth, as the distance between GCs and the interstitial blood vessels increases.
Expression of cx43, the main structural protein in gap junctions, is postulated to be
regulated by oestrogen (Merk 1972; Wiesen & Midgley, 1994). Regulation of cx43
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mRNA levels in response to oestrogen stimulation has been demonstrated in several
different tissue types and species. Oestrogen has been shown to upregulate cx43
expression in rat endometrium; the female rat preoptic area and human myometrium
(Grummer et al., 1994; Gulinello & Etgen, 2005; Di et al., 2001). Although, these
previous studies demonstrate the ability of oestrogen to upregulate cx43 in several
tissue types there is no definitive study supporting this response within the ovarian
follicle (Granot & Dekel, 2002). In addition, 17P-oestradiol upregulates levels of N-
cadherin mRNA in rodent GCs (MacCalman et al., 1995; Farookhi et al., 1997).
The presence of the N-cadherin adhesion molecule prevents apoptosis of GCs by
promoting cell-to-cell signalling (Makrigiannakis et al., 1999). Thus,
communication between the cells of the follicle is impaired in the absence of
oestrogen. The anti-apoptotic effect of oestrogen on GCs was also confirmed in the
hypophysectomised rat, with the withdrawal of oestrogen resulting in an increase in
apoptosis (Billig et al., 1993; Markstrom et al., 2002).
Although oestrogen is involved in aspects of differentiation and follicular
development there is evidence accumulating to suggest that the presence of oestrogen
is not an absolute requirement, with follicle development and growth able to proceed
with low or absent oestrogen (Coney et al., 1987; Zelinksi-Wooten et al., 1994;
Spears et al., 1998; Guo et al., 2004). Evidence from knockout mice also supports
the fact that follicle development can occur in the absence of normal oestrogen
signalling. In the ERKO mouse follicle development only arrests at the pre¬
ovulatory stage demonstrating that the early stage of development can proceed in the
absence of oestrogen acting via ERa (Lubahn et al., 1993). The ovarian phenotype
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of the BERKO mouse becomes more severe with age, the fact that at 3 weeks of age
the ovaries are morphologically similar to those of wildtype mice suggests that
follicle development can be supported in the absence of ERp mediated oestrogen
signalling (Krege et al., 1998). The a|3ERKO mouse lacks both ERa and ERp
resulting in sex-reversed follicles and a complete lack of oocytes (Couse et al., 1999;
Dupont et al., 2000). Although this demonstrates a role for oestrogen signalling in
the formation or maintenance of primordial follicles the lack of normal follicular
morphology does not allow any determination of the role of oestrogen on later stages
of follicle growth and development. It should also be taken into consideration that
these knockout mouse models have raised levels of LEI as well as altered androgen
and oestrogen levels (Lubalin et al., 1993; Krege et al., 1998). Thus, the phenotypes
cannot purely be considered to be a result of lost oestrogen receptor signalling.
Oestrogen is also able to act through non-classical pathways that do not involve
either the a or p forms of its receptor (Moore & Evans, 1999).
1.5.6 Effects of Androgens on Follicular Growth and Atresia
In contrast to the previously described stimulatory effect on follicle recruitment,
androgens have been implicated as having a role in atresia and cell death in rodents.
Analysis of rat ovaries, demonstrates an apparent increase in apoptosis after
administration of testosterone (Billig et al., 1993). Subsequent studies on rhesus
monkey and human ovaries, and mouse follicles in vitro, do not support an apoptotic
effect of androgen (Murray et al., 1998; Vendola et al., 1998; Weil et al., 1998 &
1999; Otala et al., 2004). The conflicting results could represent a species-specific
role of androgen within the ovary. However, the rat studies described above all
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utilised the hypophysectomised rat as a model. Thus, the loss of gonadotrophins may
explain why these studies gave conflicting results as to the effect of androgen
administration. High levels of apoptotic GCs within a follicle are a sign that follicle
health is poor and is the first observable sign of a follicle entering atresia. However,
the presence of apoptotic cells should not automatically lead to a follicle being
categorised as unhealthy. It should be remembered that apoptosis of GCs around the
antral cavity is implicated in the formation of the antrum in healthy follicles (Baker
et al., 2001).
Although follicle development can occur in the absence of androgen, there are
reports of it having a stimulatory effect on mouse follicle development in vitro
(Spears et al., 1998; Murray et al., 1998) (See Table 1.2). Follicles cultured in the
presence of non-aromatisable androgens have improved rates of growth and antral
development. This observation can be attributed to a direct effect of the androgens,
as their non-aromatisable nature prevents conversion to oestrogens. In the rhesus
monkey, androgens also seem to promote follicular growth through the AR (Vendola
etal., 1998; Weil et al., 1998 & 1999) (See Table 1.2).
Administration of androgen to an in vivo primate model (rhesus monkey) does not
result in any increase in apoptosis; there is actually a reduction in the numbers of
apoptotic GCs (Vendola et al., 1998) (See Table 1.2). The administration of
androgens only continued for 10 days, thus, it is possible that in the long-term
androgens would result in increased rates of apoptosis. However, it would be
difficult to distinguish any direct effect of androgen on increased apoptosis. The fact
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that androgen recruits more follicles into the growing pool yet does not increase
ovulation rate, means that there will be a higher number of follicles undergoing
atresia. Culture of human ovarian cortical slices, in the presence of androgens, also
adds weight to an anti-apoptotic effect of androgen. Non-aromatisable androgen,
dihydrotestosterone (DHT), significantly reduces the level of apoptotic DNA in the
ovary (Otala et al., 2004). Thus, this effect is not mediated through conversion of
androgen to oestradiol, and is a true effect of androgen rather than oestrogenic
activity. In human ovaries, staining for Ki67, a marker of cell proliferation, shows
that follicles of PCOS ovaries, although abnormal in appearance, are actively
proliferating rather than undergoing atresia as originally assumed (Takayama et al.,
1996). The use of ovaries from BERKO7" mice may help to clarify the role of
androgen in the rodent ovary. The early stages of follicle development in these mice
appear normal, although there is an increase in the recruitment of primordial follicles
into the growing pool (Cheng et al., 2002). However, later antral stage development
is severely impaired with high numbers of follicles entering atresia. Interestingly,
these BERKO7' ovaries have abnormal localisation of the AR. Normally the level of
AR in late antral follicles declines, but this was not found to be the case for the
follicles of the BERKO7" mice (Cheng et al., 2002). The addition of an anti-
androgen rescued the late antral follicles from atresia, suggesting that the apoptotic
effects of androgen may be stage specific, having a stimulatory effect on pre- and
early-antral follicles but inducing atresia by the late antral phase of development
(Cheng et al., 2002). Thus, there is a growing body of evidence to support the
concept that androgens stimulate follicular development in several species as
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1.6 OOCYTE ACQUISITION OF DEVELOPMENTAL COMPETENCE
Developmental competence consists of a range of processes occurring in both the
nuclear and cytoplasmic compartments of the oocyte. When complete these result in
an oocyte which is meiotically competent (able to resume meiosis) and is capable of
supporting the key post-fertilisation events including the cortical reaction; pronucleus
formation; early cleavage steps; activation of the embryonic genome and progression
through the pre-implantation stages of development to form a blastocyst.
The processes by which an oocyte acquires developmental competence occur during
oocyte growth and during the final post-LH surge nuclear and cytoplasmic
maturation stages. Although many studies investigating developmental competence
only consider pre-implantation embryonic development, the condition of the oocyte
can influence later development, potentially extending into adult life. The role of
oocyte viability does, however, become harder to determine with increased
development. The full range of molecular events involved in the acquisition of
oocyte competence is as yet unknown.
In the mouse the activation of the zygotic genome occurs at the 2-cell stage, so prior
to this the oocyte is itself required to support early embryonic development.
Extensive studies have demonstrated that stepwise acquisition of competence occurs
with oocyte growth and follicle development, particularly from the late antral stage
onwards, and is influenced by the bi-directional communication between the oocyte
and the somatic cells of the follicle (Eppig, 2001; Matzuk et al., 2002; Murray &
Spears, 2005). Developmental competence is achieved when the required
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modifications have been made to both the nucleus and the cytoplasm of the oocyte in
an integrated fashion (Moor et al., 1998).
The organisation of the chromatin is vital for correct gene expression and
developmental competence. Chromatin conformation partly determines whether the
oocyte is capable of undergoing nuclear maturation. When Debey et al. (1993)
analysed oocytes from antral follicles, the chromatin structure fell into two groups,
those with a surrounded nucleolus (SN) and those with a non-surrounded nucleolus
(NSN) (Figure 1.4). Stained chromatin of SN oocytes was compacted around the
nucleolus, while NSN oocytes had a more diffuse staining pattern (Mattson &
Albertini, 1990; Debey et al., 1993; Zuccotti et al., 1995). The chromatin pattern
was found to predict whether the oocytes could develop past the 2-cell embryo stage
after fertilisation: SN oocytes were able to develop further, while development of the
NSN oocytes was blocked at the 2-cell stage (Zuccotti et al., 1998). There is a
significantly raised level of gene expression in SN compared to NSN oocytes which
correlates to the increased developmental competence observed in SN oocytes
(Christians et al., 1999). This chromatin remodelling coincides with the laying down
of genomic imprints on the oocyte genome, also a vital step in the acquisition of
developmental competence.
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Figure 1.4:- Hoescht stained images of a non-surrounded nucleolus (NSN)
GV oocyte and a surrounded nucleolus (SN) GV oocyte. These oocytes have
different transcriptional activity and developmental competence. Images
taken from Bouniol-Baly et al., 1999.
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1.6.1 Nuclear Maturation
Nuclear maturation is defined as the resumption and completion of meiosis by the
oocyte in response to the LH surge (reviewed by Mehlmann, 2005). This final
maturation of the oocyte occurs over a relatively short time span in contrast to the
more protracted earlier stages of oocyte development. It is characterised by germinal
vesicle breakdown, condensation of the oocyte chromosomes and progression
through the final stages of meiosis I before arrest at metaphase of meiosis II (Eppig
et al., 1994) (See also Section 1.6.1.1). Being competent to complete nuclear
maturation does not mean that an oocyte is developmentally competent. This is
because developmental competence requires a series of nuclear and cytoplasmic
processes to occur jointly. Although maturation of the nuclear and cytoplasmic
compartments can proceed independently of one another integration of these
processes is required if full developmental potential is to be achieved (Eppig et al.,
1994; Moor et al., 1998).
Resumption of meiosis can occur in the absence of gonadotrophin stimulation, as
oocytes removed from the antral follicular environment undergo spontaneous
germinal vesicle breakdown (GVBD) and other processes associated with nuclear
maturation, including chromatin condensation and resumption of meiosis (Pincus &
Enzmann, 1935). Although these spontaneously matured oocytes appear
morphologically normal, in some species the subsequent developmental competence
is reduced. This demonstrates that, although these oocytes have undergone nuclear
maturation, not all the processes required for the acquisition of developmental
competence have occurred (Thibault, 1977; Niwa et al., 1976; Leibfried & Bavister,
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1983). However, examination of spontaneously matured mouse oocytes found that
these oocytes had obtained full developmental competence (Schroeder & Eppig,
1984). The reduced developmental competence of spontaneously matured oocytes
observed in early experiments could be due to inadequacies in the culture media,
with successful maturation of isolated cumulus-oocyte complexes (COCs) now
possible.
The observation that oocytes could spontaneously mature led to the hypothesis that
there is a factor which inhibits nuclear maturation present in the follicle or
alternatively that there is activation of a maturation promoting factor (MPF) (Tsafriri
& Charming, 1975; Mitra & Shultz, 1996). cAMP is part of a signalling pathway
involving PDE3A which has been shown to be a vital component in the maintenance
of meiotic arrest (Shitsukawa et al., 2001; reviewed by Mehlmann, 2005). The
hypothesis that an active factor was involved in nuclear maturation led to the
isolation of a meiosis activating sterol from follicular fluid (FF-MAS). This is able
to overcome the negative effects of cAMP, stimulate resumption of meiosis and is
positively regulated by gonadotrophins (Byskov et al., 1997; Xie et al., 2004).
1.6.1.1 Meiosis in the Oocyte
An oocyte within the growing follicle is held in meiotic arrest until exposed to the
FH surge during pre-ovulatory follicle development. This hormonal stimulation
triggers a series of events which cause the oocyte to re-enter meiosis and undergo
classical oocyte maturation. The end result of these processes is production of an
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oocyte arrested in metaphase of the second meiotic division which is ready for
fertilisation.
One of the earliest events leading to the resumption of meiosis is the entry of cyclin
B to the germinal vesicle. Immediately after this there is GVBD and MPF is
activated as the oocyte enters metaphase I. The kinetics of MPF activity will act to
determine the duration of the first meiotic division. At the onset of meiosis I there is
activation of the microtubule organising centres (MTOCs), these sites represent
regions where there is distinct polymerisation of the microtubules (Figure 1.5).
There is preferential activation of those MTOCs that are located close to the
chromosomes and the microtubules around these regions are stabilised. These
microtubules then undergo organisation into a bipolar spindle array around the
oocyte chromosomes (Figure 1.5).
Once the formation of the bipolar spindle is complete the chromosomes align at the
spindle equator and form the metaphase plate (Figure 1.5). At this stage in meiosis
the kinetochores of the bivalent chromosomes are not able to interact with or anchor
the microtubules. This situation persists for the majority of the first meiotic
metaphase. In the absence of this interaction an alternative mechanism is required to
align the chromosomes on the spindle equator. It appears that this requirement is
fulfilled by "polar wind" whereby the force exerted by the spindle microtubules
against the arms of the chromosomes causes them to move and form the metaphase
plate (Brunet & Vemos, 2001). This polar wind is mediated by microtubule motors
such as Kif4 and Kif22, associated with the chromatin (Vernos el al., 1995;
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Bringmann et al., 2004). Although the chromosomes are located at the spindle
equator their accurate alignment only occurs after the kinetochores become activated
and trigger the formation of K-fibres (Brunet et al., 1999). The transition of
metaphase to anaphase does not occur until the spindle microtubules are attached to
the kinetochores and the chromosomes are properly aligned to form the metaphase
plate. Premature transition into anaphase is prevented by the spindle assembly
checkpoint and only occurs when the spindle has migrated from its initial location at
the centre of the oocyte to the periphery. This peripheral localisation of the spindle
is vital for the asymmetric division that is necessary to maintain the maternal
cytoplasmic stores in the oocyte rather than them being lost in the polar body.
Separation of the chromosomes represents the exit of the oocyte from the first
meiotic metaphase into anaphase. Once the first meiotic spindle has reached the
periphery of the oocyte and there is degradation of cyclin B there is extrusion of the
first polar body (Brunet & Maro, 2005).
Immediately after the first polar body has been extruded there is formation of the
second meiotic spindle and the oocyte enters the second meiotic arrest maintained by
the action of Cytostatic Factor (CSF) (Brunet & Maro, 2005). The meiotic spindle
remains at the periphery of the oocyte and is maintained as a stable structure in this
location during the meiotic arrest. Oocytes will remain arrested in meiosis II for
several hours with the chromosomes perfectly aligned on the metaphase plate and
high MPF activity. It is not until fertilisation (or artificial activation) that the spindle
will rotate and the extrusion of the second polar body will occur as the second
meiotic division progresses (Brunet & Maro, 2005).
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Figure 1.5:- Diagram representing formation of the meiosis I spindle in the
oocyte. Activation of microtubule organising centres (MTOCs) causes
polymerisation of the surrounding microtubules. There is preferential
activation of those MTOCs that are located close to the chromosomes.
Microtubules are organised into a bipolar spindle array around the oocyte
chromosomes which then align at the spindle equator and form the metaphase
plate. Accurate alignment only occurs after the kinetochores become
activated and trigger the formation of K-fibres. Blue lines represent
chromosomes; MTOCs are dark green; light blue discs represent
kinetochores; light green represents polymerised microtubules around the
chromosomes. Image is taken from Brunet & Maro, 2005.
65
1.6.2 Cytoplasmic Maturation
In addition to the nuclear maturation occurring after LH stimulation as described
above (Section 1.6.1), the oocyte cytoplasmic compartment must have been modified
during follicle development for full developmental competence to be acquired
(Albertini, 2003). Within this thesis, the term "cytoplasmic maturation" is defined as
encompassing all the incremental changes in the cytoplasmic compartment that lead
to the step wise acquisition of competence occurring over the period of oocyte
growth. The aspects of cytoplasmic maturation that are initiated in response to the
LH surge are defined as final LH-induced cytoplasmic maturational processes.
These changes precede and then overlap with the process of nuclear maturation. The
processes of cytoplasmic maturation are very important in determining oocyte
quality (Albertini, 2003). This is demonstrated by the fact that transfer of a nucleus
from a developmentally incompetent oocyte to the cytoplasm of a competent oocyte
results in complete developmental potential being acquired (Obata et al., 1998).
One important aspect of cytoplasmic maturation is the ability to ensure that only a
single sperm enters the oocyte. Polyspermy is prevented by the release of cortical
granules which act to alter the ZP structure such that further sperm binding is
impaired (Miller et al., 1993; reviewed by Albertini, 2003). The ability to release
these cortical granules is obtained during cytoplasmic maturation with immature
oocytes demonstrating higher levels ofpolyspermy than mature oocytes (Ducibella et
al., 1990; Abbott et al., 1999). Production of the cortical granules within the mouse
oocyte has finished by the time the period of oocyte growth is complete (Ducibella et
al., 1988; Albertini, 2003). However, although present in the oocyte the cortical
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granules are not yet competent to fuse with the membrane and trigger the cortical
reaction in response to sperm entry. This final functional ability is only acquired
during final LH-induced cytoplasmic maturation and actually depends upon the
initiation of calcium waves triggered by fertilisation (Albertini, 2003).
One of the later aspects of competence acquired by the oocyte is the ability to
generate calcium (Ca2+) waves after fertilisation. The mechanisms required to
initiate and maintain these Ca2+ waves are constructed by the time the end of the
oocyte growth phase is reached. However, final LH-induced cytoplasmic maturation
• 7+ • •
is required before Ca oscillations can be successfully activated (Cheung et al.,
2000). In order that the oocyte can respond to sperm penetration with an appropriate
release of intracellular Ca2+ and become activated it must be able to respond to
inositol 1,4,5-trisphosphate (IP3) (Xu et al., 2003). Oocytes become capable of
responding to exogenous IP3 as metaphase II is reached during nuclear maturation
(Mehlmann & Kline, 1994).
Cytoplasmic maturation is also required if the male pronucleus is to form correctly,
with protein synthesis during development being vital to this oocyte mediated
process (Albertini, 2003. In several species, for example hamster, the conversion of
the sperm nucleus to a male pronucleus requires glutathione, levels of which
normally rise during the final LH-induced cytoplasmic maturation. If synthesis of
this factor is impaired the normal decondensation of the sperm nucleus fails to occur
(Perreault et al., 1988; Sutovsky & Schatten, 1997). The oocyte is also responsible
for the sperm histone remodelling, the histone exchange activity necessary for this is
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acquired over the period of oocyte growth and correlates to the time when meiotic
competence is acquired (McClay et al., 2002).
1.6.3 Oocyte Maturation
Within this thesis, the term "oocyte maturation" describes all the processes that
together result in the incremental increases in developmental potential that occur
over the period of oocyte growth that corresponds to the time of pre-antral and antral
follicle development prior to the LH surge. This terminology encompasses the
acquisition of meiotic competence as well as the cellular alterations to nuclear and
cytoplasmic components that occur largely over the later growth phase of the oocyte.
Thus, "oocyte maturation" is not used to cover only the specific process of nuclear
maturation that occurs in response to the LH surge.
1.7 EFFECTS OF STEROIDS ON THE OOCYTE
When the steroidogenic pathways of the follicle are disrupted, by preventing the
conversion of cholesterol to pregnenolone, the maturation of the ovine oocyte is
affected leading to severely reduced fertilisation rates (Moor et al., 1980). In this
study by Moor et al. (1980) steroidogenesis was inhibited in cultured follicles at one
of two stages: conversion of cholesterol to pregnenolone or by blocking the action of
the 17a-hydroxylase enzyme system. Follicles were cultured for 24 hours with
inhibition of steroidogenesis occurring for either the entire 0-24 hour culture period
or 16-24hours of the culture time. The oocytes were subsequently fertilised in vivo
before being recovered and assessed for pronuclear formation and development. In
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those oocytes which had not undergone successful fertilisation the stage of meiosis
(MI or Mil) and whether any sperm penetration or polyspermy had occurred was
recorded (Moor et al., 1980). Using this ovine culture system it was found that
higher fertilisation rates can be achieved by the administration of exogenous steroids,
even in the absence of cholesterol cleavage (Moor et al., 1980). Although it is
accepted that appropriate androgen and oestrogen exposure is required for normal
oocyte maturation and developmental competence, the precise mechanisms involved
are not well understood. More detailed analysis of the individual effects of each of
these steroids has proved difficult due to the complex feedback pathways present
within the follicle. It appears that the ratio of androgens to oestrogens as well as the
absolute concentrations are important to the acquisition of developmental
competence (Moor et al., 1980; Andersen, 1993; Zelinski-Wooten et al., 1993; Xia &
Younglai, 2000).
The spontaneous maturation of mammalian oocytes removed from the follicular
environment has made investigation of the factors that influence maturation more
complex. Xenopus oocytes do not undergo this spontaneous maturation process, thus
more is known about the role of steroids on oocyte maturation in this species. When
the maturation process ofXenopus and mammalian oocytes are compared there are
some significant similarities. Both maintain meiotic arrest though high intracellular
cAMP levels and comparable signalling mechanisms control the resumption of
meiosis. In Xenopus, androgens have been identified as the main determinant of
oocyte maturation (Lutz et al., 2001). As several aspects of oocyte maturation are
conserved between Xenopus and mammals, it is plausible that androgens may also
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play a key role in mammalian oocytes (White et al., 2005). However, the effect of
androgens on the mammalian oocyte remains undetermined.
There are conflicting data available regarding the effects of androgen exposure on
the mammalian oocyte. Androgen was largely believed to be detrimental to the
acquisition of developmental competence (Anderiesz & Trounson, 1995). However,
more recent studies have questioned this, and in some cases proposed a beneficial
effect of androgen exposure (Murray et al., 1998, 2005; Silva & Knight, 2000). In
support of this, it has been observed that when physiological concentrations of
androgen are added to bovine in vitro maturation media the cleavage rate of embryos
improves (Silva & Knight, 2000). This observed improvement in embryo
development was not maintained throughout pre-implantation development, with
normal rates of blastocyst formation occurring (Silva & Knight, 2000). There is now
an accumulation of studies, across several species, which refute the previously
described negative effects of androgen on the oocyte (bovine - Silva & Knight, 2000;
murine - Murray et al., 1998, 2005; porcine - Grupen et al., 2003). Potentially,
some of these differing results are due to the wide range of androgen concentrations
used. Studies which demonstrate reduced developmental competence after exposure
to extremely high levels of androgen may be the result of a toxic effect at these
concentrations. The timing of androgen exposure may also impact on the results,
early in follicular development the follicular environment is dominated by androgens
while over later stages of development oestrogen is more prevalent. Steroidal
exposure which more closely mimics this normal physiological pattern of hormonal
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concentrations may be expected to have a less detrimental effect on developmental
competence in vitro.
When mouse oocytes are isolated from the follicle, they undergo spontaneous GVBD
in response to the reduction in cAMP. However, it is possible to prevent this aspect
of oocyte maturation by artificially maintaining cAMP levels. Using this model,
exposure to androgens has been shown to illicit a stimulatory effect on oocyte
maturation, resulting in GVBD and mitogen activated protein kinases (MAPK)
signalling (Gill et al, 2004). This result parallels observations in Xenopus oocytes,
where androgen is thought to be the primary steroid capable of determining
maturation (Lutz et al., 2001). Although, this study adds weight to the argument that
androgens have a positive effect on the oocyte, it may still be the case that
inappropriate exposure to this steroid could cause adversely precocious maturation.
In contrast, the presence of oestradiol appears to inhibit the process of nuclear
maturation in several species, including pig, mouse and bovine oocytes (Li et al.,
2004; Beker et al., 2002; Beker-van Woudenberg et al., 2004). Utilisation of the
ArKO"/_ mouse demonstrates that the acquisition of developmental competence does
not depend upon the presence of oestrogen (Huynh et al., 2004). Thus, when these
studies are considered in conjunction, it appears that although oestrogen is not
required for oocyte competence, the presence of oestrogen at an inappropriate stage
of development or in excess may impair oocyte maturation.
Steroidal exposure has an impact on cytoplasmic maturation processes, as
demonstrated by analysis of human oocytes' Ca2+ release (Tesarik & Mendoza,
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1995). Oocytes exposed to oestrogen initially exhibit an overall increase in
cytoplasmic Ca2+ levels followed by detection of Ca2+ oscillations (Tesarik &
Mendoza 1995). Subsequent exposure to androstenedione is able to influence the
oestrogen induced Ca2+ changes. Addition of this androgen inhibits the fluctuations
in Ca2+ level observed after oestrogen treatment alone, this effect persists even after
removal of the androgen and re-exposure to oestrogens (Tesarik & Mendoza, 1997).
Oestrogen exposure appears to confer a developmental advantage to the oocyte, yet
the potentially beneficial changes to Ca2+ release are negated by androgens. This
result could be construed as demonstrating a negative influence of androgens on
oocyte maturation and subsequent embryo development. However, it may be that it
not just the presence of steroids which can be of significance but also the order of
that exposure. Additionally, the effects of steroids on cytoplasmic maturation do not
appear to be conserved between species, with oestrogen having no effect on the
ability of porcine oocytes to undergo cytoplasmic maturation (Dode & Graves,
2003).
1.8 FOLLICULAR ATRESIA
1.8.1 Morphology and Mechanism
Only a very small number of the follicles present in the ovary after birth will ever
fully develop and ovulate a mature oocyte, with as many as 99.9% of all follicles
dying through the process of atresia. The process of atresia in follicles at different
developmental stages and of each cell type appears to vary. In growing follicles that
become atretic, it is the GCs which appear to be the first cell type affected. The
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actions of endogenous endonucleases cause DNA fragmentation prior to any
morphological changes. Subsequently GCs become pyknotic, with darkly stained
nuclei, as the chromatin condenses. These shrunken pyknotic GCs are removed from
the follicle by neighbouring GCs, potentially through phagocytosis. This clearance
of apoptotic cells is slow as the follicle is an avascular structure, until the basement
membrane breaks down during atresia. All the biochemical and morphological
changes seen in GCs are consistent with programmed cell death by apoptosis. As
follicular degradation progresses, the oocyte, which has lost contact with the
surrounding GCs, begins to lose its shape; the ZP is invaded by cells and eventually
the oocyte becomes segmented (Devine et ah, 2000). Primordial follicles also
undergo atresia but there are significant differences when compared to the
observations made in atresia of growing follicles. In contrast to atretic growing
follicles, the GCs of primordial follicles appear normal in their morphology. It is the
oocytes of these follicles which show the first evidence of apoptosis, with
cytoplasmic vacuolisation and organelles becoming unidentifiable (Devine et al.,
2000; apoptosis in the ovary is reviewed by Amsterdam et al., 2003). As follicles
increase in size there is an increase in the percentage that become atretic.
1.8.2 Control of Atresia
Whether a follicle will become atretic or continue to grow and develop depends upon
both the hormones it is exposed to and the presence of the appropriate receptors
allowing it to respond. The primary determinants as to whether follicles enter atresia
are the gonadotrophins. Antral follicles depend upon FSH if they are to escape
atresia and acquire dominance. Follicles which have reached the pre-ovulatory stage
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of growth will enter atresia if they do not receive the ovulatory LH surge. The
effects of gonadotrophins as survival factors are mediated through activins, inhibins
and the Igf-system (Yang & Rajamahendran, 2000). Hormonal stimulation rescues
the vast majority of follicles which might otherwise become atretic, suggesting that
very few follicles are lost due to inherent abnormalities in either the oocyte or the
follicle as a whole. In addition to the gonadotrophins there are growth factors
thought to be involved in preventing the onset of apoptosis within follicles, with both
EGF and FGF being shown to be capable of preventing DNA fragmentation in
cultured rat GCs (Tilly et al., 1992; reviewed by Markstrom et al., 2002).
1.9 OVULATION
Ovulation can be considered in terms of an inflammatory response followed by tissue
remodelling and repair stimulated by LH. In response to the LH surge the oocyte
undergoes significant changes as the germinal vesicle breaks down, the
chromosomes condense and there is a resumption of meiosis (reviewed by
Mehlmann, 2005). Completion of the first meiotic division is marked by the
expulsion of the first polar body containing half the chromosomes. The oocyte
enters the second meiotic division and is arrested at the metaphase stage due to a
cytostatic factor involving mos kinase (c-mos), until fertilization occurs; with oocytes
from c-mos'' mice undergoing parthenogenetic activation (Hashimoto et al., 1994).
As the oocyte undergoes these meiotic divisions there is coordinated cytoplasmic
maturation which includes the loss of the cytoplasmic processes which allowed
communication between the oocyte and GCs.
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In addition to influencing the oocyte, the LH surge also acts on the follicle as a
whole. It causes an increase in follicular fluid volume, a weakening of the matrix
between GCs and an increase in blood flow to the follicle. The GCs alter their
steroidogenic pathways due to the interaction of LH with its GC receptors, such that
progesterone is synthesised rather than oestrogens. As follicle development
progresses, there is an increase in follicular fluid resulting in a thinning of the mural
GC layers. At ovulation the follicle wall ruptures, releasing the follicular fluid and
the COC which is then swept into the oviduct by the fimbria. The disruption of the
follicular wall is partly due to the actions of proteolytic enzymes including
collagenase, plasminogen activator and gelatinase. The residual portion of the
follicle within the ovary collapses to form the corpus haemorragucum, with time the
blood clot is broken down and the CL forms.
1.9.1 Mechanism of LH Stimulation of the Ovulatory Response
Prior to the resumption of meiosis, the number of gap junctions between the cumulus
cells and the oocyte is reduced. LH stimulates MAPK expression in the follicular
somatic cells which acts to alter the phosphorylation of cx43, a vital component in
gap junction maintenance (Sela-Abramovich el al., 2005). The loss of
communication via gap junctions means the oocyte can no longer maintain the high
cAMP levels required for the maintenance of meiotic arrest and oocyte maturation is
initiated. The oocyte is capable of expressing the active form of MAPK after LH
stimulation but this response is only observed after several hours, when oocyte
maturation is already underway. Thus, this up-regulation of MAPK in the oocyte
does not cause the loss of gap junctions (Sela-Abramovich et al., 2005).
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LH is able to have direct effects on the follicle via its receptors but it is also able to
mediate its effects through stimulation of paracrine factors. One such pathway
involves up-regulation of members of the epidermal growth factor related (EGF-like)
proteins, including amphiregulin, epiregulin and beta-cellulin in response to LH
stimulation (Park et al., 2004). Amphiregulin and epiregulin are able to cause
meiotic maturation of the oocyte to an extent comparable to LH exposure, but the
response is more rapid suggesting that the normal delay in maturation represents the
switching on of the EGF-like gene expression (Park et al., 2004). LH stimulates
metalloprotease action within the follicular cells which release the membrane-bound
EGF-like proteins allowing them to act as paracrine mediators of LH in the ovulatory
process (Ashkenazi et al., 2005). LH and all three of the EGF-like factors
investigated are able to stimulate expression of several genes vital to the ovulatory
response namely hyaluron synthase-2 (Has2), cyclooxygenase-2 (cox-2) and
TNFalpha-stimulated gene-6 (Tsg-6) (Park et al., 2004; Ashkenazi et al., 2005).
Normal ovulation depends upon the cumulus cell synthesis of a mucoid extracellular
matrix largely consisting of the glycosaminoglycan hyaluronan produced by Has2
(Eppig, 1979). The cumulus cell matrix also contains the hyaluronan binding protein
Tsg-6 which is a target for prostaglandins (PGs). Cox-2 is the rate limiting enzyme
responsible for synthesis in the ovary, with cox-2 deficient females having impaired
cumulus expansion and reduced ovulation rate (Lim et al., 1997; reviewed by Eppig,
2001).
76
1.10 FERTILISATION AND PRE-IMPLANTATION DEVELOPMENT
Fertilisation occurs in the ampulla region of the oviduct when the oocyte is fertilised
by a single sperm, followed by formation ofpro-nuclei and the initiation of embryo
development (Figure 1.6). The oocyte and cumulus cells secrete a factor which aids
fertilisation due to a chemotaxic effect on sperm (Oliveira et al., 1999; Sliwa, 2001).
Although follicular fluid ofboth humans and mice has been shown to have a
chemotaxic effect on sperm it is unlikely that the secretion of this factor would be
restricted to the pre-ovulatory COC as only a small volume of follicular fluid enters
the fallopian tube at ovulation and the fluid would not set up a reliable concentration
gradient to influence the sperm. This suggests that any chemotactic factor would
continue to be produced by the COC after ovulation (Giojalis & Rovasio, 1998;
Oliveira et al., 1999).
When a sperm binds to an oocyte, there is localised proteolytic degradation of the
ZP. This enables the sperm to reach the surface membrane of the oocyte where the
head of the sperm will be enveloped by microvilli. The subsequent fusion between
sperm and oocyte membranes results in the male nucleus moving into the oocyte
cytoplasm. This initiates a Ca2+ wave from the point of sperm entry due to an
increase in intracellular Ca2+ (Saunders et al., 2002; Knott et al., 2003). These Ca2+
oscillations associated with oocyte activation are regulated by the sperm-specific
factor, phospholipase C-zeta (PLC-zeta) (Saunders et al., 2002; Kouchi et al., 2004;
Nomikos et al., 2005). Once these stages have been successfully completed, the
oocyte containing the sperm nucleus is termed a zygote. It is vital that the oocyte
prevents the entry of more than one sperm, thus the zona reaction occurs to stop
polyspermy. This multi-step process prevents further sperm binding to the ZP,
inhibits proteolytic breakdown of the ZP and alters the oocyte cytoplasm so no
further sperm can enter. At fertilisation, the oocyte re-enters meiosis as a result of
MPF breakdown by a Ca2+ stimulated enzyme. Completion of the second meiotic
division is marked by the Ca2+ and protein kinase-C-mediated formation of the
second polar body. The maternal and paternal chromosomes maintain their separate
identities as they become surrounded by membranes to form two pronuclei (Figure
1.6). These move to a more central position and synthesise DNA in anticipation of
the initiation of mitosis.
Once the pronuclear membranes break down and the chromosomes take up their
positions on the mitotic spindle the zygote has achieved syngamy, the mixing of
chromosomes from the two gametes. The cell undergoes mitotic division resulting in
the formation of a 2-cell embryo (Figure 1.6). Embryos become transcriptionally
active at a species specific stage of development; in mice this ability to synthesise its
own mRNA rather than translating maternal mRNA stores starts at the 2-cell stage.
Even after transcriptional activation proteins previously translated from the maternal
mRNA will persist through the early stages of development resulting in a prolonged
maternal effect on the embryo. The embryo continues to divide and will undergo
compaction to form a morula at the 8 to 16 cell stage depending on the species,
followed by development of the blastocoel cavity to form a blastocyst (Figure 1.6).
Blastocysts consist of two populations of cell, the outer layer of trophectoderm and









Figure 1.6:- Pre-implantation embryo development:- After fertilisation
the zygote forms the male and female pronuclei. When these combine
syngamy has been achieved and the embryo undergoes mitotic
cleavage. Embryo development to the hatching blastocyst stage can be
supported in vitro.
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The trophectoderm does not contribute to the fetus but gives rise to the trophoblast
cells which are vital for implantation and placentation (reviewed by Johnson &
McConnell, 2005; Armant, 2005). The fetus and much of the extra-embryonic tissue
arise from the ICM (reviewed by Armant, 2005). The embryo remains surrounded
by the ZP until the hatching of the blastocyst, the ZP acting to hold the blastomeres
together prior to compaction. This prevents twinning and the mixing of blastomeres
from different embryos which would result in the formation of a chimaera. The
embryo enters the uterus between the morula and blastocyst stages: it is not until the
blastocyst has hatched from the ZP that it is able to interact with the lining of the
uterus allowing implantation and placenta formation to occur. Providing a fetus is
healthy it will continue to grow and develop throughout gestation, which in the
mouse lasts for around 19-21 days.
1.11 DNA METHYLATION IN THE MAMMALIAN GENOME
1.11.1 Regions of the Genome Containing DNA Methylation
It is perhaps surprising that the vast majority of studies that have investigated the
DNA methylation patterns and dynamics of the germ cells have concentrated on the
small number of imprinted genes and the phenomenon of genomic imprinting
(Marchal et al., 2004). These investigations have utilised and developed a range of
techniques for assessing the location, pattern and quantity of DNA methylation
present in the genome (Table 1.3). Although important for normal development and
gene transcription the DNA methylation present at the imprinted gene loci only
accounts for a small proportion (<1%) of the methylated cytosine residues that are
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found in the mammalian genome. The largest proportion of DNA methylation is
found in the CpG rich repeat sequences of the mouse genome (Lees-Murdock et al.,
2003; Rollins et al, 2006). This imbalance in the studies carried out means that less
is known about the DNA methylation that is found in these non-imprinted genome
regions and the effects that result from changes to global methylation levels at these
repeat loci in different developmental contexts.
There are different types of repetitive sequences present in the genome, these include
the minor and major satellite sequences; short interspersed nuclear elements (SINEs);
long interspersed nuclear elements (LINEs), Intracistemal A-particles (IAPs) and
endogenous retroviruses (Lees-Murdock et al., 2003; Marchal et al., 2004). Minor &
Major Satellite Sequences are located in the juxtacentromeric regions of
chromosomes and consist of repeat sequences of a few base pairs (20- to 200-bp
repeats) (Lees-Murdock et al., 2003; Marchal et al., 2004). Although these satellite
sequences are not transcribed they are thought to play a role in both centromere
function and kinetochore assembly (Lees-Murdock et al., 2003). The remaining
repeat sequence classes are found to be interspersed across the genome at various
loci. SINEs, LINEs and IAPs are all derived from transposable elements (Marchal et
al., 2004). These transposable elements and the endogenous retroviruses are able to
undergo reverse transcription and insert into new locations in the genome (Lees-
Murdock et al., 2003). Further analysis of the localisation pattern of these repeat
sequences demonstrates that SINEs are largely found in R-bands, LINEs are located
in G-bands while LAPs are found to be widely dispersed across the full length of the
chromosomes (Marchal et al., 2004).
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Table 1.3:- Table summarising the common techniques used to assess DNA methylation
Chemical Methods




















sequences are then used on
the gels as a probe in
hybridisation experiments.





Allow methylation profiling of genomic DNA
Disadvantages
Technically demanding
Very low sensitivity such that large levels of
radioactivity are required if high enough signals
are to be obtained.




















Similar to the above
technique but PCR is used
to amplify very small




genomic primer; ligation of
an adaptor and elongation;
PCR and visualisation. A
methylated cytosine site is
not cleaved so there will be
no PCR fragment present.
Advantages
Allow methylation profiling of genomic DNA
Disadvantages
Technically demanding















Treatment of DNA with
sodium bisulfite results in
conversion of cytosine
residues to uracil. The 5-
methylcytosine is converted
to uracil with much less
efficiency than
unmethylated cytosines.
Subsequent PCR results in
conversion of the
unmethylated cytosine
residues to thymine while 5-
methylcytosine remains as
cytosine.
Generally methods utilising the bisulfite
chemistry provide the advantage that virtually
any CpG present in the genome can be
detected.
The key problem with techniques using the
bisulfite method is that it is particularly prone






Table 1.3 continued:- Table summarising the common techniques used to assess DNA















Analysis of the nucleotide
sequence of the above PCR
products allows the
methylation status of the
cytosines in the original
genomic DNA to be
established
Advantages
Clear identification as to whether the original
cytosine was methylated or not
Robust, sensitive and reproducible
Careful optimisation can be used to eliminate
many of the technical problems
Simple to interpret results
Disadvantages
After modification the DNA strands are no
longer complementary - thus the PCR
conditions may vary depending on the template
strand
A heterogeneous methylation status in the
region of interest can influence the efficiency
with which different fragments are amplified in
PCR
Long regions of DNA can undergo sufficient















Requires two primer sets -
one for the methylated
sequence and one for the
unmethylated sequence.





Sensitive so allows assessment of cytosine
methylation if amount of tissue is limited.
Disadvantages
Specificity is restricted to the primer-binding
sequences

















incorporated into the target
position when bisulfite
treated DNA is used as the
template.
Advantages
Good for quantitative analysis
Avoids use of restriction enzymes
Allows analysis of small amounts of DNA
Simultaneous assessment of multiple CpG sites
possible
Disadvantages
Specific primers may be difficult to design if
the region of interest is in a CpG-rich area.
















converted to a TTGA
sequence in the PCR
product of bisulfite treated
DNA and cannot be




Allows assessment of DNA methylation levels
at specific loci even from small amounts of
DNA
Not as prone to false positives as some other
techniques
Disadvantages
Restricted to assessing methylation at specific
restriction sites.
The methylation status of the restriction site
may not represent that of the entire region of
interest.








Table 1.3 continued:- Table summarising the common techniques used to assess DNA
Enzymatic Methods
Method Application Overview Pros & Cons Reference
Advantages












are used to assess the
methyiation status of the
recognition site. If the site
is methylated then it is
resistant to cleavage. The
resulting fragments can be
detected by either southern
hybridisation or PCR.
Disadvantages
Assumes that the methyiation status of the
restriction site is representative of the entire
CpG island or genomic region which does not
necessarily hold true.
Incomplete digestion of the DNA will result in
an overestimate of the DNA methyiation level.
Can be a particular problem when high
molecular weight DNA is digested (this can be
compounded when the particularly sensitive
technique of PCR is used for analysis).
The fact that non-methylated alleles are
represented by the lack of signal after PCR (i.e.
negative display of results).
In some cases fragments can be too small to




















endonucleases that can only
cleave their rare recognition
sites if they are
unmethylated. These
fragments are then labelled
with a radioisotope and





Simplicity of the technique
Allows genome wide searches for differentially




























Genomic DNA is denatured
and then incubated with
anti-5-methylcytosine
antibody. The intensity of
staining, as determined by
fluorescein-conjugated
secondary, is proportional
to the degree of
methyiation. The strongest









Suitable for assessment of global methyiation
Allows chromosomal DNA methyiation
patterns to be mapped
Disadvantages
No detail on methyiation status of individual
CpGs
Prolonged exposure to HC1 to denature the
DNA can result in purinisation of the CpG








Investigations into genomic imprinting have uncovered the important role of DNA
methylation in transcriptional repression. This function is paralleled in the non-
imprinted repeat sequences where DNA methylation has a role in maintaining the
retroviruses and other elements in an inactive state, termed the genome defence
model (Bestor, 1999; Bird, 2002; Lees-Murdock et al., 2003). This role of DNA
methylation is demonstrated by the analysis of endogenous retroviruses. These
sequences are flanked by long terminal repeats (LTRs) which contain the enhancer
and promoter elements for the retroviruses. When the DNA methylation on the
LTRs is reduced there is an increase in the transcription of the retroviruses
demonstrating that methylation of these regions acts to repress transcription (Lees-
Murdock et al., 2003). As well as transcriptional repression the presence of DNA
methylation is also correlated with genomic stability. The consequence of loss of
DNA methylation at classical satellite 2 and 3 sequences in humans with ICF is
aberrant chromosome formation (Lees-Murdock et al., 2003). An alternative theory
as to the importance of DNA methylation of the repeat sequences in the genome has
been proposed. This suggests that the transcription of such large amounts of DNA
that do not code for functional gene products would create a large amount of
"transcriptional noise" in the cells such that it could interfere with vital gene
expression and the normal processes of the cell (Bird, 2002).
1.11.2 What is Genomic Imprinting?
Genomic imprinting is the parent-of-origin, allele-specific, gene expression and is
determined by epigenetic modification of genes, such that gene transcription is
altered while the actual gene sequence remains unchanged. Genomic imprinting
results in only one inherited copy of the relevant imprinted gene being expressed in
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an embryo. For paternally imprinted genes, the paternal allele is epigenetically
modified to prevent transcription, ensuring that the embryo has only mono-allelic
expression from the maternally inherited copy. The opposite is true of maternally
imprinted genes, when only the copy inherited from the father is expressed. The fact
that expression is limited to one allele means that the level of mRNA transcribed and
the subsequent amount of translated protein are lower than those from genes with
biallelic expression, hr this way genomic imprinting acts as a dosage control
mechanism (Allegrucci et al., 2005). The fact that particular genes are differentially
expressed, according to their parent-of-origin, means that during development the
parental genomes are functionally non-equivalent (Surani 1998). Genomic
imprinting is vital for normal gene expression patterns in an individual, with errors
sometimes resulting in inappropriate gene transcription or repression. Within the
mouse genome, approximately 80 imprinted genes have so far been identified
(Beechey et al., 2005). It is likely that there will be a similar number of imprinted
genes in humans, although fewer have been found to date. Except where stated, this
review refers to work on the mouse, as this species has been by far the most
extensively studied species.
Within the mammalian genome, the majority of cytosine residues found as CpG
dinucleotides (i.e. those cytosines positioned next to a guanine residue) have a
methyl group added to their carbon 5-position (Costello & Plass 2001) (Figure 1.7).
This equates to ~3 x 107 methylated cytosine residues in total (Bestor, 2000). It is
this addition of the methyl group, referred to as DNA methylation, which is the best
studied mechanism involved in imprinting. However, it is not the sole epigenetic
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mechanism with a role in controlling imprinted gene expression. Chromatin
configuration, modifications to histone proteins (phosphorylation, acetylation and
methylation) and the presence on DNA of regulatory protein complexes are also all
mechanisms involved in transcriptional control of imprinted genes (Meehan, 2003;
Allegrucci et al., 2005). In addition, there is emerging evidence that regulation of
imprinted gene expression in mouse placental is dependent on histone modifications
independently of DNA methylation. Several paternally repressed genes lack parent-
specific DNA methylation, and genetic ablation of methylation does not lead to loss
of their imprinting in the trophoblast. Instead the silent paternal alleles are marked in
the trophoblast by the repressive histone modifications (dimethylation at Lys9 of
histone H3 and trimethylation at Lys27 of histone H3), which may be dependent on
the Eed-Ezh2 Polycomb complexes (Lewis et al, 2004). Studies on embryonic stem
cells and early embryos suggest that this chromatin based repression is established
early in development, but in the embryo, this imprinting is stably maintained only at
genes that also have promoter DNA methylation (Umlauf et al, 2004). It is
important to point out, however, that the majority of methylated DNA in the genome
is not concerned with genomic imprinting. Heavy methylation of DNA is correlated
to a more condensed structure which is resistant to transcription. It remains unclear
as to whether the alterations to DNA methylation, chromatin configuration or histone
modifications are the initial epigenetic signal causing gene repression. It may be the
case that there is a system whereby several of these epigenetic modifications act co¬
operatively to initiate, maintain and reinforce the control of gene transcription
(Nakao, 2001; Geiman & Robertson, 2002; Fuks, 2005). Thus, if an animal inherits
a methylated copy of a gene from its mother and a non-methylated copy from its
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father, the maternal copy will have its transcription repressed leaving the paternal
copy as the only active gene. DNA methylation is an epigenetic modification which
can be inherited in a stable manner. When DNA replicates the two resultant daughter
strands of DNA are each hemimethylated. Stable inheritance is ensured by the action
of a maintenance DNA methyltransferase which preferentially methylates
hemimethylated DNA to produce properly symmetrical methylation of the DNA
strands (Riggs & Xiong, 2004). Dnmtl preferentially binds to hemimethylated DNA
in vitro and, unlike Dnmt3a and Dnmt3b, is localised to the replication foci of
dividing cells making it a strong candidate for fulfilling this role in vivo (Bestor
2000; Margot et al., 2001). The epigenetic mark of DNA methylation is also
reversible allowing gender specific patterns to be initiated in germ cells.
1.11.3 Why Did Genomic Imprinting Evolve?
The most commonly proposed theory explaining the development of genomic
imprinting is the Genetic Conflict or parental investment theory (Moore & Haig
1991). This theory arose from the observation that many imprinted genes are
implicated in the growth and development of the mammalian fetus or placenta. In
addition to this, imprinted genes have been shown to exhibit directionality in their
actions, that is the majority of the paternally expressed genes, such as Igf2 and Peg3,
promote fetal growth and nutrient uptake while in contrast the maternally expressed
genes, such as Igf2r and Gnas, tend to curb fetal growth (Reik & Dean 2001; Tycko
& Morison, 2002). Females who could restrict fetal growth and produce more
offspring from their limited resources would, in the long term, be more successful.
In contrast, males would derive long-term benefit from their progeny being larger
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and stronger even if they achieved this to the detriment of the mother by utilising
more maternal nutrients.
An alternative theory to account for the presence of imprinted genes within the
genome is the Evolvability Model (Beaudet & Jiang 2002). This predicts that
species which have genomic imprinting are more able to evolve in response to
environmental pressures, as they can induce rapid changes by altering which of the
two alleles is silenced and which is expressed. An individual organism can carry an
allele which promotes growth that while imprinted has no phenotypic effects. Thus,
if increased growth becomes advantageous, the relevant allele is already present in
the gene pool: by rapid reversal of the imprinting, the allele can be expressed. There
is also the "ovarian time bomb" concept which proposes that genomic imprinting
evolved to protect the female from ovarian disease: Varmuza & Mann (1994)
hypothesised that imprinting could limit the level of growth and development of any














Figure 1.7:- DNA methylation involves the addition of a methyl group (CH3)
to the cytosine residue in CpG dinucleotides resulting in the formation of 5-
methylcytosine. This methylation of cytosine is a reversible process and 5-
methylcytosine is susceptible to deamination resulting in its mutation to
thymine, unless repaired this can lead to single base mutations. A - Adenine;
C - Cytosine; G - Guanine; T - Thymine.
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1.12 HOW ARE DNA METHYLATION PATTERNS REGULATED?
DNA methyltransferases (Dnmts) carry out methylation of DNA; these can be
broadly divided into Dnmtl, Dnmt2 and Dnmt3 families. The three families of
Dnmts are related, albeit distantly, and are believed to have diverged from their
common ancestors prior to the separation of the animal and plant kingdoms (Howell
et al. 2001). Members of both the Dnmtl and Dnmt3 families have been identified
as having active transmethylase activity and their functions have been partially
elucidated, with the Dnmt3 family being primarily concerned with laying down new
methylation patterns while the Dnmtl family appears mainly involved in
maintenance of these patterns during cell division. Initial studies on Dnmt2 did not
find any active methylation function for this protein but more recent research has
challenged this concept, with work by several groups finding that this enzyme can
act as a methyltransferase which targets a very specific DNA sequence, explaining
the low level of identifiable activity (Liu et al. 2003; Hermann et al. 2003; Tang et
al. 2003). Although capable of binding to methylated DNA the definitive binding
specificity of Dnmt2 has yet to be determined (Hermann et al., 2003). Golding &
Westhusin (2003) have shown that DNMT2 is actually the most prevalent DNMT in
the bovine adult ovary and testis. The situation is different in Drosophila, with the
Dnmt2 ortholog, dDnmt2, being the only Dnmt which methylates the Drosophila
genome (Hung et al., 1999, Tweedie et al., 1999). More recently a role of dDnmt2
in determining the lifespan ofDrosophila has been proposed. Over-expression of the
protein allows flies to live longer, and a threshold level of dDnmt2 expression
appears to be vital for normal lifespan (Lin et al., 2005). Although no such
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investigation has been carried out in mammals, this work in Drosophila introduces a
possible new and intriguing role for the Dnmt2 gene in other species.
1.12.1 Laying Down of Methylation Patterns
To allow reprogramming of the germ cell, the genome must undergo demethylation
(as described later) (Hajkova et al., 2002). Once the initial imprints have been
removed the appropriate new pattern must be established, thus ensuring that the
paternal- and maternal-specific imprints are laid down in the sperm and oocyte
respectively. The enzymes which are capable of laying down the new methyl groups
onto previously unmethylated DNA are from the Dnmt3 family. Members of this
family which have active transmethylase activity are Dnmt3a and Dnmt3b, which
share a high degree of sequence homology but have been shown to have different
expression patterns and timing through development (La Salle et al., 2004; Lucifero
et al., 2004). The third member of this family, Dnmt31, shares sequence homology
with the other enzymes but is missing the catalytic domain needed to add methyl
groups onto DNA (Aapola et al., 2001). After both examining the localisation of this
protein and using mice with a disrupted Dnmt3l gene, a role in the establishment of
maternal imprints in the oocyte has been hypothesised for this enzyme, as discussed
below (Bourc'his et al. 2001; Hata et al. 2002)
1.12.2 Maintenance of Methylation
When a methyl group is added onto already hemi-methylated DNA during cell
replication (necessary if the daughter cells are to maintain the methylation pattern of
the cell undergoing mitosis), the process is termed maintenance methylation (Riggs
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& Xiong, 2004. Dnmtl has the primary responsibility for maintaining the
methylation status ofDNA (Bestor, 2000; Margot et al., 2001; reviewed by
Robertson, 2002). The most common form of this methyltransferase is that found in
all somatic cells, Dnmtl s, and has been shown to be vital for development (Li et al.,
1992; Biniszkiewicz et al., 2002). In addition there are two splice variants identified
which are specific to the germ cells and early embryo (Mertineit et al., 1998).
Dnmtlp is found in pachytene spermatocytes whilst Dnmtlo is only identifiable in
the oocyte and pre-implantation embryo (Mertineit et al., 1998). It is not until
embryonic day 7 (E7) that the embryo is capable of producing full length Dnmtls
protein (Mertineit et al., 1998).
Interestingly, although Dnmtl has been identified as the main maintenance
methylase in vivo, studies in vitro have shown that this enzyme has a higher de novo
methylase activity than either Dnmt3a or Dnmt3b (Yoder et al., 1997). In vivo
Dnmtl de novo methylase activity has yet to be found, but the possible implications
of this in vitro activity should be borne in mind (Howell et al. 2001). There are
interactions between the Dnmt enzymes which enable them to carry out the functions
of maintenance and de novo methylation (Fatemi et al., 2002). Thus, it is difficult to
classify a particular Dnmt as an exclusive maintenance or de novo methylase.
Cooperation between Dnmt3a and Dnmtl in the de novo methylation of DNA has
been demonstrated (Fatemi et al., 2002). Using an in vitro model the level of de
novo methylation activity was considerably higher when both Dnmt3a and Dnmtl
were present in combination rather than individually (Fatemi et al., 2002). Further
assessment demonstrated that a physical interaction between these two Dnmts was
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not an absolute requirement (Fatemi et al., 2002). Taking these results into account
it is proposed that Dnmt3a acts to add de novo methylation in a distributive fashion.
This hemimethylation then attracts Dnmtl which is able to methylate the unmodified
strand at this site. In addition this pre-existing methylation seems to stimulate the
ability ofDnmtl for de novo methylation (Fatemi et al., 2002; Liang et al. 2002).
This then results in the entire DNA domain undergoing methylation in a processive
manner (Fatemi et al., 2002; Kim et al., 2002).
1.12.3 How Does Methylation Lead to Repressed Gene Transcription?
There are several main mechanisms by which the methylation of DNA can prevent
the transcription of genes (as reviewed by Attwood et al., 2002). The first of these is
by the methyl group causing direct interference preventing particular transcription
factors from binding to methylated DNA (Iguchi-Ariga and Schaffner 1989; Lande-
Diner & Cedar, 2005). The second mechanism results from methyl binding domain
proteins (Mbds) binding to methylated DNA (Wade, 2001; Lande-Diner & Cedar,
2005; Figure 1.8). Of the Mbds identified to date, Mbds 1-3 and MeCP2 are
involved in transcriptional repression (Nan et al. 1997; Fujita et al. 1999; Ng et al.
1999; Wade, 2001), while Mbd4 is thought to have a role as a mismatch repair
protein (Hendrich et al. 1999; Hendrich & Tweedie, 2003). Mbdl and MeCP2 both
contain transcriptional repression domains which act via histone deacetylases
(HDACs) (Hendrich & Tweedie, 2003). HDACs cause local deacetylation of the
histone tails which in turn results in remodelling of the chromatin into a more
condensed structure that is resistant to transcription (Taunton et al. 1996; Wade
2001). Mbdl mediates transcriptional repression through recruitment of a histone
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methylase capable of binding HDACs (Ng et al. 2000; Wade, 2001; Fujita et al.
2003), while MeCP2 acts to bind a co-repressor complex containing an HDAC
(Jones et al. 1998; Nan et al. 1998), although MeCP2 has also been shown to cause
transcription repression in the absence of HDAC activity perhaps through histone
methylation (Nan et al. 1998; Yu et al. 2000; Wade, 2001; Fuks et al., 2003). Mbd2
and Mbd3 are both components of a large protein complex, MeCPl (Feng & Zhang
2001). MeCPl binds methylated DNA in a non-sequence-specific manner. The
binding of MeCPl to methylated DNA is due to the presence of Mbd2 in the
complex (Ng et al. 1999). Interestingly, the mammalian form of Mbd3 appears not
to bind directly to methylated DNA (Hendrich & Bird 1998; Fraga et al., 2003). The
MeCPl complex binds methylated DNA less tightly than MeCP2, which suggests
that long-term transcriptional repression may be maintained by the permanent
binding of MeCP2, with more transient transcriptional silencing determined by the
binding of the MeCPl complex (Ng et al. 1999). Although not involved in gene
repression the importance of Mbd4 becomes clear when a characteristic of
methylated CpG dinucleotides is considered. Where DNA is methylated, the 5-
methylcytosine residue is prone to mutation through deamination to thymine
(Hendrich & Tweedie, 2003; Figure 1.7). This means it is particularly important to
have a repair mechanism capable of targeting this mutation (Bird, 1980; Hendrich &
Tweedie, 2003). Mbd4 preferentially binds to methylated regions of the genome and
has been shown to remove this mismatched thymine residue (Hendrich et al., 1999;
Hendrich & Tweedie, 2003). In addition, mice with mutated Mbd4 alleles have a







Figure 1.8:- Mechanisms which mediate DNA methylation dependent repression of
gene transcription. A - methyl group acts as a physical barrier to prevent
transcription factors binding to gene promoter. B - Methyl binding domain protein
binds to methyl groups on DNA and then recruits co-repressor complexes containing
histone deacetylases. C - Components of the MeCPl activity include Mbd2 and the
NuRD complex containing Mbd3. Mbd2 binds to methyl groups on the DNA
promoter to recruit the MeCPl complex and repress transcription (TF - transcription
factor; CH3 - methyl group; HDAC - histone deacetylase; Mbd - methyl binding
domain protein; NuRD -Nucleosome remodelling & histone deacetylation complex)
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Human genetic studies suggest that 20% ofbase substitutions causing disease result
from the conversion of methylcytosine to thymine (Krawczak et al., 1998). These
point mutations are also implicated in the development of some cancers, while
Mbd4~'~ mice have increased rates of tumorigenesis (Millar et al., 2002). In addition
to the Mbd family, there is a further binding protein termed Kaiso which is capable
of methylation dependent repression of gene transcription. Although it is not an Mbd
containing protein, it is capable ofbinding to methylated DNA via its zinc finger
(Prokhortchouk et al. 2001). Kaiso has been shown to be a vital component of
amphibian development, blocking translation of this protein is lethal (Ruzov et al.
2004) but the extent of its role in mammalian systems has yet to be established.
Methylation-dependent transcriptional repression is covered by many good reviews
such as Wade (2001) and Li (2002).
Transgenic studies show that mice lacking Mbdl (Mbdl'") have no observable
phenotype, although problems within the nervous system are evident at the molecular
level (Zhao et al. 2003). Mice homozygous for a disrupted Mbd2 gene (Mbdl1')
mice are also viable, although they exhibit impaired maternal behaviour (Hendrich et
al. 2001). Mbd3 null mutations (Mbd3''~) are embryo lethal (Hendrich et al. 2001).
The abnormal phenotype ofMeCP2'1' mice develops from several weeks of age and
is lethal by 8 weeks of age, with all known abnormalities having their origin in the
nervous system (Guy et al. 2001). The fact that Mbdl'1', Mbd2~'~ and MeCP2''' mice
have no apparent phenotype outside of the nervous system suggests there is a degree
of redundancy within the Mbd mediated system of transcription control. Although a
mouse containing both disrupted Mbd2 and MeCP2 genes has demonstrated that both
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these proteins function in separate pathways, this does not rule out co-operation
between other members of the Mbd family (Guy et al. 2001).
1.13 DNA METHYLATION IN GERM CELLS AND EMBRYOS
1.13.1 Primordial Germ Cells
The epigenetic dynamics of the PGCs and gametes are reviewed by Allegrucci et al.
(2005). When PGCs are first seen in the mouse embryo at E7 they, and the
surrounding somatic cells, carry the maternally and paternally inherited imprinting
patterns. This DNA methylation pattern is maintained in PGCs as they migrate to the
developing gonad. Co-incident with their arrival in the gonadal ridge, the mouse
PGCs begin to undergo global demethylation from around El 1.5 to remove their
inherited imprinting pattern (Hajkova et al., 2002). During this period, DNA
methylation of the somatic cells is maintained (Figure 1.9). Demethylation of
imprinted gene loci in germ cells is clearly vital if the correct sex-specific epigenetic
information is to be subsequently laid down during oocyte and sperm maturation.
Demethylation is complete by El3-14, correlating to the period when the male and
female mouse PGCs begin to enter mitotic and meiotic arrest respectively. However,
there are some repetitive sequences present in the PGCs which do not become
entirely demethylated (Hajkova et al., 2002). It has been suggested that
mitotic/meiotic arrest might necessarily follow demethylation because replication of
umnethylated DNA has an increased risk of unrepressed retro-transposons moving
and causing mutations (Walsh et al. 1998). The time at which this demethylation
occurs, and also the amount of methylation lost, appears to be identical regardless of
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the gender of the embryo (Hajkova et al. 2002). Whether the loss of methylation
occurs by a passive or active mechanism or a combination ofboth is not yet known,
although the speed with which this occurs would suggest involvement of an active
mechanism.
As previously described the PGCs of mammals undergo demethylation during E12.5-
13.5 as they migrate to the primitive gonad. Although the imprinted genes lose their
methylation patterns to allow for the subsequent gender specific patterns of DNA
methylation to be laid down in the germ cells the repetitive sequences retain a
significant amount of their DNA methylation in PGCs (Marchal et al., 2004). A
detailed study of the methylation levels of several classes of repeat sequences have
allowed a more thorough understanding of the methylation dynamics of these regions
in the PGCs. At El 2.5 the IAPs of the female PGCs do not show any substantial
demethylation however by El 5.5 lower methylation levels were detected at these
regions (Lees-Murdock et al., 2003). When LI elements were assessed they had
lower methylation levels at E12.5 than the IAP and the same pattern of methylation
loss by El5.5 was observed. The minor satellite sequences had the lowest
methylation levels of any of the repeat sequences that were analysed at E12.5 (Lees-
Murdock et al., 2003). Again the same dynamic of DNA methylation loss by El 5.5
was observed and in all the repeat sequences examined the lowered levels of DNA
methylation were maintained at El7.5.
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1.13.2 Oocyte Development
In female embryos the gonad forms as an ovary with germ cells forming primordial
follicles. As long as the primordial follicle and the oocyte contained within it are not
activated to enter the growing population, the methylation level of the oocyte
genome remains low and unchanged. It is during the growth phase of the oocyte that
the maternal imprints are laid down on the genome (Figure 1.9). The imprints are
not all established at the same time: instead, each imprinted gene has a specific time
at which it will become methylated (Obata & Kono, 2002; Lucifero et al., 2004).
Obata & Kono (2002) analysed parthenogenetic embryos created by nuclear transfer
of oocyte nuclei from different stages of follicle development, with the aim of
establishing the timing of the maternal imprinting within the oocytes, and showed
that Snrpn, Znfl27 and Ndn genes are imprinted early in follicle development during
the primordial to primary follicle stages whilst imprinting ofPeg3, Igf2r and p57KIP2
happens at the secondary follicle stage. There are also genes which become
imprinted at even later stages of follicle development, including Pegl/Mest during
tertiary to early antral stages and Impact which only becomes imprinted in the oocyte
within an antral follicle (Obata & Kono 2002). A further study by Lucifero et al.
(2004) investigated the methylation of imprinted genes by dissecting follicles from
ovaries of different postnatal ages and examining the oocytes. This confirmed the
earlier Obata & Kono study in that Peg3, Igf2r and Snrpn began to gain methylation
earlier in development that Pegl. By the early antral stages some differentially
methylated regions (DMRs) were fully methylated in all genes other than Pegl,
while it was not until oocytes were fully mature that Pegl appeared to undergo rapid
de novo methylation. Thus, the imprinting pattern of the oocyte is not fully laid
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down until it is within a mature follicle ready to ovulate. This has clear implications
for ARTs, where follicle and oocyte maturation is usually artificially stimulated; any
such process must support the correct completion of oocyte imprinting.
Over the period of oocyte growth, the general level of DNA methylation increases as
both the appropriate maternal pattern of imprinting is laid down and non-imprinted
sequences also become methylated. The Dnmt involved has yet to be identified,
although it has been suggested that one or more members of the Dnmt3 family could
be responsible. Dnmt3a, 3b and 31 are all expressed during postnatal oocyte growth.
Dnmt3l is expressed at a higher level than either Dnmt3a or Dnmt3b although all
three genes have maximal expression levels occurring at approximately the same
stage of oocyte development (Lucifero et al. 2004). Dnmtls protein is not found in
either growing oocytes or in pre-implantation embryos. Instead, an alternatively
spliced more stable transcript, Dnmtlo, is expressed at these stages. In the growing
oocyte, Dnmtlo is found in both the cytoplasm and the germinal vesicle, but once the
oocyte is fully matured, it is localised to the cytoplasm where it is stored until it is
required during later embryo development (Carlson et al. 1992; Mertineit et al.
1998). Since Dnmtlo translation only occurs early in oocyte development, the
stability of this form of Dnmtl is clearly important.
The methylation dynamics of the imprinted gene loci during oocyte development are
gradually being elucidated. However, the same is not true of the non-imprinted
sequences over the same time period. However work has shown that IAPs and Lis
are heavily methylated in the mature oocyte (Lees-Murdock et al., 2003). The IAPs
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examined had methylation at 66% of the cytosine residues, the transposable element,
Etn had 78% of the investigated cytosines that were methylated (Kim et al., 2004).
This was contrasted by the centromeric satellite sequences of mature oocytes which
had a relatively low level of DNA methylation (21%) compared to the somatic cells
(Kim et al., 2004). Dnmt31 does not have the active transmethylase activity which is
a characteristic of the other Dnmt3 family proteins, Dnmt3a and 3b. However, Hata
et al. (2002) found that Dnmt3l expression was vital ifnormal maternal imprints
were to be laid down in the oocyte and that this function may be mediated through its
ability to bind and co-localise with both Dnmt3a and 3b. Mice with a disrupted
Dnmt3l gene are sterile. Males produce no mature sperm (see below); females
undergo apparently normal oocyte growth and the resulting oocytes can be fertilised,
but the absence of maternal Dnmt3l is embryo lethal to heterozygote offspring by
E9.5 (Bourc'his et al. 2001). Interestingly, a conditional knockout with disrupted
Dnmt3a in the germ cells has an almost identical phenotype to the Dnmt3lmouse
(Kaneda et al. 2004): when females whose oocytes lacked Dnmt3a were crossed with
wildtype males all offspring died by El 1.5, with embryos lacking methylation on the
normally methylated maternally imprinted genes (resulting in inappropriate gene
expression). This study demonstrates the essential role of Dnmt3a in the
establishment of maternal imprints. Kaneda et al. (2004) also investigated the role of
Dnmt3b using a conditional knockout: these animals were found to be phenotypically
normal and were able to produce viable offspring.
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Figure 1.9:- Epigenetic reprogramming of the germ cells. The maternal (pink
shaded region) and paternal (blue shaded region) imprints are lad down during
germ cell development, such that by the time the oocyte and spem are fully mature
the correct pattern ofDNA methylation is present on the genome(female imprints-
pink ovals; male imprints- blue ovals). After fertilisation, (yellow shaded area)
both parental genomes undergo global demethylation ofnonimprinted sequences:
imprinted genes are protected from this process. During early enbryo development
the imprinted genes of both the somatic and primordial germ cell (PGC) retain the
parental imprints. From Embryonic Day (E) 11.5 the PGCs begin toundergo
demethylation to erase the inherited parental imprints, but thesomatic cells of the
embryo maintain the parental imprints through embryo developmentand into
adulthood. The process of PGC demethylation is complete by E13Subsequent
reprogramming of the germ cells occurs when the genderspecific imprinting
patterns are once more laid down. Hajkovaet ah, 2002; Kerjean et ah, 2000;
Oswald et ah, 2000; Ueda et ah, 2000; Santos et ah, 2002; Lucifero et ah, 2004;
reviewed by Allegrucci et ah, 2005.
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1.13.3 Sperm Development
As with the oocyte, new imprints are laid down as sperm develop (Figure 1.9), with
the increase in DNA methylation levels not just attributed to the establishment of
paternal imprints but also the methylation of other non-imprinted sequences, such as
intracisternal A particles (IAPs), becoming methylated (Walsh et al. 1998). The
paternally expressed (i.e. maternally imprinted) human MEST/PEG1 gene is
demethylated during fetal life and then remains unmethylated through all stages of
sperm development in adult life (Keijean et al., 2000). Ueda et al. (2000) analysed
the methylation level of an imprinted gene, H19, in male germ cells and found that
the H19 imprint is laid down early in germ cell development before meiosis occurs.
The same result was found in humans, with the HI9 gene becoming methylated
before meiosis at the spermatogonial stage of development (Kerjean et al. 2000). In
general, though, there is less information about the laying down of imprinting
patterns during sperm development compared to what is known about imprinting in
oocytes.
The resumption of mitotic division of male germ cells at puberty coincides with an
increase in the level ofDnmtl within the spermatocytes. During the early stages of
meiosis the level of Dnmtls in spermatocytes is high but a reduction in the level of
the Dnmtl enzyme has been observed in pachytene stage spermatocytes (Jue et al.
1995). This is due to the expression of an alternatively spliced version, Dnmtlp,
which does not appear to be translated. Although Dnmtls within the sperm is
normally found in both the nucleus and the cytoplasm, it is concentrated at nuclear
foci during some stages of meiosis and it may be that this correlates with the laying
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down of paternal imprints (Jue et al. 1995). Dnmt3l is expressed in the murine testes
from E12.5 in non-dividing prospermatogonia with peak expression seen at the time
of birth, after which there is a dramatic post-natal reduction in expression level (La
Salle et al. 2004; Bourc'his & Bestor 2004). Dnmt3a expression in the testis is
raised before birth and during early postnatal life, in contrast to the level ofDnmt3b
expression which is lower during embryonic life and rises postnatally (La Salle et al.
2004). Mice lacking Dnmt3l have smaller testes, and by adulthood there are virtually
no spermatozoa present resulting in sterile animals (Hata et al. 2002). Dnmt31 is
required if normal meiosis and silencing of retrotransposons is to occur (Bourc'his &
Bestor 2004). The loss ofDnmt3a results in a similar although less extreme
phenotype than that seen in the Dnmt3l''~ mouse (Hata et al. 2002). More recently
the male Dnmt3a conditional knockout was created, with no germ cell Dnmt3a
expression but with somatic cell levels maintained (Kaneda et al. 2004).
Spermatogenesis is severely impaired in these mice so that by 11 weeks of age there
are no spermatozoa in the testis, demonstrating a vital role for Dnmt3a in this
process. Offspring from these conditional knockout males have errors in the
methylation of some paternally imprinted genes.
1.13.4 Fertilisation and Early Embryo Development
As shown in Figure 1.9, the fertilised embryo contains methylated DNA some of
which will be located in imprinted genes (both maternal and paternal) while the
majority of the DNA methylation will be positioned on non-imprinted sequences
(again of both maternal and paternal origin). Early on in embryo development, the
embryo loses its methylation at the non-imprinted DNA sequences. It now appears
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that this DNA methylation is lost in a parent-of-origin specific order, at least in some
species. Imprinted genes are resistant to these early demethylation processes. The
embryo's germ cells will lose methylation of the imprinted genes during gonadal
development, while somatic cells maintain these methylation patterns throughout
embryonic development and, in the main, throughout the life of the newly formed
organism, (although imprinted patterns are lost or altered in some tissues, such as the
liver; McLaren & Montgomery 1999).
In some species (such as the mouse), the paternal genome is actively demethylated
immediately after fertilisation (Oswald et al. 2000). The occurrence and degree of
this demethylation appears to be species-specific, and its regulation is currently
unknown. Cross-fertilisation using gametes from several species of animal has
found that although there are sperm characteristics which affect the degree of
demethylation, the main factor determining whether the paternal genome becomes
demethylated is oocyte-specific (Beaujean et al. 2004c). In the search for the factor
responsible for this post-fertilisation active demethylation, Mbd2 was proposed as a
candidate after an in vitro study by Bhattacharya et al. (1999). However, a
subsequent study utilising Mbdl1' oocytes has found that the rapid demethylation of
the paternal genome still occurs in its absence (although this result doesn't eliminate
the possibility of redundancy) (Santos et al., 2002). The maternal genome undergoes
passive demethylation which is slower to occur and is linked to the replication of
DNA in the absence of any maintenance methylase activity. Although the general
trend after fertilisation is for non-imprinted sequences to undergo demethylation,
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there does appear to be some specific incidences of de novo methylation such as the
DMRs of the Dnmtlo gene in the 1 -cell to blastocyst stage embryo (Ko et al. 2005).
Dnmtlo remains localised to the cytoplasm of the embryonic cells at all pre-
implantation stages with the exception of the 8-cell embryo. During this stage, the
protein has been shown to translocate to the nuclei, where it is thought to play a role
in maintaining the methylation level of imprinted genes (Carlson et al. 1992;
Mertineit et al. 1998; Ratnam et al., 2002). Dnmt3a is expressed by pre-implantation
embryos and there is no evidence of the protein being excluded from the nucleus at
any developmental stage (Ko et al. 2005). Although Dnmt3b is not transcribed in the
pre-implantation embryo the protein is present at all stages from the 1-cell to
blastocyst: while mainly localised to the cytoplasm, it is not fully excluded from the
nucleus (Ko et al. 2005).
Until recently embryos which consisted of two maternal or two paternal genomes
were unable to develop to term. Work examining the competence ofparthenogenetic
embryos found they were able to develop at best until E9.5. By creating an embryo
with one set of chromosomes from a fully grown and the other from a non-growing
oocyte, Kono et al. (1996) showed that embryo development could be extended to
El 3.5. It was thought that this increase in the length of time the embryo survived
was due to the ability of the non-growing oocyte chromosomes (with, therefore, no
female imprints yet laid down) to partially compensate for the lack of a paternally
imprinted set of chromosomes. Parthenotes which died at E9.5 and E13.5 had
incorrect biallelic expression of the normally monoallelic H19 gene. The most recent
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work by Kono et al. (2004) has resulted in the birth and survival of a viable
parthenote. This was achieved using non-growing oocytes from a transgenic mouse
with a 13-kilobase deletion of H19. The mouse had H19 expression consistent with
that normally seen from the paternal genome. As H19 in turn influences the
expression of the imprinted Igf2 gene, the embryo had monoallelic expression of
both HI9 and Igf2 (from the wild type fully grown oocytes only), as would be the
case in normal embryos. The fact that normal embryo development is possible after
the female genome is altered to more closely resemble the genomic imprinting
pattern of the male genome demonstrates the importance of this mechanism in
controlling development, reinforcing the idea that the presence of mammalian
genomic imprinting might act as a barrier to parthenogenesis (see above).
1.13.4.1 X-Inactivation
The process of random inactivation of one of the two X-chromosomes in the somatic
cells of the early female embryos is a vital developmental process. DNA
methylation has an established role in ensuring that X-inactivation occurs correctly
and that long-term silencing of gene transcription is maintained (Reviewed by
Ehrlich, 2003a). However, DNA methylation is not required to initiate the silencing
of the inactive X-chromosome (Xi) and is in fact necessary for protecting the X-
chromosome that is to remain active. The mechanism by which Xi is silenced
involves the transcription ofXist which is an untranslated but functional RNA which
coats the Xist expressing chromosome causing gene inactivation. The key role of
DNA methylation in this process is on the active X-chromosome as on this
chromosome the Xist 5' region is methylated to prevent transcription of the Xist
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RNA. Once inactivation of the X-chromosome has been initiated DNA methylation
plays a role in ensuring these silenced genes are not reactivated but methylation.
Thus, methylation functions to maintain rather than initiate the gene silencing on Xi
(Reviewed by Bird, 2002).
1.14 ERRORS IN GENOMIC IMPRINTING
With genomic imprinting being a basic mechanism clearly vital for many aspects of
development, there are, not surprisingly, many instances of developmental defects
due to imprinting errors whether occurring naturally or during human intervention
(Table 1.4).
1.14.1 Assisted Reproductive Techniques
In recent years, there has been increasing concern that children conceived with the
aid of ARTs could have increased occurrence of disorders linked to imprinting
problems. At the turn of the century, two studies (Cox et al. 2002; Orstavik et al.
2003) reported the occurrence of three children conceived using intra cytoplasmic
sperm injection (ICSI) with Angelman Syndrome (AS), a neurological disorder
characterised by developmental delay and seizures, suggesting that the risk of AS
may be increased by the use of ICSI. The fear of such a link was then increased with
three studies that examined patients with Beckwith-Wiedemann Syndrome (BWS) to
see if a higher than expected proportion of these cases came from ART babies; all
studies found a disproportionate number of such cases (DeBaun et al. 2003; Maher et
al. 2003; Gicquel et al. 2003). BWS is characterised by both pre- and post-natal
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overgrowth and defects of the abdominal wall. Children who had been conceived
using ART and suffered from BWS had the methylation status of their H19 and LIT1
genes established, with only one of the identified children demonstrating normal
methylation patterns on both these genes. Data suggest that ART results in a three-
to six-fold increase in the incidence of the normally rare BWS, although some of the
studies may in fact be underestimating the true risk (DeBaun et al. 2003). However,
a link between ART and imprinting disorders has not been definitively confirmed,
one large scale Danish study (involving 442 349 non IVF and 6053 IVF children)
found no incidences of imprinting disorders amongst the children conceived by ART
(Lidegaard et al., 2005). Thus, the apparent link identified by earlier studies (Cox et
al. 2002; Orstavik et al. 2003 DeBaun et al. 2003; Maher et al. 2003; Gicquel et al.
2003) could be due to the statistical approach required for such small studies
(Gosden et al., 2003). The cause of the link between ART and imprinting disorders
is currently unknown. It could be due to some aspect of the ARTs involved. There
is a wide range of different ARTs which are now routinely used within clinics.
Techniques might expose one or both of the germ cells to an altered hormonal
regime in vivo, a period of time in culture or mechanical manipulation. Any such
alterations to the normal environment of the oocyte or sperm could result in changes
to some aspect of their imprinting mechanisms. Alternatively, it could be due to
some error within the germ cells used, bearing in mind that couples seeking to use
ARTs have reduced natural fertility.
The potential problems do not end with the germ cells; the pre-implantation embryo
is also often exposed to a period of culture which could again alter the epigenetic
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reprogramming known to occur at these early stages. One such example is abnormal
biallelic H19 expression of mouse embryos cultured in Whitten's medium (Doherty
et al. 2000). It is not just in humans and mice that potential problems with
imprinting have been seen. In large domestic mammals such as sheep and cattle,
Large Offspring Syndrome (LOS) was identified when embryos had been exposed to
some time in culture (Young et al. 1998). Further investigations into LOS in sheep
have identified changes in the expression level of the imprinted gene, IGF2R due to
epigenetic changes (Young et al. 2001). Similar overgrowth problems seen in mice
and humans are often caused by errors in several different imprinted genes including
Ig/2 and H19 (Eggenschwiler et al. 1997).
If sperm used for in vitro fertilisation (IVF) have lowered global methylation levels
there is no alteration in either fertilisation rate or in early embryo quality, however
there is a reduction in pregnancy rate demonstrating the importance of normal
gamete DNA methylation on embryo development and ultimately ART outcome
(Benchaib et al. 2005). The analysis of sperm DNA methylation levels was carried
out using flow cytometry of sperm suspension which had been stained with 5-
methylcytosine antibody (Benchaib et al., 2005). The results obtained represent the
mean methylation levels of the sperm population present in each semen sample
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There is recent evidence that sperm obtained from males with low sperm counts due
to abnormal spermatogenesis have incorrect genomic imprinting (Marques et al.
2004), although such sperm can then be used e.g. in ICS! Marques et al. (2004)
found that although the maternal imprints had been erased from all sperm, the
paternally methylated HI9 gene was under-methylated in some sperm from the
oligozoospermia donors. Any embryo derived from one of these hypomethylated
sperm could have inappropriate expression of the imprinted H19 and IGF2 genes, the
effect of which is not known.
1.14.2 Somatic Cell Nuclear Transfer
Studies investigating the failure of animals created by somatic cell nuclear transfer
have also turned their attention to the role of genomic imprinting. The fact that many
of the errors seen in these animals have epigenetic causes has been demonstrated by
examining the offspring ofmice bom as a result of somatic cell nuclear transfer. The
mice obtained using somatic cell nuclear transfer were obese but this trait was not
passed onto the offspring demonstrating that this was not a genetic error but due to
epigenetics. This finding is important as it suggests that, despite any problem in
animals derived using somatic cell nuclear transfer, it is possible that their germ cells
are able to correctly undergo genomic imprint reprogramming (Tamashiro et al.
2002). In bovine embryos produced using somatic cell nuclear transfer it has been
found that the levels of methylation in the cells of the embryo are higher than normal
at the 4-cell and 8-cell stages. Although there is initial demethylation of the donor
genome, passive demethylation does not occur to the level seen in normal embryos.
In addition to a reduction in the amount of demethylation there also appears to be
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inappropriate de novo methylation occurring at early stages of embryo development
(Dean et al. 2001). It is also possible that errors in the Dnmt enzymes normally
present in the early embryo could account for alterations in methylation seen in these
embryos. Analysis of mouse embryos resulting from somatic cell nuclear transfer
shows inappropriate presence of Dnmtls within the pre-implantation embryo; this
isoform of Dnmtl is never present in normal embryos. It was also observed that at
the 8-cell stage, when Dnmtlo would normally translocate into the nuclei of
embryonic cells, some nuclei within each embryo were devoid of any Dnmtl isoform
suggesting that these cells are unable to maintain normal methylation patterns
(Chung et al. 2003).
1.14,3 Disease
In some cases imprinting errors can occur which, although not embryo lethal cause
abnormal physiological processes and lead to disease. Such diseases can arise when
any imprinted gene becomes hypermethylated or hypomethylated. Effects are not
always limited to the loss of function of a single gene, as some imprinted genes
affect the expression of other genes, such as H19 and IGF2. The linked Prader-Willi
Syndrome (PWS) and AS are examples of disorders that can occur when correct
imprinting is lost. A loss of a currently unidentified imprinted gene results in PWS
when the deletion is paternally inherited, whereas the same errors cause AS to
develop when maternally transmitted (Moncla et al. 1999). Other examples of
diseases which result after incorrect imprinting include BWS, Silver-Russell
Syndrome and transient neonatal diabetes.
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Disease can also result from defects in mechanisms regulating imprints. One of the
key groups of enzymes with a role in genomic imprinting are the Dnmts which are
responsible for the addition of methyl groups to the DNA. When problems arise
within this aspect of the imprinting mechanism it can lead to disease in the
individual. One such example is immunodeficiency, centromeric region instability,
and facial anomalies syndrome (ICF) which is a result of a mutation in DNMT3b
(Reviewed by Ehrlich 2003b). Another major component of the imprinting
mechanism is the family of methyl binding domain proteins. MeCP2 is a protein
which contains a methyl binding domain. It has a role is controlling the transcription
of imprinted genes through its ability to bind to methylated DNA. The importance of
this protein for normal development and physiological function is demonstrated by
Rett syndrome which occurs when MECP2 is mutated (Amir et al. 1999).
There are some diseases with multiple causes which only in some cases involve
errors to the imprinting mechanism or alterations to imprinted genes. Cancer is one
such disease, with some cases of cancer being identified as having a cause linked to
genomic imprinting while many other incidences of the disease occurring due to
unrelated problems. In some instances, human tumour cells have been found to
overexpress one or more ofDNMTls, 3a and 3b, with the largest upregulation
occurring to DNMT3b (Robertson et al. 1999). These results support the previous
observations of abnormal methylation levels seen in tumour cells. One cancer which
demonstrates such raised DNMT levels is acute myelogenous leukaemia; it may be
that this over-expression of the DNMT enzymes accounts for the hypermethylation
and silencing of an important tumour suppressor gene (Mizuno et al. 2001).
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1.15 PROJECT BACKGROUND
The study described in this section and some of the data presented within this thesis
form the basis of a joint first author paper. Throughout this thesis the reference is
cited as Murray et al. (2005) (Appendix G).
In previous work by the laboratory, oocytes were exposed to altered levels of
androgens and oestrogens in culture to investigate their effect on follicle
development and oocyte maturation. The subsequent developmental competence of
these oocytes was then assessed using IVF. The in vitro method used was a whole
follicle culture system capable of supporting follicular development of isolated pre-
antral follicles until the Graafian stage (Spears et al., 1994). Follicles were exposed
to altered steroidal regimes in vitro for the duration of the culture period before
oocytes were recovered and used in IVF. Exposure to raised androgen levels (Figure
1.1 OA) were achieved through the addition of Arimidex, a potent inhibitor of
aromatase activity, to the medium; this also resulted in a significant reduction of
oestradiol production by the follicles due to the loss of aromatisation of androgens to
oestrogens (Figure 1.1 OB). At present, only the concentration of androstenedione
has been assayed; it may also be interesting to determine the levels of testosterone or
DHT produced by the follicles cultured in the presence of Arimidex. Oestrogen
levels were increased through the medium being supplemented with the synthetic
oestrogen, diethylstilboestrol (DES). However, DES is not able to cross-react with
the highly specific oestradiol assay thus the additional oestrogenic activity of this
synthetic oestrogen cannot be measured using the assay (Figure 1.1 OB). The final
treatment group consisted of high levels of androgen and oestrogen in combination.
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The above alterations to the steroidal environment had no effect on either the growth
rate of the follicles, levels of apoptosis or antral formation. In order to build on this
previous study the high steroid treatment culture groups described within this thesis
utilise the same Arimidex and DES doses as the original Murray et al. study.
Although alteration of the steroidal environment had no apparent effect on follicular
morphology there was a significant effect of high steroids on the developmental
competence of the oocyte. In IVF experiments, oocytes which had been exposed to
raised levels of oestrogen either alone or in combination with raised androgens had
significantly reduced fertilisation rates (P<0. 01) (Figure 1.11). In contrast the
oocytes exposed to medium containing only raised androgen levels had an improved
rate of fertilisation (Figure 1.11 A). However, these effects of steroids did not persist
during embryo development with no effect seen in the ability of 2-cell embryos to
develop to the blastocyst stage regardless of the steroidal milieu they were exposed
to during follicular development (Figure 1.1 IB). Although the results from this work
suggest that raised steroid levels have an effect on oocyte maturation, the mechanism
through which they exert this is unknown. As previously described in Section 1.14,
DNA methylation of the oocyte genome is a vital component of the maturation
process which can be influenced by the environmental conditions. Taking this into
consideration it is possible that the observed effects of steroids on fertilisation rate
could be mediated through alterations to DNA methylation during oocyte maturation
(Figure 1.12).
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Figure 1.10:- A) Concentration of androstenedione produced by
follicles grown in different steroid environments. B) Concentration of
17-P-oestradiol produced by follicles grown in different steroid
environments. Media was sampled on day 6 of culture. Values are
mean ± SEM (n > 9 for each group). * p<0.001.
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Figure 1.11:- Oocytes which had been exposed to altered steroidal regime
during pre-antral and antral development were used for in vitro fertilisation
(IVF). Experimental treatment groups were: A only - high androgen; E only
- high oestrogen; A+E - high androgen and oestrogen in combination. A) A
significant alteration in fertilisation rate was observed after exposure to
altered steroid levels (P<0.01). Fertilisation rates were reduced after culture
with oestrogen (whether alone or in combination with high androgen). When
only androgen levels were raised during culture the oocytes had improved
developmental competence, with a higher percentage being fertilised. B)
There was no effect of steroid environment on the percentage of 2-cell
embryos capable of developing to the blastocyst stage. Three repeats of this
experimental protocol were carried out. The number of oocytes in each




Figure 1.12:- Diagram depicting some of the key processes occurring over the period of oocyte and
follicle development. After recruitment (green dashed line) into the growing population of follicles
the oocyte of the early pre-antral follicle enters a period of rapid growth, as demonstrated by the red
arrow. The oocyte is meiotically incompetent (represented by blue bar) and gains meiotic
competence (represented by purple bar) around the time of antrum formation (represented by white
bar) as the oocyte achieves its maximum size. Follicular synthesis of oestrogens and androgens are
represented by the black arrows extending across the majority of follicle development. Each
imprinted gene becomes methylated at a gene-specific time point over oocyte development, ranging
from early pre-antral to late antral stages. The yellow shaded region represents the period of follicle
development that correlates to that seen in the follicle culture system used in the experimental
chapters of this thesis. The oocytes within pre-antral follicles at the start of culture have not yet
completed their growth, are meiotically incompetent and will have incomplete maternal DNA
methylation patterns. (Spears et al., 2004; Murray & Spears, 2001; Obata & Kono 2002; Lucifero
et al., 2004; Mehlmann, 2005)
Yellow cell - granulosa cells. Brown cell layers - theca cell layers. Triangles represent increasing
DNA methylation of imprinted genes (blue) and Intracisternal A particles (lAPs) (green).
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1.16 RESEARCH AIMS
The importance of androgens and oestrogens for normal ovarian function and the
production of developmentally competent oocytes has been a key area of research for
several decades. However, the role of these steroid hormones is still widely debated,
with conflicting results as to their influence on the mammalian oocyte. The
increasing use of ARTs means an understanding of the mechanisms by which these
hormones exert their influence has become ever more vital. Thus, the principal goal
of this thesis is to investigate the effects of androgens and oestrogens on oocyte
maturation using the mouse as a model.
It has been established that alterations in genomic imprinting and DNA methylation,
can negatively influence the developmental competence of the oocyte. There is an
accumulation of evidence, which suggests that altered genomic imprinting can result
from exposure of the oocyte or embryo to altered environmental conditions. There is
conflicting evidence as to the role of the steroid hormones on the maturation and
developmental competence of the mammalian oocyte. There is a correlation between
the timing of oocyte exposure to altered levels of steroids, such as after the
administration of superovulatory exogenous gonadotrophins, and the vital process of
DNA methylation of the oocyte genome (Figure 1.12). Therefore, it is possible that
changes to the level or pattern of androgen and oestrogen exposure could result in
aberrant DNA methylation and have an impact on subsequent gene expression.
Thus, this thesis will investigate the effects of androgens and oestrogens on
mammalian oocyte maturation.
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More specifically this thesis will aim to further the understanding of the methylation
dynamics of the oocyte by:-
• Analysing the expression of key enzymes involved in control of imprinted
gene expression (Chapter 3)
• Investigating changes to the methylation dynamics of the oocyte in response
to steroids (Chapter 4 and 5)






All animals used in Chapters 3, 4 and 5 of this thesis were F1 hybrids from a
C57Black/6J x CBA background while Chapter 6 used mice with a C57Black/6J
background in addition to the F1 animals. All mice were housed in environmentally
controlled rooms with 12 hour light: 12 hour dark photoperiod with both food and
water freely accessible. All animals were kept in accordance with UK legal
requirements.
2.2 Dissecting Medium
The osmolarity of Leibovitz L-15 medium (Invitrogen, UK) was adjusted to within
the range 285-293mOsmKg"1 using sterile hospital grade water (Phoenix
Pharmaceuticals, USA). 3 m grab1 of Bovine Serum Albumin (BSA, Fraction V,
tissue culture grade, Sigma-Aldrich, UK) was added to the Liebovitz and allowed to
dissolve prior to filter sterilising (syringe - Becton Dickinson Biosciences, UK; filter
- 0.22pm cellulose acetate filter, Iwaki). The dissecting medium was warmed in
watchglasses placed in a 37°C oven prior to use. Dissecting medium was freshly
made for every experiment and was not kept beyond 8 hours at 37°C.
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2.3 Superovulation
Mice were injected intra-abdominally with 0.1ml PMSG (5IU/1 OOjal Phosphate
Buffered Solution (PBS), Intervet UK Limited, UK) and 48 hours later a second
injection of 0.1ml hCG (5IU/100pl PBS, Intervet UK Limited, UK) was
administered using insulin syringes (Sherwood, UK). 12 hours after the second
injection the mice were killed by cervical dislocation and the ovaries and oviducts
were removed into sterile dissecting medium (as described in Sections 2.2 and 2.4).
2.4 Removal of Ovaries and Oviducts
Female mice were killed by Schedule 1 cervical dislocation. When appropriate the
ovaries or ovaries and oviduct were removed through an abdominal incision and
immediately placed in warmed (37°C) dissecting medium (as described in Section
2.2). The dissection was carried out in a laminar flow hood (Astecair, BioQuell, UK)
to maintain a sterile environment.
2.5 Follicle Dissection (Day 0)
Ovaries were halved and placed in fresh dissecting medium and kept at 37°C until
use. Pre-antral follicles, 175 + 2 pm in diameter, were dissected using an insulin
syringe (Sherwood, UK) and a mounted acupuncture needle (Acumedic Limited,
UK) under a dissecting microscope (Zeiss, Carl Zeiss Ltd, UK) with heated stage
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(Linkam Scientific Instruments, UK) at 37°C. Both the horizontal and vertical
diameters of each follicle were measured using an ocular micrometer and the mean
of these two values used to determine the follicle size. As the processes of follicle
and oocyte development are correlated, follicle size can be used as an accurate stage
determinant (Gosden et al., 1993). Follicles were dissected from the ovary as rapidly
as possible with each half being worked with for only 30 minutes before disposal.
Once dissected out from the ovary follicles destined for culture were transferred to
the culture wells within 45 minutes to give them the best chance of survival. In cases
where a period of time in culture was not part of the experimental protocol oocytes
were recovered from the dissected follicles as rapidly as possible to prevent
deterioration.
2.6 Oocyte Recovery
2.6.1 Recovery from Follicles and Fixation
Follicles were placed into M2 medium (Sigma-Aldrich, UK) supplemented with
20plmF' of dbcAMP (Sigma-Aldrich, UK) to prevent the oocytes spontaneously
resuming meiosis when released from the follicular environment. M2 medium was
stored at 4°C after opening and disposed of after one month. dbcAMP was added
immediately prior to use of the M2 medium and was not stored at the working
dilution. Follicles were ruptured using insulin needles (Sherwood, UK) and the
recovered COCs were then repeatedly passed up and down a fine BSA coated glass
pipette to mechanically remove the cumulus cells from the oocyte. Oocytes were
fixed in freshly made 4% paraformaldehyde (PFA, Sigma-Aldrich, UK) overnight at
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4°C. After fixation oocytes were carefully removed from the PFA and placed in
autoclaved PBS (Sigma-Aldrich, UK) where they could be stored at 4°C for up to a
week before use.
2.6.2 Recovery from Oviducts
The ovaries and oviducts were removed post-mortem into sterile dissecting medium
(as described in Sections 2.2 and 2.2). The oviducts were ruptured using insulin
syringes (Sherwood, UK) and the COCs retrieved. If these oocytes were to be fixed
for immunohistochemistry they were transferred into fresh dissecting medium
supplemented, immediately before use, with SOOfigml"1 hyaluronidase (Sigma-
Aldrich, UK) to remove the cumulus cells. Oocytes were then fixed in freshly made
4% paraformaldehyde (PFA, Sigma-Aldrich, UK) overnight at 4°C. After fixation
oocytes were carefully removed from the PFA and placed in autoclaved PBS (Sigma-
Aldrich, UK) where they could be stored at 4°C for up to a week before use.
Alternatively if the oocytes were required for IVF no removal of cumulus cells was
undertaken and COCs were immediately utilised in the IVF protocol.
2.7 Intact Follicle Culture System
2.7.1 Basic Culture Medium
The main constituent of the culture media used in all the experiments was a-
Minimum Essential Medium (a-MEM, Invitrogen, UK). Sterile hospital grade water
(Phoenix Pharmaceuticals, Germany) was added to give a final working osmolality
of 285mOsmKg~1. a-MEM was stored at 4°C for a maximum of 7 days once
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adjusted to the final working osmolarity. The a-MEM was supplemented with
charcoal stripped fetal bovine serum (SOplmf1); 1 IU ml"1 rhFSH to support follicle
growth (Puregon®, Organon Laboratories Ltd, UK); ascorbic acid (140pm ml"1,
Sigma-Aldrich, UK). Charcoal stripping of the fetal bovine serum was carried out in
the laboratory using the method of Huot & Shain (1988) in order to remove the
endogenous steroids. Ascorbic acid was added to the medium as previous work from
our laboratory has demonstrated its positive effect on follicle integrity and survival
(Murray et al., 2001). Once all of the components had been added the medium was
filter sterilised (syringe - Becton Dickinson Biosciences, UK; filter - 0.25pm, Iwaki,
UK).
2.7.2 Culture System
The culture system employed was an intact follicle culture protocol with a single
follicle per well. 96 well non-tissue culture treated round-bottomed plates (Iwaki,
UK) were used for all cultures. 30pl of medium was aliquoted into the first two rows
of wells and covered with 75 pi of filtered silicon oil (Merck, Germany) (syringe -
Becton Dickinson Biosciences, UK; filter - 0.45pm, Iwaki, UK). Trays were
incubated overnight (37°C in a humidified 5% CO2, 95% air atmosphere incubator,
Thermo Electron Corporation, UK).
Trays were incubated (37°C in a humidified 5% CO2, 95% air atmosphere incubator,
Thermo Electron Corporation, UK) with the time outside the incubator being kept to
a minimum to ensure the optimum temperature was maintained. Dissected pre-antral
follicles (as described in Section 2.5) were placed in the first row of wells on the day
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of dissection (Day 0). The following day follicles were transferred into the second
pre-prepared row of medium (Day 1). Fresh medium was made and filtered on day 2
(as described in Section 2.7.1), 60pl of medium was placed into each culture tray
well and covered with 75 pi of silicon oil (Merck, Germany). Plates were returned to
the incubator for at least one hour, to allow equilibration of the medium, before
follicles were transferred into these freshly prepared wells. The follicles were not
moved for the remainder of the culture period. Follicles were examined every day to
check their health and growth. Measurements of follicle diameter were carried out as
described in Section 2.5 and the health of the follicle was visually assessed.
2.8 Polymerase Chain Reaction (PCR)
The master mix for PCR containing 10X buffer (200mM Tris-HCl (pH 8.4), 500mM
KC1, Promega, UK), magnesium chloride (Promega, UK), dNTP mixture (Promega,
UK), and platinum Taq polymerase (supplied at 5 U/pl, Invitrogen, UK) had the
appropriate PCR primers (Eurogentec, UK) added as specified in the relevant
Sections 3.3.4 and 6.3.2 (Table 6.1). After the addition of the relevant volume of
cDNA or DNA the volume was made up to 25pi per tube with autoclaved distilled
water. All components of the master mix were stored at -20°C and were thawed and
mixed in the appropriate volumes only when required. The master mix was kept on
ice at all times prior to the sterile 0.5ml PCR tubes being loaded onto the PCR
machine (M J Research, UK). The concentration of all constituents was optimised
for each gene of interest (Section 3.3.4 And 6.3.2 (Table 6.1)). The PCR cycle
parameters used were also optimised for each gene of interest (detailed in Section
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3.3.4 and 6.3.2) but all followed a common protocol of a denaturation step followed
by annealing, and then an elongation phase. These three stages are then repeated a
number of times, dependent on the particular primers being used. The number of
cycles used in the PCR protocols within this thesis varied from 26 to 40 cycles. A
single subsequent extended elongation step was then carried out to complete the PCR
cycles. Negative controls were used in each PCR reaction. One negative control
involves the addition of water to the master mix in place of either a cDNA or DNA
sample. Additionally, in Chapter 3 a no-reverse transcriptase (no-RT) negative was
also included in each PCR experiment.
2.8.1 Gel Electrophoresis and Visualisation of PCR Products
After removal from the PCR machine each 25 pi sample had 5 pi of loading buffer
added to it and was mixed thoroughly. Loading buffer consisted of glycerol 50%
(Sigma-Aldrich, UK) and 0.5M EDTA pH8 0.04% (Sigma-Aldrich, UK) in distilled
H2O. This step was carried out in a separate area than that used to set up the PCR
reactions. Gel electrophoresis was used to establish the presence and molecular
weight of the PCR products. 2% agarose gels (Flowgen Bioscience Ltd, UK)
containing ethidium bromide were poured into a mini-gel tank (BioRad Laboratories
Ltd, UK) and allowed to set for at least 45 minutes before being covered with lx
TBE (not containing ethidium bromide) as a running buffer. The wells in the gel
were loaded with lOpl of the PCR product (containing loading buffer) or ladder and
run at 50V (powerpack - BioRad Laboratories Ltd, UK) for between 1-2 hours until
the ladder and products were well separated. The ladder used for product size
detennination and, where required, quantification was the DNA molecular weight
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marker XIV (Roche, Germany). Aliquots of this ladder were stored at -20°C
avoiding repeated freeze/thawing. The PCR products were visualised with a UV
transilluminator (BioRad Laboratories Ltd, UK) and images captured with an
attached camera and computer system (Alpha Imaging System, Alpha Innotech
Corporation, USA).
2.9 Confocal Imaging
To enable confocal images to be acquired oocytes were placed on Superfirost
positively charged slides (VWR International Ltd, UK) and excess liquid removed to
allow adherence to the glass. The oocytes were then mounted in lOpl of vectashield,
stored at 4°C, (Vector Laboratories, USA) and covered with a glass slide (thickness
1, BDH, UK). Slides were stored at 4°C, wrapped in foil, before imaging for no
more than 6 hours to limit any loss of fluorescent signal. Samples were observed
using the Leica upright TCS-NT confocal microscope with Argon/Krypton laser
(Leica Microsystems Ltd, UK). Either single oocyte images or Z-stacks, using the
automated stage, were obtained using the Leica Imaging software (Leica
Microsystems Ltd, UK). All images were taken using a dry x40 lens followed by x2
zoom, with a pinhole setting of 1 airy unit and constant photomultiplier tube (PMT)
setting within each experiment.
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Chapter 3
The effect of exogenous gonadotrophins on the




Although the effects of oestrogens and androgens within the follicle have been the
subject of extensive investigation, the full extent of the role they play remains to be
elucidated. Previous results from this laboratory used an individual follicle culture
system to investigate the effects of raised steroid levels on follicle development.
Although there was no apparent effect on either follicular growth or rates of atresia,
there was an impact on the developmental competence of the oocyte (refer to Section
1.15). After exposure to raised levels of an oestrogenic compound, DES, oocytes
exhibited a reduced fertilisation rate during IVF. In contrast, exposure to raised
androgen levels was found to improve the percentage of oocytes undergoing
successful fertilisation (Figures 1.9A and 1.11 A). This result raised the question of
what the mechanism was by which raised oestrogen and androgen influenced the
developmental competence of these oocytes.
The important role that genomic imprinting of germ cells plays on embryo
development is well established. Severe disruptions to this mechanism are
detrimental to subsequent development and in some cases even embryo lethal. Thus,
the laying down ofDNA methylation on the oocyte genome is a vital process of
oocyte maturation. It is known that maternal imprints are laid down in growing,
rather than quiescent, oocytes. Each imprinted gene becomes methylated at a gene-
specific time, during primary to pre-ovulatory development (Kono et al., 1996; Bao
et al., 2000; Obata & Kono, 2002; Lucifero et al., 2004). It has previously been
shown that some pre-implantation embryos, exposed to a period of time in culture,
have altered expression of imprinted genes (Doherty et al., 2000; Khosla et al., 2001;
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Mann et al., 2004). It may be that during the period of epigenetic reprogramming in
the early embryo the imprinted genes, which should maintain their imprints, are
particularly vulnerable to changes in environment (Doherty et al., 2000; Khosla et
al., 2001). In a similar way, the initial laying down of maternal imprints may be
more susceptible to environmental factors during the relevant period of oocyte
development. Perhaps then, it is not surprising that the environment that the oocyte
is exposed to, as the maternal imprints are being acquired, has been found to alter
imprinted gene expression. This is demonstrated by the altered methylation status of
specific imprinted genes of oocytes after follicle culture, with the Igf2r locus losing
methylation while HI9 has been shown to become hypermethylated during culture
(Kerjean et al., 2003).
Potentially, there are multiple factors which could contribute to errors in genomic
imprinting occurring after oocytes or embryos have been exposed to culture
conditions. There is no single conclusive piece of evidence which demonstrates that
altered hormonal exposure reduces oocyte developmental competence, through
alterations to the mechanisms involved in genomic imprinting. However, there is an
accumulation of data which suggest that epigenetic changes, which occur during
oocyte growth, are influenced by the hormonal environment. The percentage of
embryos with impaired blastocyst development increases, both in vitro and in vivo,
when they are derived from superovulated rather than naturally ovulated oocytes
(Ertzeid & Storeng, 2001; Van der Auwera & D'Hooghe, 2001). The exogenous
administration of superovulatory gonadotrophins results in alterations to the steroidal
milieu that the oocyte is exposed to during growth and maturation (Kajta, 1998).
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Therefore, the reduced developmental capacity of the subsequent embryos suggests
that aberrant oocyte maturation occurs when the hormonal environment is altered.
Children conceived with the aid of ARTs appear to have an increased incidence of
normally rare imprinting disorders (Cox et al. 2002; Orstavik et al. 2003; DeBaun et
al., 2003; Maher et al. 2003; Gicquel et al. 2003). This may represent a correlation
between altered oocyte and embryo environment, with errors in the mechanisms of
genomic imprinting. Of particular relevance may be a recent study examining the
incidence of BWS after ART. There was not found to be any correlation between the
cause ofparental infertility, type of ART or culture medium used and the
conceptions resulting in the birth of BWS children (Chang et al., 2005). The only
common factor between all the cases of BWS after ART examined in this study was
found to be ovarian stimulation (Chang et al., 2005). The small sample size means
no conclusive role of ovarian stimulation in the development of BWS in subsequent
offspring can be proved. However, this finding supports a potential impact of raised
gonadotrophin and steroid levels on the epigenetic stability of the oocyte. Another
investigation has found that embryos exposed to altered culture conditions can have
aberrant DNA methylation levels (Shi & Haaf, 2002). However, the use of
superovulation prior to either in vivo or in vitro fertilisation means it has not been
possible to determine whether the impaired DNA methylation originates in the
oocyte or occurs during early embryo development (Shi & Haaf, 2002). The
possibility that superovulated oocytes have altered DNA methylation in response to
the altered steroid exposure is unresolved, but could account for the observed
reduction in developmental competence.
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Utilising nuclear transfer, to investigate the developmental potential of chromatin
from different stage oocytes, demonstrated that those isolated from adults had
acquired the necessary epigenetic modifications earlier in development than those
from juvenile mice (Bao et al., 2000). One possibility is that oocytes from adult
mice have been exposed to a different gonadotrophin and steroidal environment than
those from juvenile animals. This alteration in hormonal exposure may account for
the time difference in acquiring epigenetic maturity (Bao et al., 2000).
A correlation between hormonal environment, including altered steroid levels, and
impaired developmental competence has been repeatedly demonstrated (Moor et al.,
1980; Andersen, 1993; Zelinksi-Wooten et al., 1993; Silva & Knight, 2000; Xia &
Younglai, 2000). Additionally, the requirement for correct genomic imprinting in
normal development is now evident. Investigations into the effect of steroids on
genomic imprinting have been restricted due to the delayed and sometimes minor
impact on development. Many epigenetic changes are not evident during early
development, while some, such as those leading to the development of cancer, may
not be seen until adult life (Mizuno et al., 2001; Szyf, 2003). This delay in any
observable phenotype is also demonstrated by several strains of KO mice, such as
animals lacking Mbd2 or Dnmt3l (Hendrich et al., 2001; Bourc'his et al., 2001).
This has complicated the issue of identifying both the time at which epigenetic
mutations occur, and the factors which cause them.
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3.1.1 Dnmt and Mbd genes in the Ovary
One cause of inappropriate DNA methylation is a change in the transcription or
translation of the Dnmt genes. The enzymes encoded for by this family of genes are
responsible for de novo and maintenance methylation, as previously discussed in
section 1.12. However, the influence of any single Dnmt is complicated by the high
level of co-operation that has been identified as existing between several enzymes in
this family (Kim et al., 2002; Liang et al., 2002). The expression level and
localisation of each Dnmt in the ovary is closely controlled, as both inappropriate
levels and timing ofDNA methylation can have detrimental effects on development
(Kaneda et al., 2004; Biniszkiewicz et al., 2002).
Dnmtl splice variants act as maintenance methylases in vivo although, in vitro they
also have de novo methylase activity (Howell et al., 2001). As this study is focused
on the Dnmts present in the ovary only DnmtIs and lo splice variants will be
considered. Although both DnmtIs and Dnmtlo mRNA transcripts are present in the
oocyte, there is no translation of Dnmt Is and only the Dnmtlo protein is found
(Ratnam et al., 2002, Figure 5.1 A). Initial studies analysing the Dnmtl transcripts in
both embryos and the testes have begun to determine factors that influence this
gene's expression. Pre-implantation mouse embryos exposed to a period of time in
culture have a significant increase in Dnmtl expression when compared to in vivo
obtained embryos (Wang et al., 2005). In the testes of hypophysectomised rats there
is no change to DnmtIs levels, either in the absence of androgens or after exogenous
testosterone administration, suggesting that this gene is not hormonally regulated in
the male gonad (Jue et al., 1995). However, no previous study has been carried out
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to determine whether there is hormonal regulation of any of the Dnmt genes in the
ovary. As previously discussed in section 1.12, Dnmt2 has only recently had a role
in active methylation attributed to it. The binding ability of this enzyme was initially
overlooked, as it has a highly specific binding pattern in mammals.
Dnmt3a, 3b and 31 are all expressed in the growing oocyte. As previously discussed
in Section 1. i3.2 the use of transgenic mice has allowed preliminary study of the role
of each of these Dnmt proteins in the oocyte. In the absence of Dnmt3b normal
maternal imprints are present, however, use of a germ cell specific conditional
Dnmt3a~'~ mouse line reveals that Dnmt3a is required for maternal imprinting in the
oocyte and methylation at IAPs (Kaneda et al., 2004). Although Dnmt31 has no
active methyltransferase activity a vital regulatory role in genomic imprinting is
demonstrated by the phenotype Dnmt31'' mice. The oocytes of female Dnmt3l~'~ mice
with disrupted Dnmt3l alleles do not contain the normal maternal imprints, resulting
in an embryo lethal maternal effect (Bourc'his et al., 2001).
It has been established that oocyte quality can be impaired by sub-optimal
environmental conditions during oocyte maturation and that the effects of this may
only become evident during embryonic or even more advanced stages of
development. However, the full range of factors and the mechanisms by which they
influence oocyte maturation are not yet known. Superovulation is a regularly used
technique both in medical and research settings which results in alteration of the
hormonal environment during oocyte maturation by the administration of exogenous
gonadotrophins. However, there are some reports of impaired developmental
competence of oocytes after superovulation which raises questions as to the role of
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raised gonadotrophins and steroid levels on oocyte maturation. Additionally, the
recent observation that children born after ART, where oocytes will have been
obtained after ovarian stimulation, appear to have an increased incidence of
imprinting disorders strengthens the need for an increased understanding of the
effects of raised hormone levels on the oocyte. Potentially, the increased levels of
gonadotrophins and steroids could be having an effect on the process of genomic
imprinting within the oocyte during maturation. The laying down of maternal
imprints requires the activity of Dnmt proteins, thus any alterations to the expression
of these genes could impair the initiation of normal maternal DNA methylation. The
subsequent repression of methylated genes requires the presence ofbound Mbd
proteins, thus changes to the expression of the genes involved in genomic imprinting
could cause reduced developmental competence of oocytes and imprinting disorders
in later life. This chapter aims to investigate the possibility that the administration of
exogenous gonadotrophins could have an effect on Dnmt or Mbd gene expression in
the oocyte. Initial work to optimise the protocols required to analyse expression of
these genes will be carried out on whole ovary as these samples will provide larger
levels of RNA to work with. Subsequently, these established protocols can be used
to analyse the gene expression in isolated oocytes to identify any effect ofhigh levels
of exogenous gonadotrophins on the expression ofDnmt or Mbd genes.
3.2 AIM
The aim of this study was to determine whether the administration of exogenous
gonadotrophins, is associated with alteration of ovarian Dnmt and Mbd gene
expression levels.
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3.3 MATERIALS AND METHODS
3.3.1 Experimental Protocol
Three F1 females were allocated to each of the treatment groups at three weeks of
age, as detailed in Table 3.1. Pregnant mare semm gonadotrophin (PMSG) (Intervet
UK Limited, UK), recombinant human (rh) LH (Serono, Switzerland) and human
chorionic gonadotrophin (hCG) (Intervet UK Limited, UK) were made up in saline to
a concentration of 5 IU/lOOpl and injected subcutaneously. The two injections were
given 48 hours apart. Animals were killed by cervical dislocation 5 hours after
administration of the second injection, prior to ovulation occurring. The ovaries
were removed as described in Section 2.4 and immediately snap frozen in liquid
nitrogen. The intact frozen ovaries were then transferred to a -80°C freezer where
they were stored until required for RNA extraction. Two runs of this experimental
protocol were carried out.
3.3.2 RNA Extraction
Total RNA was extracted using the RNeasy Mini Kit (Qiagen, UK) according to the
manufacturers instructions provided with the kit for the isolation of Total RNA from
animal tissues. An overview of this protocol is as follows. Ovarian tissue samples
were initially disrupted in lysis buffer from frozen using a sterile test-tube pestle and
mortar system. All equipment was RNase-free. To ensure a complete
homogenisation of the small ovarian samples with the lysis buffer, the tissue sample
was passed through a sterile insulin syringe (Sherwood, UK) 6 times. Homogenates
were centrifuged for 3 minutes at maximum speed and the subsequent supernatant
transferred to a fresh microcentrifuge tube. 1 volume of 70% ETOH was added to
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this lysate and mixed thoroughly. This mixture was then transferred into a RNeasy
mini-column (provided with the kit) placed in a collection tube before centrifugation
at >10,000 rpm for 15 seconds. The flow through was then discarded and additional
Buffer RPE from the kit added onto the column. The centrifugation step was
repeated and the collection tube contents again discarded. A further 500pl of buffer
RPE was pipetted onto the column followed by a 2 minute spin at >10,000 rpm.
After the column has been placed into a fresh collection tube a further centrifugation
step was carried out to ensure no carry over of buffer. The final elution step involved
placing the column into a fresh tube before adding 50pl of RNase-free water to the
column and carrying out a final spin for 1 minute at >10,000rpm. Once extracted the
ovarian RNA samples from each treatment group were pooled. Samples were then
frozen and stored at -70°C until required for cDNA synthesis.
3.3.3 cDNA synthesis from total RNA
2(0.1 of total RNA had lpl of Random Primers (200ng/pl, Promega, UK), 1 pi dNTP
Mix (lOmM of dATP, dCTP, dGTP and dTTP, Promega, UK) and 8 pi water added
to it before being heated at 65 °C for 5 minutes followed by cooling on ice for a
further 2 minutes. After this 4pl x5 MMLV-RT reaction buffer (Promega, UK), 2pl
DTT (0.1M, Promega) and lpl RNase inhibitor (Sigma-Aldrich, UK) were added to
the mixture which was left at room temperature for 2 minutes. At this stage 1 pi M-
MLV-RT (200U, Promega, UK) was added followed by a further 10 minutes at room
temperature and then an incubation of 50 minutes at 37°C. The final step was
deactivation of the enzyme by heating at 70°C for 15 minutes. The no-RT control
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was produced by the same protocol but with the exception of the M-MLV-RT being
replaced by sterile water. All tubes were then cooled and stored at -20°C.
Table 3.1:- Injection protocol for each treatment group. PMSG - Pregnant Mares
Serum Gonadotrophin; hCG - Human Chorionic Gonadotrophin; LH - Luteinising
Hormone
TREATMENT INJECTION 1 INJECTION 2
Treatment 1 Saline Saline
Treatment 2 PMSG Saline
Treatment 3 PMSG hCG
Treatment 4 PMSG/LH Saline
Treatment 5 PMSG/LH hCG
3.3.4 RT-PCR
The master mix for PCR containing xlO buffer (Promega, UK), magnesium
(Promega, UK), dNTPs (Promega, UK)), and platinum Taq polymerase (Invitrogen,
UK) had the appropriate PCR primers (Eurogentec, UK) added as detailed in Table
3.2. The concentration of each constituent and the PCR programme were optimised
for each gene of interest as shown in Table 3.3 A and B and Table 3.4. RT-PCR, gel
electrophoresis and visualisation of the products was carried out as described in
Section 2.8 and 2.8.1. PCR amplification of samples of interest, an H2O blank and
































































































































Table 3.3:- Tables showing the RT-PCR protocols for each Dnmt gene (A) and each
Mbd, MeCP2 and cyclophilin gene (B).
A DnmtIs Dnmtlo Dnmt3a Dnmt3a2 Dnmt3b Dnmt3l
Final Concentrations
10X PCR Buffer IX IX IX IX IX IX
















(lOOpM) 0.8pM 0.8pM 0.8pM 0.8pM 0.8pM 0.8pM
anti-sense primer




1U 1U 1U 1U 1U 0.65U
Autoclaved
distilled H2O
Make total volume up to 25 pi
Cycle Number 26 26 26 32 30 40
Anneal temp 55 55 61 61 55 64
Programme A A B B B C
B Mbdl Mbd2 Mbd3 Mbd4 MeCP2 cyclo
Final Concentrations
10X PCR Buffer IX IX IX IX IX IX
















(lOOpM) 0.8pM 0.8pM 0.8pM 0.8pM 0.8pM 0.8pM
anti-sense primer
(lOOpM) 0.8pM 0.8pM 0.8pM 0.8pM 0.8pM 0.8pM
Platinum Taq
Polymerase (5U/pl)
1U 1U 1U 1U 1U 1U
Autoclaved distilled
H20
Make total volume up to 25 pi
Cycle Number 26 26 26 35 35 26
Anneal temp 58 55 55 55 55 55
Programme B B B B B B
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Table 3.4:- Table listing the RT-PCR cycle parameters for the genes specified in
Table 3.3. To determine the value of X refer to appropriate gene in Table 3.3.
PCR Programme A PCR Programme B PCR Programme C
Den atu ration 94°C for 10 sec 95 °C for 1 min 94°C for 3 mins
Annealing 55°C for 10 sec X°C for 1 min 94°C for 20 sec






72°C for 2 min 72°C for 7 min 72°C for 1 min
3.3.5 Semi-Quantitative Analysis
3.3.5.1 Linear Range
To allow the amount of PCR product present relative to the housekeeping gene,
cyclophilin, to be evaluated the PCR reaction for all genes had to be within the linear
range. That is the kinetics of the reaction must not have reached the plateau caused
by a component of the master mix having become a rate limiting factor (Figure 3.1).
The linear range of all the genes of interest and the housekeeping gene, cyclophilin,
were established by comparing the amount ofproduct synthesised after different
numbers of PCR cycles.
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3.3.5.2 Quantitation
The yield of cDNA was determined by analysing the density of the housekeeping
gene PCR product present after 26 cycles. Densitometry analysis was carried out
using the Alpha Imaging System Software (Alpha Innotech Corporation, USA). The
volume of cDNA used in the subsequent RT-PCRs was altered such that samples
from all treatment groups gave the same level of cyclophilin PCR product. The
densitometry facility on the gel imaging software was used to analyse the density of
each gene of interest PCR product band. The band from each treatment group was
then normalised to the Group 1 control which was allocated a value of 1.
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3.4 RESULTS
RT-PCR was carried out for each Dnmt and Mbd gene and the results were
quantified using comparative densitometry. The RT-PCR gels showing the PCR
products for each treatment from one run of this experiment are shown for each gene
(Figures 3.2-3.11). In all cases H2O and no-RT negatives were also loaded onto gels
and visualised after electrophoresis. All of these samples gave the expected negative
result. The normalised densitometry results for each of the two experimental runs
were both plotted on a single graph for each gene (Figures 3.2-3.11). For some
genes, such as Dnmtlo (Figure 3.3) and MeCP2 (Figure 3.11) consistent results were
obtained from the two experimental runs. However, when compared to the saline
controls, there was no change in the expression levels of these genes after treatment.
In other cases, such as Dnmt3a (Figure 3.4) and Dnmt3b (Figure 3.6) there appeared
to be differences in expression level with gonadotrophin treatment. However, no












□ Experimental Run 1









1. Saline/Saline 4. PMSG -h LH/Saline
2. PMSG/Saline 5. PMSG -h LH/hCG
3. PMSG/hCG
Figure 3.2:- Semi-quantitative RT-PCR for Dnmtls. A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group 1 value,
allocated a value of 1, within each PCR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian
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Treatment Group
Key
1. Saline/Saline 4. PMSG + LH/Saline
2. PMSG/Saline 5. PMSG + LH/hCG
3. PMSG/hCG
Figure 3.3:- Semi-quantitative RT-PCR for Dnmtlo A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group l value,
allocated a value of l, within each PCR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotropin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian





□ Experimental Run 1







4. PMSG + LH/Saline
5. PMSG + LH/hCG
Figure 3.4:- Semi-quantitative RT-PCR fox Dnmt3a A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group 1 value,
allocated a value of 1, within each PGR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian





□ Experimental Run 1












1. Saline/Saline 4. PMSG + LH/Saline
2. PMSG/Saline 5. PMSG + LH/hCG
3. PMSG/hCG
Figure 3.5:- Semi-quantitative RT-PCR for Dnmt3a2. A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group l value,
allocated a value of l, within each PCR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian





















□ Experimental Run 1




1. Saline/Saline 4. PMSG + LH/Saline
2. PMSG/Saline 5. PMSG + LH/hCG
3. PMSG/hCG
Figure 3.6:- Semi-quantitative RT-PCR for Dnmt3b A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group 1 value,
allocated a value of 1, within each PCR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian







1 2 3 4 5
Treatment Group
Key
1. Saline/Saline 4. PMSG + LH/Saline
2. PMSG/Saline 5. PMSG + LH/hCG
3. PMSG/hCG
Figure 3.7:- Semi-quantitative RT-PCR for Dnmt3l A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group 1 value,
allocated a value of 1, within each PCR run. PMSG - Pregnant Mare Serum
Gonadotropin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian







□ Experimental Run 1
















4. PMSG + LH/Saline
5. PMSG + LH/hCG
Figure 3.8:- Semi-quantitative RT-PCR for Mbdl A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group 1 value,
allocated a value of 1, within each PCR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian






□ Experimental Run 1















1. Saline/Saline 4. PMSG -b LH/Saline
2. PMSG/Saline 5. PMSG Hb LH/hCG
3. PMSG/hCG
Figure 3.9:- Semi-quantitative RT-PCR for Mbd2 A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group 1 value,
allocated a value of 1, within each PGR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian
























□ Experimental Run 1
■ Experimental Run 2
Key
1. Saline/Saline 4. PMSG + LH/Saline
2. PMSG/Saline 5. PMSG + LH/hCG
3. PMSG/hCG
Figure 3.10:- Semi-quantitative RT-PCR for Mbd3 and Mbd4 A) RT-PCR
gel image, lane numbers represent treatment groups and the arrow represents
product size. B) Ivlbd3 - Graph of densitometry results normalised to the
Group 1 value, allocated a value of 1, within each PCR run. C) Mbd4 - Graph
of normalised densitometry results. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian





□ Experimental Run 1











4. PMSG + LH/Saline
5. PMSG + LH/hCG
Figure 3.11:- Semi-quantitative RT-PCR for MeCP2 A) RT-PCR gel image,
lane numbers represent treatment groups and the arrow represents product
size. B) Graph of densitometry results normalised to the Group 1 value,
allocated a value of 1, within each PCR run. PMSG - Pregnant Mare Serum
Gonadotrophin; hCG - human chorionic gonadotrophin; LH - Luteinising
hormone. Three mice were used for each treatment group and the ovarian
mRNA pooled. Two experimental replicates were carried out.
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3.5 DISCUSSION
The initial aim of this study was to investigate alterations to gene expression levels in
the oocyte. The start point in this experiment was to investigate any ovary wide
changes in gene expression levels seen after the administration of exogenous
gonadotrophins. Whole ovary was used as this would enable high levels of RNA to
be extracted and allow optimisation of both the RT-PCR protocols for each Dnmt and
Mbd gene and the quantification techniques. All of these genes investigated in this
study, with the exception ofMbdl, Mbd4 and MeCP2, have previously been shown
to be expressed in the postnatal mouse ovary (Mertineit et al., 1998; Aapola et al.,
2001; Kantor et al., 2003; Huntriss et al., 2004; Lees-Murdock et al., 2005; Vassena
et al., 2005).
However, even using whole ovary RNA there were problems with both optimisation
and quantification which required extensive alterations to the protocol to resolve. As
a result of these limitations of the technique the experimental samples analysed were
limited to whole ovary and the intended extension of this analysis into follicles or
oocytes alone was not carried out since very low RNA levels would be extracted
from this material, adding yet further difficulties to the analysis.
When considering the ovarian samples obtained there was very little correlation
between the PCR results obtained from each of the two experimental runs. As a
result, no further runs of this experiment were carried out. This lack of further
experimental runs precluded the use of statistical analysis on the data. Although, it
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may be the case that the steroid hormones do not affect Dnmt or Mbd gene
expression in any of the ovarian cell types, the methodology used in this study would
not be sensitive enough to determine any subtle alteration in expression level. When
the relative numbers of each cell type within the ovary are considered the proportion
of mRNA that will have originated from the oocytes is small in comparison to that
from the somatic cells. In addition, the presence of mRNA from all ovarian cells
within each sample means the possibility of the exogenous gonadotrophins having
different effects on each cell type could not be assessed. It is possible that a stimulus
causing an up-regulation of gene expression in one cell type actually results in
lowered gene expression in another. Thus, any subtle changes to gene expression
levels in the oocyte would be masked. Additionally, it must be considered that
several isoforms of the Dnmts exist, which would not have been individually
detected by the primers used in this study. Isoform specific primers were used for
Dnmt3a and Dnmt3a2 but this was not the case for Dnmt3b. The current study
utilised pan-Dnmt3b primers so any change in transcription level of individual
isoforms would not have been detected (Chen et al., 2005).
There is also the possibility that either translation or activity of the proteins are
altered by an altered hormonal environment. A family of avian methylated DNA
binding proteins (MDBPs) normally bind to methylated DNA but this binding
activity is reduced in the presence of oestradiol (Jost et al., 1991). This is thought to
be a control mechanism to ensure the normal expression of vitellogenin, a vital egg
component, in the female liver. Oestradiol causes a partial dephosphorylation of
MDBP-2 reducing its binding efficiency (Bruhat & Jost, 1995; 1996). The murine
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Dnmtl has been found to be post-translationally modified by phosphorylation of
serine 514 and may represent a mechanism by which its activity can be regulated
(Glickman et al., 1997). The Dnmt genes are also subject to transcriptional
regulation by methylation. One such example of this is Dnmtlo which has a tissue
specific DMR which acts to control transcription of this isoform (Ko et al., 2005).
The regulatory region of the tissue specific DMR undergoes developmentally
controlled de novo methylation and demethylation while there appears to be no such
modification of the Dnmtl s and Dnmtlp 5' region (Ko et al., 2005). However,
Doherty et al. (2000) found that alterations in Dnmtl activity in the embryo is not the
cause of the aberrant expression of imprinted genes observed after culture. This
suggests that although the culture system can influence the methylation status of
genes this is not mediated through alterations to the Dnmt enzymes.
3.5.1 Further Work
Although this study did not demonstrate any differences in ovarian Dnmt or Mbd
expression it would be of interest to investigate whether the altered gonadotrophin
stimulation results in changes to oocyte gene expression. The analysis of ovarian
gene expression described above utilised traditional end-point RT-PCR. This
technique only involves the assessment of the product once all the PCR cycles have
been carried out. As shown in Figure 3.1 the reaction must be terminated during the
exponential amplification phase ifmeaningful quantitative data is to be obtained.
Thus, experiments to establish a suitable number of cycles for each sample must be
carried out, which is time consuming and if very low volumes ofRNA are available
may not be possible. The quantitative analysis of end-point RT-PCR relies on
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agarose gel and ethidium bromide which have a poor sensitivity and resolution, such
that small changes in expression levels cannot be determined. Real-time RT-PCR
has been developed relatively recently and has the benefit of allowing rapid
quantification of PCR products. During real-time PCR the reaction products are
quantitated after every cycle so the range of exponential amplification can be easily
assessed. During the time period when the experiments described in this chapter
were carried out the only available PCR technique was the end-point RT-PCR.
However, the department has recently acquired a real-time PCR machine utilising the
SYBR-green dye assay. The SYBR-green binds to double stranded DNA and once
bound the resulting bright fluorescence can be detected and quantified. Use of this
real-time RT-PCR system would enable the efficient analysis ofDnmt and Mbd
expression in isolated oocytes from which only small levels of RNA could be
extracted and changes in gene expression level may be small. In addition to the in
vivo approach described in this chapter, an in vitro experiment analysing oocyte
expression of each Dnmt and Mbd after exposure to either raised gonadotrophins or
steroids could be used to further investigate the possible effect of the hormonal
environment on genomic imprinting and DNA methylation.
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Chapter 4




Hormonally induced changes to DNA methylation have been found in terminally
differentiated cell types. One such example, which is of particular interest in relation
to the current study, involves alteration to DNA methylation after oestradiol
administration, where exogenous oestradiol caused the avian hepatic vitellogenin
gene promoter to become hypomethylated (Wilks et al., 1982; Saluz et al., 1986).
As previously discussed, in Section 3.5, oestradiol reduces the binding efficiency of
avian MDBP-2 to methylated DNA (Bruhat & Jost, 1995; 1996). Subsequent to this,
there is demethylation of the vitellogenin gene promoter, starting four hours after
oestradiol exposure (Jost et al., 1991). However, there are no previous studies which
have investigated the effects of steroids on the DNA methylation levels of the
oocyte.
Shi & Haaf (2002) found there was a correlation between the use of superovulation
and abnormal methylation patterns in the 2-cell mouse embryo. The percentage of
embryos with abnormal methylation levels correlated to the observed embryonic
losses during the pre-implantation stages of development. This finding suggests that
evaluating the DNA methylation level of an embryo could be a method by which
developmental potential could be predicted. Although, embryos are no longer viable
after DNA methylation levels have been assessed this technique could be used during
the optimisation of culture conditions to determine the impact of different factors on
developmental competence. As changes in embryonic DNA methylation levels have
been implicated in having a significant impact on development, then carrying out
such an analysis on oocytes may prove to be a valid predictor of oocyte
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developmental competence. As oocyte quality cannot be determined by visual
assessment, the effects of altered environment on the oocyte are difficult to assess.
Utilising the potential correlation between DNA methylation level and
developmental competence could aid the optimisation of in vitro culture conditions.
Genomic imprints of the oocyte can be affected when exposed to a period of time in
culture, with several imprinted genes demonstrating altered DNA methylation levels
(Kerjean et al., 2003). It is not just the imprinted genes which acquire their DNA
methylation during oocyte growth. Retro-transposons and regions of satellite DNA
must also become correctly methylated, with IAPs (transposable elements) gaining
DNA methylation during post-natal oocyte growth (Lucifero et al., 2004). This
methylation is thought to be important in ensuring these regions are maintained in a
transcriptionally silent state, thus preventing their transposition in the genome
(Walsh et al., 1998). In the male germline, these repeat sequences have been shown
to undergo re-methylation during embryonic life (Lees-Murdock et al., 2003).
However, in the female germline, low methylation levels are maintained during
embryonic stages. It is not until the post-natal oocyte growth phase, that the repeat
sequences undergo reprogramming of DNA methylation patterns (Lees-Murdock et
al., 2003; Kim et al., 2004). Thus, it may be that over the period of oocyte
development, when DNA methylation at both maternally imprinted and non-
imprinted sequences are laid down, the mechanism is more easily perturbed by
inappropriate concentrations of steroids or other factors.
As each imprinted gene and non-imprinted sequence has a particular period of time
during oocyte growth over which the methyl groups are laid down, it may be that the
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time of exposure to steroids determines which genes are susceptible (Obata & Kono,
2002; Kim et al., 2004; Lucifero et al., 2004). Cultured mouse embryos with
aberrant HI9 expression can still have normal Snrpn expression (Doherty et al.,
2000), suggesting that some imprinted genes may be more sensitive to environmental
conditions and demonstrating that aberrant DNA methylation can occur at specific
locations rather than be genome wide. In both mice and humans, it appears that
much of the DNA methylation is laid down over the later stages of oocyte growth
(Lucifero et al., 2004; Geuns et al., 2003). This period of epigenetic reprogramming
is comparable to the pre-antral to Graafian stages supported by the culture system
routinely used in our laboratory in which late pre-antral intact follicles were cultured
in the presence of either raised androgens, raised oestrogens or both steroids raised in
combination (Spears et al., 1994; Murray et al., 1998; Spears et al., 1998; Murray et
al., 2005). At the end of the culture period oocytes were recovered and used in an
IVF procedure. Exposure to raised androgens alone over the period of follicle
culture resulted in a higher percentage of recovered oocytes undergoing fertilisation.
In contrast, exposure to raised oestrogens, whether alone or in combination with
androgens, resulted in fertilisation rates that were lower than controls. Thus, there is
a correlation between the time at which oocytes normally undergo DNA methylation
reprogramming and the altered steroidal exposure of oocytes in vitro, which has
previously been found to alter fertilisation rate (Murray et al., 2005). This makes
DNA methylation of the oocyte after culture and exposure to steroids a valid
mechanism for further investigation.
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4.2 AIM
Both the acquisition of maternal genomic imprints and methylation of other non-
imprinted and repeat sequences play significant roles in oocyte developmental
competence. Thus, this study aims to investigate whether exposure to raised
androgens and oestrogens, both in vivo and in vitro, alters the level of DNA
methylation.
Experiment 1:- How does the global DNA methylation level of the oocyte alter
during pre-antral to Graafian stage follicular growth?
Experiment 2:- Do raised levels of steroids in vitro affect oocyte global DNA
methylation?
Experiment 3:- How do global DNA methylation levels of naturally ovulated
oocytes compare to those obtained by superovulation?
167
4.3 MATERIALS AND METHODS
4.3.1 General Chapter Materials and Methods
4.3.1.1 Methylation Immunohistochemistry
Oocytes were fixed in freshly made 4% PFA (Sigma Aldrich, UK) overnight and
washed in PBS (Sigma-Aldrich, UK) before being permeabilised in Triton-XlOO
(0.5% in PBS, Sigma-Aldrich, UK) for 30 minutes at room temperature. This was
followed by DNA denaturation (4N HC1, BDH, UK, for 1 hour at 37°C) and a wash
with Tween-20 in PBS (0.05%, Sigma-Aldrich, UK) for 30 minutes at room
temperature before saturation of non-specific binding sites with BSA (2% in PBS,
Sigma-Aldrich, UK) for 1 hour at room temperature. 5-methyl cytosine primary
antibody, stored undiluted at 4°C, (Eurogentec, Belgium) was diluted 1:50 in BSA
(2% in PBS); 15pl wash and incubation drops were placed in plastic embryo dishes
(BD Falcon, USA) and covered with silicon oil (Merck, Germany). Oocytes were
moved through the wash drop and into the incubation drop where they were left for 1
hour at 37°C. A wash step was carried out at room temperature for 30 minutes in
Tween-20 (0.05% in PBS) prior to the secondary antibody incubation. The
secondary was diluted 1:200 in BSA (2% in PBS) and 15pl wash and incubation
drops were placed under oil. Oocytes were moved through the wash drop into the
incubation drop where they were left for 1 hour at room temperature in the dark. A
final wash in PBS for 30 minutes was carried out before oocytes were mounted on
superfrost positively charged slides (VWR International Ltd, UK) in vectashield
mounting medium (Vector Laboratories, USA). Slides were then stored at 4°C in the
dark. Triton X-100, 4N HC1, Tween-20, PBS and BSA solutions were all stored at
4°C for up to one month. Antibodies were not stored at the working dilution, with
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the appropriate antibody solutions only being prepared immediately before use.
Once the immunohistochemistry protocol was complete slides were stored at 4°C in
the dark and images obtained within 6 hours to prevent loss of signal.
4.3.1.2 Propidium Iodide Staining
Fixed oocytes were permeabilised, denatured and washed as for the methylation
immunohistochemistry described above up until the saturation of non-specific
binding sites. Instead these oocytes were placed in RNase A (2mg/ml PBS, Sigma-
Aldrich, UK)) for 1 hour at 37°C before being transferred to PI (25mg/ml, Sigma-
Aldrich, UK) for 30 minutes. After a final wash in Tween-20 in PBS (0.05%,
Sigma-Aldrich, UK) oocytes were mounted on positively charged Superffost slides
(VWR International Ltd, UK) in vectashield (Vector Laboratories, USA). Samples
were observed using the Leica upright TCS-NT confocal microscope with
Argon/Krypton laser (Leica Microsystems Ltd, UK) as described in Section 2.9. A
small number of oocytes underwent the methylation immunohistochemistry before
being counterstained with PI.
4.3.1.3 Methylation Image Analysis and Normalisation of Data
The threshold for the intensity of staining for each experimental run was calculated
using the Imaris software package (Bitplane AG, Switzerland). Determination of this
threshold value was carried out in the following way. The central image of the Z-
stack was identified and the stained regions highlighted using the co-localisation
function of the Imaris software which gives a threshold value for the image. The
mean threshold for that experimental run could then be calculated. Once the
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threshold value had been established all the stored images could be analysed using
the Scion Image Software Package (Scion Corporation, USA) as described in Figure
4.1. Comparisons of raw data could only be made within each experimental run,
since the intensity of the confocal microscope laser will reduce with age. This means
that the level of fluorochrome excitation and therefore level of staining intensity will
vary between experimental runs. To allow all data obtained to be compared data was
normalised to the mean of the control group. Each oocyte from one culture was
compared to the mean of that cultures control group
1/Mean x oocyte total = normalised value
Once normalised data had been calculated for every experiment these values were
plotted on a scattergram.
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4.3.2 Experiment 1:- How does the global DNA methylation level of the oocyte
alter during pre-antral to Graafian stage follicular growth?
4.3.2.1 Oocytes from in vivo follicles
Four 6 week old F1 females, which had not previously been housed together, were
placed with a 12 week old F1 vasectomised male overnight prior to the removal of
the ovaries as described in Section 2.4. Females which are housed together tend to
have synchronised cycles, while the presence of the male should act as a stimulus to
enhance follicular development in any female near to oestrous. Any female which
had oocytes in the oviduct, and had therefore already ovulated, was removed from
the study. Healthy follicles of sizes comparable to those obtained on Days 0, 2, 4
and 6 of culture were dissected from the remaining ovaries (Section 2.5). Thus,
follicles of the following sizes were obtained 175 ± 2pm (Day 0); 200 ± 2pm (Day
2); 290 ± 2pm (Day 4) and 340 ± 2pm (Day 6). These follicles were ruptured and
the recovered oocytes fixed overnight in 4% PFA, as detailed in Section 2.6.2, prior
to methylation immunostaining (as described in Section 4.3.1.1).
4.3.2.2 Oocytes from cultured follicles
Pre-antral follicles were dissected from 3 week old F1 mouse ovaries and cultured
for 0, 2, 4 or 6 days in standard medium (described in Sections 2.4 and 2.5). The
basic culture medium and system used has previously been described in Section 2.7.1
and 2.7.2. Follicles removed from culture were ruptured and the oocytes denuded of
cumulus cells by repeated pipetting (Section 2.6.1). Oocytes were immediately fixed
in fresh 4% PFA overnight, before being stored in PBS until the end of the 6 day
culture period. Subsequently, all oocytes from the culture were stained with either 5-
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methylcytosine antibody or propidium iodide (PI) as detailed in Sections 4.3.1.1 and
4.3.1.2. A small number of oocytes were counterstained with PI after the
methylation immunostaining. Only a visual assessment of the methylation levels
was carried out for these oocytes.
4.3.3 Experiment 2:- Do raised levels of steroids in vitro affect oocyte global
methylation?
As described previously in Section 2.5, pre-antral follicles were dissected from 3
week old F1 ovaries and cultured for 5 days. Cultures were carried out as previously
described in Section 2.7, but the standard medium detailed in Section 2.7.1 was
supplemented after filtration with Arimidex and/or DES which had been solubilised
in ethanol (ETOH). The treatment groups are detailed in Table 4.1 below and are
identical to those determined by previous work in the laboratory and detailed in
Murray et al. (2005). DES acts to raise the oestrogen levels present in the media,
however this treatment had no effect on the androgen levels. DES is a non-steroidal
oestrogen with a higher affinity to both ERa and ER[3 than oestradiol (Kuiper et al.,
1997; Bolger et al., 1998; Nikov et al., 2001). The binding of DES to the ERs results
in confonnational changes to the receptor that are similar to those observed when
oestradiol is the ligand (Nikov et al., 2001). In addition, the ER-DES complex has a
comparable binding affinity for the oestrogen response elements as the ER-oestradiol
complex in both humans and Xenopus (Nikov et al., 2001). When in vitro matured
mouse COCs are exposed to DES the oocytes have a delayed cell cycle progression
while at high doses of DES an abnormal condensed chromosome structure is
observed. However, there is no apparent alteration to germinal vesicle stage oocytes
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or GVBD even at the highest doses of DES used (Can & Semiz, 2000). The
androgen levels were altered by the Arimidex, a non-steroidal aromatase inhibitor
which has been shown to have no estrogenic or anti-estrogenic effects (L0nning et
al, 1998; Section 1.15). This raises androgens by preventing their conversion to
oestrogens in the GCs of the follicle. This treatment has the double effect of raising
androgens and also lowering the level of oestrogens (as shown in Figure 1.10 A and
B). At the end of culture period follicles were ruptured and the oocytes were fixed at
4°C overnight in fresh 4% PFA for use in the methylation immunohistochemistry
(Sections 2.6.1 and Section 4.3.1.1). Methylation levels were obtained using the
confocal microscope (Section 2.9) analysed and normalised to allow comparisons
between experimental runs. Chromatin structure was assessed for each treatment
groups and the number of SN and NSN were recorded. Oocytes exposed to A+E
were obtained by carrying out five repeats of the culture system, while three
replicates of the A only and E only cultures were carried out.
Table 4.1:- The raised steroid treatment groups used in culture












To confirm that any observed alterations in global DNA methylation levels were a
true change and not a result of the treatment affecting the permeability of the oocyte,
the ability of the secondary antibody to permeate the oocyte after culture was tested.
Oocytes from the control and A+E treatment groups were used in the normal
methylation immunohistochemistry protocol, with the exception of the primary
antibody incubation. After exposure to the secondary antibody, the oocytes were
only briefly washed in Tween-20 in PBS (0.05%, Sigma-Aldrich, UK) before being
mounted on slides. The level of secondary antibody within the oocyte was assessed
using the Leica confocal microscope and software (Section 2.9).
4.3.4 Experiment 3:- How do global DNA methylation levels of naturally
ovulated oocytes compare to those obtained by superovulation?
To obtain naturally ovulated oocytes, 6 six week old F1 females were caged
overnight with 12 week old F1 surgically vasectomised males. The following
morning the ovaries and oviducts were removed post-mortem into sterile dissecting
medium (as described in Sections 2.2 and 2.4). The oviducts were ruptured using
insulin syringes and the COCs retrieved (Section 2.6.2). These were transferred into
fresh dissecting medium supplemented with hyaluronidase (300pgmf', Sigma-
Aldrich, UK) to remove the cumulus cells from the oocytes. Superovulated oocytes
were obtained from 3 six week old F1 females, as described in Section 2.3. All
oocytes were fixed overnight at 4°C in fresh 4% PFA prior to methylation
immunostaining as described above (Section 4.3.1.1). As described in Section
4.3.1.3, methylation levels were analysed and the data normalised to the mean of the
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naturally ovulated group. Three repeats of this experimental protocol were carried
out and the results analysed separately.
4.3.5 Statistics
Results from Experiment 2, analysis of DNA methylation levels after exposure to
raised steroid levels in culture, were analysed using nonparametric ANOVA and
were subsequently analysed using Dunn's multiple comparison test. The results of
the chromatin configuration analysis were analysed using Chi-Square tests.
The results within each experimental run of Experiment 3, comparing DNA
methylation levels of naturally ovulated and superovulated oocytes, were compared
by unpaired t-tests with Welch correction.
176
4.4 RESULTS
4.4.1 Experiment 1:- How does the global DNA methylation level of the oocyte
alter during pre-antral to Graafian stage follicular growth?
4.4.1.1 Oocytes from in vivo follicles
Oocytes from in vivo derived follicles, of comparable size to those previously
obtained from culture, showed an increase in global DNA methylation level over the
period of oocyte growth and development (Figure 4.2). These oocytes have a diffuse
pattern of staining at the pre-antral stage, but the staining around the nucleolus in
oocytes from larger in vivo follicles is less defined than that seen after culture.
4.4.1.2 Oocytes from cultured follicles
Analysis of the images from the initial control cultures showed that over the culture
period the global methylation levels of the oocytes increased considerably (Figure
4.3, Swales & Spears, 2005). In addition to the change in global DNA methylation
level, the pattern of staining can also be seen to alter with oocyte development. On
Day 0 the staining is diffuse, while by Day 6 the pattern is more compact and there is
a well defined region of strong staining around the nucleolus. The chromatin levels
and pattern also changed over the culture period in a manner comparable to that of
the methylation staining (Figure 4.4). In oocytes which were counterstained with PI,
after immunostaining for DNA methylation, the two stains were found to have an








Figure 4.2 - Global DNA methylation level of oocytes increases over the
period of growth and development associated with the pre-antral to Graafian
stages in vivo. Oocytes are from follicles of equivalent size to Day 0, 2, 4 and
6 in culture. Follicles were dissected from the ovaries of four 6 week old F1
mice. Three replicates of this experiment were carried out. Day 0 equivalent
(175 ± 2pm) n=18; Day 2 equivalent (200 ± 2pm) n=14; Day 4 equivalent
(290 ± 2pm) n=9; Day 6 equivalent (340 ± 2pm) n=14. The scale bars
represent 10pm.
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Figure 4.3:- The global DNA methylation level of oocytes increases over the
period of growth and development associated with follicle development from
pre-antral to Graafian stages in culture. Follicles were dissected from the
ovaries of four 3 week old F1 mice and randomly assigned to each time point.
Two repeats of this culture system were carried out. Confocal images of
global DNA methylation levels of oocytes removed from culture on Day 0
(n=8), Day 2 (n=8), Day 4 (n=8) and Day 6 (n=10) and stained using a 5-
methyl-cytosine antibody and FIT-C secondary. The scale bars represent
10p.m.
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Day 0 Day 2
Day 4 Day 6
Figure 4.4 - Confocal images showing chromatin of oocytes over the
period of growth and development associated with follicle
development from pre-antral to Graafian stages in culture. Follicles
were dissected from the ovaries of four 3 week old F1 mice and
randomly assigned to each time point. Two repeats of this culture
system were carried out. Oocytes were removed from culture stained
with propidium iodide on Day 0 (n=8), Day 2 (n=10), Day 4 (n=T0)
and Day 6 (n=l 1). The scale bars represent 10pm.
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Figure 4.5:- Confocal images of an oocyte from a Day 6 cultured
follicle immunostained for methylation before counterstaining with
propidium iodide (PI). The almost identical localisation of both the
methylation and chromatin stains can be seen. A) Image showing
methylation channel only: B) Image showing PI channel only: C)
Image showing an overlay of both channels. Follicles were dissected
from the ovaries of four 6 week old F1 mice and cultured. Two
repeats of this culture were carried out. At the end of culture the
oocytes were divided between several immunohistochemistry
protocols with 6 oocytes allocated to this methylation and PI staining
group. The scale bars represent 10pm.
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4.4.2 Experiment 3:- Do raised levels of steroids in vitro affect oocyte global
methylation?
Differences in global DNA methylation level were observed after exposure to raised
steroids (Figures 4.6 and 4.7). There was a significant increase (P< 0.0001) in
methylation after A+E treatment while in the A only group there was a significant
decrease (PO.OOl) in global methylation level. The E only treatment group did not
give a result which significantly differed from the control group. The effect of each
treatment group on global DNA methylation levels was consistent in all runs of this
experiment. Thus, the data from all the experimental repeats was combined and
analysed together. When chromatin configurations were assessed more than 80% of
oocytes in all treatment groups had a SN chromatin arrangement (Figure 4.8). There
was a significant difference (P=0.03) in the proportions of SN and NSN oocytes
between the treatment groups. Further analysis which compared each treatment
group to the controls found that the distribution of oocytes in the SN and NSN
chromatin configuration patterns only differed significantly from controls after A+E
exposure (P=0.009).
When compared to controls oocytes from the A only group have a reduced level of
DNA methylation and a lower proportion of oocytes with an SN configuration. This
observation is true for all the treatment groups used in this study with the changing
pattern of DNA methylation levels between treatments being paralleled by the
percentage of oocytes with an SN chromatin configuration (Figures 4.7 and 4.8).
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4.4.2.1 Permeabilisation test
This assessment was qualitative thus there were no statistics used. The assessment
used the image software's ability to assess intensity along a user defined line. A line
was drawn through the oocyte passing through the centre of the nucleolus (the
section assessed was that in which the oocyte had the greatest diameter). Qualitative
assessment was made as to whether the line showed the presence of altered staining
across the oocyte (as would be the case if altered penetration of the GV was
occurring in response to steroid exposure). The majority of oocytes examined had an
unstained nucleolus but there was no evidence of differential staining of the GV
(Figure 4.9). There was no difference in the level of secondary antibody in the
control and A+E group oocytes. This demonstrated that exposure to the raised
steroids did not alter the permeability of the zona pellucida and the ability of the
antibody to enter the oocyte. Thus, the difference in staining intensity does represent
a true alteration in methylation level, rather than demonstrating an artefact of the
treatment.
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Figure 4.6:- Confocal Images of oocytes stained using the anti-5-
methylcytosine antibody after exposure to different steroid treatments in
culture. Panel A are oocytes from the control cultures (n=l 14). Panel B
are images of oocytes recovered from follicles cultured with high A+E
(n=61). Panel C are oocytes from A only cultures (n=51) and Panel D
are oocytes from E only cultures (n=48). Oocytes exposed to A+E were
obtained by carrying out 5 repeats of the culture, while three replicates of
the A only and E only cultures were carried out. Each run of the culture
system consisted of ovarian follicles dissected from a minimum of three
3 week old F1 females randomly distributed between the treatment












Control A+E A only E only
Figure 4.7:- Normalised global DNA methylation levels for each oocyte
according to treatment group, Control, High Androgen (A only), High
oestrogen (E only) and high androgen and oestrogen in combination (A+E).
Horizontal red bars represent the mean of the treatment group. Control
n=l 14; A+E n=61; A only n=51; E only n=48. Oocytes exposed to A+E
were obtained by carrying out 5 repeats of the culture, while three replicates
of the A only and E only cultures were carried out. Each run of the culture
system consisted of ovarian follicles dissected from a minimum of three 3
week old F1 females randomly distributed between the treatment groups.
*'
represents a significant difference (P<0.0001)
*"
represents a significant difference (P<0.001)
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Figure 4.8:- Analysis of chromatin configuration by treatment group.
Control, high androgen (A only), high oestrogen (E only) and high androgen
and oestrogen in combination (A+E). When compared to the controls only
the A+E treated oocytes had a significantly different distribution of SN and
NSN oocytes (P=0.009). Oocytes exposed to A+E were obtained by carrying
out 5 repeats of the culture, while three replicates of the A only and E only
cultures were carried out. Control n= 114; A+E n=61; A only n=51; E only
n=48. Each run of the culture system consisted of ovarian follicles dissected
from a minimum of three 3 week old F1 females randomly distributed
between the treatment groups. SN - Surrounded Nucleolus; NSN - Non-
surrounded Nucleolus.
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Figure 4.9:- Images of oocytes from permeability test experiment
with Panel A showing the control group and Panel B the high
androgen + oestrogen group. Follicles were dissected from the
ovaries of four 3 week old F1 mice and randomly assigned to either
the control (n=25) or A+E (n=18) treatment group. Two repeats of
the culture system were carried out. Confocal images of oocytes
removed from culture on Day 5 and stained with FIT-C secondary
were obtained to assess any alteration in antibody accessibility to the
germinal vesicle. The scale bars represent 10pm.
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4.4.3 Experiment 3:- How do global DNA methylation levels of naturally
ovulated oocytes compare to those obtained by superovulation?
As can be seen in Figure 4.1 OA, in the first run of this experiment the oocytes
obtained after superovulation had slightly lowered global DNA methylation levels.
This reduction in DNA methylation level was not found to be significant. Moreover,
when the experiment was repeated (Figure 4.1 OB) the superovulated oocytes had
significantly higher (PO.OOOl) global DNA methylation levels than oocytes
recovered after natural ovulation. In contrast the superovulated oocytes from the
third run of this experiment had a lower staining intensity than those obtained after
natural ovulation. In fact, this difference was so great that images suitable for
comparison could not be obtained. To allow relative methylation levels to be
assessed all images must be obtained with the same confocal microscope settings,
including a consistent detection level. It was not possible to obtain images from both
the natural and superovulated treatment groups utilising one detection level, as this
led to saturated staining of the naturally ovulated oocytes but no readable staining of
the superovulated group. Thus, no relative comparison between the two treatment
groups could be carried out. As the results from this experiment did not demonstrate
a consistent pattern as to whether superovulation increased or lowered global DNA
























































Figure 4.10:- Normalised global DNA methylation levels for each oocyte
according to whether it underwent superovulation or natural ovulation.
Superovulated group - for each experimental run. oocytes from three 6 week
old F1 females were recovered, pooled and a random sample used in
immunohistochemistry. Naturally ovulated group - oocytes were recovered
from 6 week old F1 females: A) first experimental run: oocytes obtained from
2 females; B) second experimental run: oocytes obtained from 1 female.
Data is not shown for the third experimental run as the intensity differences
between the two groups were too great for images to be obtained using
identical confocal parameters. Horizontal red bars represent the mean of the
group. * represents a significant difference (PO.OOOl).
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4.5 DISCUSSION
Over pre-antral to Graafian follicle development, oocytes from cultured follicles and
those derived from unstimulated in vivo follicles, exhibit increasing levels of global
DNA methylation. This finding is in accordance with the laying down of maternal
imprints and the methylation of non-imprinted repeat sequences during oocyte
development reported by other groups (Obata & Kono, 2002; Lucifero et ai, 2004).
The method used in the current study does not differentiate between the DNA
methylation at imprinted gene loci and that present on other non-imprinted
sequences. Imprinted genes account for a relatively small proportion of the total
methyl groups present on the genome, with the vast majority of methyl groups being
present on methylated repeat sequences. As the observed increase in global
methylation level over oocyte development, both in culture and in vivo, is large, it is
unlikely to be purely due to the methylation of imprinted genes. The sensitivity of
the anti-5-methylcytosine antibody and the regions it binds to must also be taken into
account when assessing the results of these experiments. The immunochemical
assessment of global DNA methylation patterns has been assisted by the
development of anti-5-methylcytosine antibodies. Originally rabbit polyclonal
antibodies were developed against 5-methylcytosine conjugated to BSA and these
antibodies suggested that satellite DNA on the juxtacentromeric long arms of
chromosomes 1, 9, and 16 is heavily methylated in humans, while the rDNA repeats
on the acrocentric short arms of group D chromosomes (13, 14, and 15) and group G
chromosomes (21 and 22) are largely unmethylated. Mouse satellite DNA is also
heavily methylated and easily detectable with anti-5-methylcytosine antibodies
(Miller et al., 1974). However, these polyclonal antibodies are difficult to raise and
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have to be constantly rc-derived and assessed. This hurdle was reduced with the
development of a mouse monoclonal to 5-methylcytosine (anti-5mC) by Niveleau et
al. (1992), which had less problems with non-specific binding to DNA and while still
a semi-qualitative approach, gave reproducible assessments of the patterns and
amounts of DNA methylation in cell lines and oocytes and embryos. As
chromosomal regions with a high density of methylated cytosines will bind more of
the anti-5mC the strength of the signal can be used to assess the distribution and level
of DNA methylation at CpG dinucleotides (Dahl & Guldberg, 2003). A large
proportion of the methylated cytosines are located in the different repeat sequences
of the genome. Thus, staining with anti-5mC largely reflects the methylation present
in interspersed repetitive sequences (Mayer et al., 2000). A high level ofbinding of
anti-5mC has been demonstrated on human metaphase chromosomes where the
antibody binds to the repetitive DNA sequences (De Capoa et al., 1998). Further
analysis of the staining patterns of chromosomes was carried out using both anti-
5mC and a probe for the satellite regions of DNA. On metaphase chromosomes
there was found to be a large region of overlap between the signals from these two
markers, whereas there was a smaller degree of overlap on the chromosome spreads
of interphase nuclei (De Capoa et al., 1998). This finding was also confirmed in
fibroblast cell lines where there was a colocalisation between heterochromatic
regions and anti-5mC binding (De Capoa et al., 1999). Within cultured lymphocytes
there are four types of binding site that have been identified for anti-5mC (Barbin et
al., 1994). These are Type I sites which correlate to the secondary constrictions and
a few juxtacentromeric regions. The Type II sites are defined as those corresponding
to the T-bands while Type III sites are considered to form an R-band pattern. The
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binding of anti-5mc to the short arms of acrocentrics makes up the final Type IV
sites (Barbin et al., 1994). The intensity of staining of these sites has been found to
differ with both Type I and II sites being strongly stained, while the signal from Type
III sites is weaker. Although the Type IV sites have the strongest anti-5mC signal
this region demonstrates polymorphic staining (Barbin et al., 1994). The fact that
these differing patterns of anti-5mC binding can be observed across the different
chromosomal regions represents the uneven distribution and localisation of the
methylated cytosines (Barbin et al., 1994). The staining of bovine fibroblast cells
with anti-5mC demonstrates that the binding of this antibody is not restricted to the
heterochromatic regions. There is also staining of the euchromatin regions present in
abanding pattern (Bourc'his et al., 2001).
During oocyte development there are changes to the chromatin configuration of the
oocyte, which constitutes an important process in oocyte nuclear maturation (Section
1.6). The pattern of methylation staining seen in this study was identical to the PI
staining of chromatin. Thus, in addition to analysis of methylation levels, the
chromatin configuration in these images was also assessed. From these results,
oocytes from pre-antral follicles demonstrate a more diffuse chromatin pattern, with
no defined region of chromatin condensation surrounding the nucleolus. All the
oocytes from Day 6 cultured follicles had more condensed chromatin and a SN.
These observations support the previously published data describing a diffuse
chromatin distribution being characteristic of transcriptionally active immature
oocytes, prior to acquisition of meiotic competence (Mattson & Albertini, 1990;
Wickramasinghe et al., 1991; Bouniol-Baly et al., 1999). The more condensed SN
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configuration correlates with oocyte maturation, cessation of transcription and the
ability to undergo germinal vesicle breakdown (Zuccotti et al., 1998; Bouniol-Baly et
al., 1999; Liu & Aoki, 2002). Oocytes which have achieved the SN chromatin
configuration have increased developmental competence (Zuccotti et al., 1998).
When the in vivo oocytes obtained from the Day 6 equivalent follicles were analysed
they had a less condensed chromatin structure than those oocytes isolated from
comparable cultured follicles. Additionally, not all in vivo derived oocytes were
found to have a SN. This suggests that there are differences in the acquisition of
developmental competence between cultured and in vivo oocytes. Although this may
represent a precocious maturation of oocytes from cultured follicles, it has been
proposed that premature acquisition of SN chromatin configuration may be
associated with initiation of atresia (Zuccotti et al., 1998; Bouniol-Baly et al., 1999;
Liu & Aoki, 2002). The differences in both DNA methylation level and pattern
between oocytes from in vivo and in vitro follicles of comparable size may represent
an alteration in developmental timing of the oocyte rather than an inherent change in
the acquisition of DNA methylation.
The culture system described here had previously been used to provide oocytes for
IVF, which allowed investigation of the effects of raised steroid levels on both
fertilisation rate and embryo development (Figure 1.11 and Murray et al., 2005).
With the exception of the E only group, this study found an inverse relationship
between global DNA methylation levels and fertilisation rate. The A only group had
the lowest DNA methylation level but the highest fertilisation rate, while the reverse
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was true for the A+E treatment. The E only group did not support this pattern. In
this treatment group, the fertilisation rate is significantly lower than that of the
control group, but there is no significant difference between the global methylation
levels for these two groups. When considering the results from this experiment it
must be noted that the control group does not represent oocytes exposed to the
"normal" physiological environment. Thus, any deviation from the control levels of
DNA methylation may not indicate a detrimental effect of the steroid treatments.
Indeed, when the previous IVF fertilisation rates (Murray et al., 2005) are considered
it would appear that those oocytes exposed to androgen during culture may in fact
have matured in a physiologically more "normal" manner. The fact that the same
culture protocol and treatment parameters were employed in both the current and
previous study (Murray et al., 2005) allows valid comparisons to be drawn. The
previous IVF results were obtained from three experimental replicates, each
demonstrating a consistent pattern, thus illustrating the reproducibility of the
experimental procedure and protocol. Additionally, the DNA methylation level and
embryo developmental capacity cannot both be measured for an individual oocyte.
Therefore these assessments will always have to be made on a separate pool of
oocytes. Although the control group has a large spread of values it is still valid to
normalise all results to the mean of this group. It was vital to have a common point
of reference to allow a comparison between experimental runs. The spread of results
in the control group does not detract from the findings in this section as it is a
comparative study rather than giving absolute values.
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Interestingly, there is a correlation between the DNA methylation levels and the
proportion of oocytes with a SN chromatin configuration. After A+E treatment
methylation levels are higher than those of control oocytes. There is a concurrent
increase in the proportion of oocytes with a SN than seen in the control group. The
A only treatment gave both the lowest percentage of SN oocytes and the lowest
global methylation levels. This trend may represent subtle differences in the
developmental competence of the oocytes within each treatment group, which could
not be determined by assessment of follicular health. Chromatin configuration, DNA
methylation and gene transcription are three connected processes. As previously
discussed in Section 1.12.3, the addition of methyl groups to DNA allows binding of
the relevant Mbd protein and co-repressor complexes, which subsequently recruit
HDACs. The deacetylation of the histones then results in condensation of the
chromatin structure, thereby repressing gene transcription. When the results of this
study are considered, there is a correlation between lowered methylation levels and a
reduction in the percentage of oocytes with the more condensed SN chromatin
configuration. Conversely, hypermethylated DNA is associated with more oocytes
achieving condensed chromatin. This finding is supported by previous studies which
found that DNA methylation plays an important role in the condensation of
chromatin, such that if DNA becomes hypomethylated then heterochromatin is under
condensed (Maraschio et al., 1992; Almeida et al., 1993; Haaf & Schmid, 2000). In
this study it may the case that steroid-induced changes in DNA methylation level
impacts on subsequent chromatin remodelling, thereby altering gene transcription. If
in the A+E group the increase in DNA methylation has resulted in precocious
chromatin condensation, it may mean that gene transcription was prematurely halted.
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In this case, the oocyte will not have the appropriate mRNA stores in place to
support fertilisation or pre-implantation development. Alternatively, it may be that
both the altered methylation levels and the SN/NSN ratio after steroid treatment
could be the outcome of altered timing of oocyte development, rather than specific
effects of steroids on DNA methylation or chromatin configuration. Intriguingly, the
A only group which had the highest proportion of oocytes at the NSN stage (which is
the configuration associated with reduced maturity), was the group with a
significantly raised fertilisation rate. This may add weight to the proposal that
premature entry into SN is a negative parameter in developmental competence
potentially due to impending atresia (Zuccotti et al., 1998; Bouniol-Baly et al., 1999;
Liu & Aoki, 2002). Although the results from this experiment demonstrate that the
steroidal environment can influence the DNA methylation level of the oocyte it is not
possible to tell how this interaction occurs or whether this change influences later
embryo development.
The superovulatory gonadotrophins act to recruit follicles into the pre-ovulatory
cohort. The development of immature growing follicles is accelerated by the
increased levels of FSH. This FSH will also have resulted in the rescue of follicles
which would otherwise be destined for atresia. This may result in oocytes being
ovulated from follicles in which atretic pathways had already been activated, prior to
the addition of exogenous FSH. When this is taken into account, it may be
anticipated that there would be differences in the quality of oocyte recovered after
superovulation, when compared to natural ovulations. The results presented here do
suggest that one important aspect of oocyte maturation, the acquisition and
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maintenance of DNA methylation, may differ between the two groups of oocytes, but
found tremendous variability in that effect. The altered average DNA methylation
levels observed in the superovulated oocytes may not represent a direct effect on
DNA methylation levels by the altered hormonal environment. It may be that the
follicles stimulated to ovulate contained oocytes which had not yet had the complete
maternal imprints laid down or were lacking methylation on some of the normally
methylated repeat sequences. The superovulation regime will override the normal
selection process which determines which follicles will develop fully. Exogenous
gonadotrophins will also promote some aspects of oocyte maturation, but these
results introduce the possibility that normal DNA methylation levels are not
achieved. However, the discrepancy between the results, from each of the three
experimental repeats, and the low sample numbers involved means that no
conclusive answer can be reached. Additionally, it must be taken into account that
the sample number within this experiment is low, particularly for the experimental
repeat in which a statistically significant difference was observed (Figure 4.1 OB). As
the power of a statistical test is proportional to the sample size of the experiment the
power of this particular finding is low again adding to the limitations of this
experiment. Whether the altered levels observed are due to differences between
individual mice cannot be assessed as there was pooling of the superovulated oocytes
in all replicates of the experiment and of the naturally ovulated oocytes obtained in
the first experimental run. In follow up work it may be beneficial to keep the oocytes
from each female separate to allow an assessment of whether differences in
methylation level are observed between individual mice as well as increasing the
number of oocytes assessed.
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The observed differences in DNA methylation levels could be a consequence of post-
ovulatory oocyte aging. Although ovulation is assumed to occur between 8-14 hours
after the administration of hCG, the exact time period between ovulation and oocyte
retrieval in either the naturally ovulating or superovulated females used in this
experiment is unknown. This introduces the possibility that the variation in DNA
methylation levels may actually represent aging of the oocyte rather than a hormonal
effect. The naturally ovulated oocytes in the first and third experimental repeats
demonstrated a trend towards higher DNA methylation levels than superovulated
oocytes. It may be expected that if aging were to have any effect on DNA
methylation levels, it would result in reduced global DNA methylation due to
degeneration of the oocyte. However, a recent study has found that in superovulated
oocytes, DNA methylation of the Pegl/Mest gene is completed between ovulation
and fertilisation (Imamura et al., 2005). This suggests that it is possible for de novo
methylation to occur post-ovulation. Additionally, they found this gene underwent
some demethylation in older post-ovulatory oocytes. When the current experiment
was repeated, the naturally ovulated oocytes were found to have significantly lower
global DNA methylation levels than the superovulated oocytes. In this case, it could
either be that a longer time period had passed between ovulation and recovery of the
oocytes, resulting in the loss of DNA methylation, or that the post-ovulatory de novo
methylation had not yet been completed.
Even bearing in mind the widely differing results from the three repeats of this
experiment the results suggest there are potential differences between the
methylation status depending on whether oocytes are obtained with no stimulation or
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after superovulation. It may be that the time span between ovulation and oocyte
retrieval is a critical aspect of these differences. The use of an additional treatment
group may help to clarify the role of post-ovulatory aging on the DNA methylation
levels of oocytes. The administration of a small dose of PMSG to stimulate follicular
growth used in the absence of the ovulatory dose of hCG would allow a natural
ovulation to occur. Thus, in terms of post-ovulatory aging this PMSG only group
would be comparable to the oocytes recovered after no stimulation. The
superovulation treatment group (receiving both PMSG and hCG) would still be of
interest but the timing of hCG administration and the subsequent time of ovulation
would need to be carefully considered. During this experiment no assessment of the
oestrous cycles of the females was attempted. By taking vaginal smears and then
only placing females with the vasectomised male as they neared oestrous it may have
been possible to obtain larger numbers of naturally ovulated oocytes for analysis.
The addition of a control group of oocytes to allow comparison of DNA methylation
levels between experimental repeats would also provide additional information as to
how consistent the level of methylation of naturally ovulated oocytes were. Oocytes
recovered from antral follicles were used as a potential control group. However, due
to the less condensed staining pattern of these oocytes the signal intensity was too
low to be captured at the same detection level as the ovulated oocytes.
Other studies that have investigated the effects of culture on genomic imprinting
found that early pre-implantation embryos had altered expression of imprinted genes
and aberrant methylation profiles (Doherty et al., 2000; Shi & Haaf, 2002). These
observations have been interpreted as being an embryonic response to the in vitro
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environment the embryo is exposed to. However, in a large amount of these studies
embryos were produced following superovulation. Thus, whether embryos were
obtained by in vitro fertilisation or were flushed after in vivo fertilisation, they
originated from oocytes which had been exposed to high levels of exogenous
hormones. It may be that some of the observed changes to imprinting and DNA
methylation in the embryo could have their origins in the superovulated oocyte, due
to an altered environment during maturation.
The fos proto-oncogene (c-fos) encodes the Fos protein which is involved in
regulation of transcription through activator protein-1 (AP-1) and cAMP response
elements (Bakin & Curran, 1999). Fos activity is thought to be a mechanism through
which extra-cellular signals can alter gene expression. DNA methylation is one of
the key epigenetic mechanisms responsible for controlling gene transcription. Thus,
the fact that Dnmtl mRNA levels increase when cells are transformed with c-fos may
represent one of the mechanisms by which Fos influences gene expression (Bakin &
Curran, 1999). This response is relatively rapid with a measurable increase in Dnmtl
mRNA evident 4 hours after induction of c-fos expression (Bakin & Curran, 1999).
The up-regulation ofDnmtl mRNA was associated with an increase in Dnmtl
protein (Bakin & Curran, 1999). Examination of the DNA methylation levels in
these transformed cells found a 20% increase above control levels (Bakin & Curran,
1999). One factor that has been demonstrated to result in an up-regulation of c-fos in
the female reproductive tract is DES, suggesting a mechanism by which oestrogenic
compounds could influence DNA methylation levels (Kamiya et al., 1996). The
effect of the androgen, dihydrotestosterone (DHT), on c-fos expression in a cell line
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has also been analysed and a significant increase in c-fos mRNA observed (Brum et
ctl., 2003). The presence of c-fos and Fos within the oocyte and ovary have not been
extensively investigated but Fos has been localised to the porcine oocyte (Rusovici &
Lavoie, 2003). A subsequent analysis of mouse ovaries did not report any Fos
protein localised to the mouse oocyte, but it was found in the CL and the theca cells
(Oktay & Oktay, 2004). Thus, the effect of steroids on c-fos expression could be a
candidate mechanism by which the changes in DNA methylation observed in the
current study are mediated. Further work to analyse the expression of c-fos in
oocytes may help to elucidate the mechanisms underlying the altered DNA
methylation levels observed after culture with raised steroids.
Within this study only a minority of oocytes were counterstained with PI. In
retrospect PI staining of all oocytes may have allowed a more detailed interpretation
of the results in this chapter. As nuclear counterstaining of all oocytes would be
advantageous future work on this topic would benefit from PI staining. The images
depicted in Figures 4.2 and 4.3 only underwent a visual assessment rather than full
computer assisted image analysis. Initially this part of the experiment was intended
as a preliminary observation to detennine the scope for using the methylation
immunohistochemistry. Thus, the need for a more in-depth approach to image
analysis was not fully appreciated. In retrospect, the additional information that
could be obtained by image analysis and PI counterstaining would be a valuable
addition to this investigation and would be undertaken if the work were to be
repeated. As DNA methylation levels were only assessed visually, the apparent
increase in methylation from day 0 to day 6 of in vitro oocyte development could
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represent a visual artefact resulting from the changing nuclear size and chromatin
condensation. In future work this concern could be avoided by determining the ratio
of mean methylation intensity to nuclear size (Beaujean et al., 2004a; 2004b). With
regard to making a visual assessment, merged Z-stack images would be beneficial to
provide information on the 3D staining pattern. However, for any assessment of
staining intensity the previously used unmerged Z-stack sections would be preferable
in keeping with the image analysis undertaken in the remainder of this chapter.
When the relative quantitation carried out in this chapter is considered there would
have been no benefit gained from the use of merged Z-stack images. Although
assessing each section separately, the image analysis method employed still ensured
that the full staining information from each oocyte was obtained, analysed and
incorporated into the overall results. Thus, the decision not to merge the Z-stack
images does not detract from the comparative DNA methylation results presented
within this study. Additionally, all the oocytes were analysed using a consistent
method to ensure they were comparable. It should also be considered that the results
are all presented relative to controls (relative quantitation) rather than attempting to
give an absolute quantitative assessment of the level of DNA methylation present.
As there are known to be differences in reproductive parameters between individual
mice all experiments were designed such that more than one female was used and the
follicles/oocytes from all the animals were pooled. This means that no conclusions
on variability between or within mice can be drawn from the results presented in the
current study. This would perhaps be an interesting line for future investigation
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where oocytes recovered from individual animals were identified within each
experimental replicate.
4.5.1 Further Work
It would be of significant interest to establish whether the changes in global DNA
methylation levels observed, after exposure to raised steroids, represented alteration
to the methylation status of imprinted or non-imprinted sequences. The detailed
analysis of specific imprinted genes methylation status could be carried out using
bisulphite sequencing. Any regions which show an alteration in overall DNA
methylation could be further analysed, using the methylation-sensitive single
nucleotide primer extension (Ms-SNuPE) technique. This allows the methylation
status of a particular cytosine residue to be analysed (Gonzalgo & Jones, 1997).
However, the small number of oocytes obtained using the in vitro model described
here would be restrictive. As can be seen in this study, the global levels of DNA
vary greatly between individual oocytes. Thus, any pooling of oocytes by treatment
group, as would be required to provide adequate levels for analysis, may mask any
changes in methylation status present in individual oocytes.
An additional consideration when analysing actual, rather than comparative, DNA
methylation levels is the protocol used. The methylation immunohistochemistry
protocol requires the use of HC1 to denature the DNA, as the antibody can only gain
access the methyl groups on single stranded DNA. However, excess exposure to
HC1 can actually cause purinisation of the CpG dinucleotide resulting in artificially
lowered methylation levels (Benchaib et al., 2005). The exposure time was not
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optimised in this study, as the rationale was to investigate methylation levels between
comparable groups of oocytes. If this same approach was to be used to establish
actual methylation levels, then this step would need to be optimised to ensure an
accurate result.
If further analysis of the actual DNA methylation levels present were not possible,
further use of the method comparing relative global DNA methylation levels would
prove worthwhile. In the cultures described in this study the steroid levels were
consistently high throughout the entire culture period. Further work examining the
precise time at which the altered steroidal environment exerts its effects would be
interesting. Ultimately, it would be important to utilise embryo transfer to
investigate the long-term effects of the steroids. Although a previous study by
Murray etal. (2005), found alterations in fertilisation rates, after steroid levels were
raised during culture, the long-term implications on embryo development and
survival of offspring have not been investigated.
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Chapter 5
Effect of androgens and oestrogens on
translocation of Dnmtlo in the oocyte
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5.1 INTRODUCTION
Oocytes and pre-implantation embryos exclusively contain Dnmtlo, an N-truncated
splice variant of Dnmtl (Carlson et al., 1992; Mertineit et al., 1998; Ratnam et al.
2002). Dnmtl s has been assigned a role in maintenance methylation due to its
preference for hemi-methylated DNA in biochemical assays. Since Dnmtls adds
methyl groups to the DNA during the S phase of cell division, the role of Dnmtl s as
a maintenance methyltransferase depends upon cell replication. It also has
significant de novo activity in vitro (Yoder et al., 1997), thus the role for this
methyltransferase in vivo may not be restricted to maintenance of methylation. There
is conclusive evidence from knockout studies that either over-expression or loss of
Dnmtls is embryo lethal due to global genome wide hyper- or hypo-methylation
respectively (Li et al., 1992; Biniszkiewicz et al., 2002). The inappropriate
expression of Dnmtls, as opposed to Dnmtlo, in embryos obtained by somatic cell
nuclear transfer has been identified as a potential cause of the poor developmental
potential observed after this experimental procedure (Chung et al., 2003).
Modification of the Dnmtl locus such that Dnmtls is expressed from the Dnmtlo
promoter results in Dnmtl s protein being produced in the oocyte (Ratnam et al.,
2002). When embryos are derived from these oocytes the Dnmtls protein undergoes
the same cytoplasmic to nuclear translocation in the 8-cell embryos as Dnmtlo.
Although the timing of Dnmtls translocation is comparable to that of Dnmtlo in
wildtype embryos, the cytoplasmic distribution differs (Ratnam et al., 2002). The
less even distribution of Dnmtls protein may be due to differing mechanisms by
which the proteins are stored and translocated. There is evidence that Dnmtlo co-
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localises with annexin V in the oocyte cytoplasm, raising the possibility that this is
part of the mechanism by which Dnmtl o is retained in the cytoplasm (Doherty et al.,
2002).
Dnmtlo is capable of substituting for Dnmtl s in embryonic stem cells suggesting
that Dnmtlo has the same functional capabilities as Dnmtls (Gaudet et al., 1998).
This finding is supported by a subsequent study which generated viable and fertile
mice that synthesised Dnmtl o in place of Dnmtls protein in all somatic cells (Ding
& Chaillet, 2002). There could, however, be a highly specific role for the more
stable Dnmtlo within the oocyte or early embryo but its function remains to be fully
determined.
5.1.1 Localisation Profile of Dnmtlo
Oocytes within primordial follicles do not contain detectable levels of Dnmtlo, but
in the growing oocyte high levels of Dnmtlo accumulate in the nucleus. Dnmtlo in
the oocyte undergoes nuclear to cytoplasmic translocation over the later stages of
oocyte development, so that in the fully mature oocyte the protein is exclusively
localised to the cytoplasm (Mertineit et al., 1998; Howell et al., 2001). This
localisation is maintained due to an active mechanism which sequesters the protein to
the cytoplasm (Doherty et al., 2002). Throughout almost all pre-implantation
development Dnmtlo remains localised in the cytoplasm, with the exception of the
8-cell embryo when the protein again translocates to the cell nuclei (Carlson et al.
1992; Mertineit et al., 1998; Cardoso & Leonhardt, 1999; Ratnam et al., 2002).
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5.1.2 Role ofDnmtlo
The identity of the methyltransferase responsible for establishing the maternal
imprints in the oocyte is still debated. However, several characteristics ofDnmtlo
have led to it being proposed as the enzyme responsible for maternal imprinting. The
fact that the accumulation ofDnmtlo in the oocyte coincides with the period of time
that maternal imprints are laid down raises the possibility of an important role for
this enzyme. Over the follicular growth phase the oocyte remains in meiotic arrest.
Therefore, Dnmtlo cannot be functioning in its expected role as a maintenance
methylase, as this is only possible during the S phase of cell division.
The role ofDnmtlo has been investigated using Dnmtlomice, which lack Dnmtlo
but have nomial somatic cell levels of Dnmtls (Howell et al., 2001). When the
reproductive capabilities of these mice are assessed the Dnmtlo'1' males have normal
fertility levels. This was not found to be the case for females: although they did
become pregnant, most embryos died between El4-21 (Howell et al., 2001). The
loss of Dnmtls is embryo lethal due to genome wide hypo-methylation, but embryos
from the Dnmtlo'1' females did not exhibit this global hypo-methylation (Li et al.,
1992; Howell et al., 2001). Although global DNA methylation levels were not
affected, some imprinted genes had aberrant methylation patterns resulting in
inappropriate expression of these genes in the embryos. It appears that one half of
the normally methylated alleles had become demethylated in the offspring of
Dnmtlo'1' females. Analysis of DNA methylation patterns in the embryo does not
reveal whether the aberrant methylation represents the failure of DNA methylation
during oocyte development or an inappropriate loss of methylation during early pre-
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implantation development. A detailed analysis of the normally maternally
methylated Snrpn promoter found that in Dnmtlo'1' oocytes normal methylation
patterns had been established, however, in the early embryos half of these alleles
were unmethylated (Howell et al., 2001). Further analysis of individual imprinted
gene sequences in oocytes is difficult so a method allowing an assessment of
genome-wide methylation status of the oocyte genome was employed. This involved
replacing the maternal pronucleus of a normal zygote with that from a fertilised
Dnmtlo1' oocyte. Viable offspring were obtained from this experiment suggesting
that normal maternal methylation patterns were present on the Dnmtlo'1' oocyte
genome. When the reciprocal experimental transplants were carried out no viable
offspring were bom (Howell et al., 2001). This demonstrates that the inappropriate
loss of methylation from one half of the normally methylated alleles was occurring
during embryonic rather than gamete development. There is conflicting evidence as
to the role of Dnmtlo in methylation of the IAP sequences in the oocyte and pre-
implantation embryo: Howell et al. (2001) found no alteration to IAP methylation in
the absence of Dnmtlo expression whereas Gaudet et al. (2004) found Dnmtlo was
required for maintenance of methylation levels at particular IAP sequences.
In the embryo, the temporary nuclear translocation of Dnmtlo has been shown to
occur independently of transcription, protein synthesis and DNA replication and
instead is hypothesised to be an event dependent on the period of time elapsed since
fertilisation (Doherty et al., 2002). This raises the possibility that the translocation of
Dnmtlo observed during oocyte maturation may also occur at a pre-determined time
point. As described in Section 1.6, the cytoplasmic and nuclear maturation of the
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oocyte must be co-ordinated if a developmentally competent oocyte is to be
produced. If the maturing oocyte is exposed to a sub-optimal environment then the
synchronisation of nuclear and cytoplasmic maturation can be perturbed. It is
possible that the translocation of Dnmtlo protein from the nucleus to the cytoplasm
of the maturing oocyte could be one aspect of maturation which is sensitive to
environmental changes. Transcripts ofDnmtlo are only present in the oocyte and
the one cell embryo yet the protein is present in the pre-implantation embryo
suggesting that the translation of the Dnmtlo protein present in the embryo occurred
during oocyte development and prior to the first embryonic cleavage (Ratnam et ai,
2002). The fact that the full complement of embryonic Dnmtlo is transcribed and
largely translated during oocyte development means the effects of altering the
translocation of Dnmtlo during oocyte maturation could have an impact during
development of the subsequent embryo.
Dnmtlo within the oocyte (if any) has yet to be conclusively determined. In addition
to this there is no reason to conclude that purely because development can progress
in the absence of oocyte Dnmtlo that inappropriate localisation of the protein could
not prove to be detrimental to oocyte developmental competence. Even if Dnmtlo
would normally have its effects during its transient nuclear localisation in the 8-cell
embryo it is entirely possible that failure to undergo normal translocation processes
in the oocyte could have an effect. Indeed it may be that incomplete removal of the
protein from the nuclear compartment during oocyte development leaves it
incorrectly positioned such that it is able to have an undesirable effect during the
early stages of embryo development. Additionally, Dnmtlo interacts with Aimexin
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V in the oocyte (this interaction is not yet understood) thus it may be that altered
translocation of Dnmtlo could have an impact on the function of Annexin V
(Doherty et al., 2002). It is highly desirable that the oocytes obtained by
superovulation and matured or cultured in vitro are as physiologically "normal" as
possible to allow both research work and reproductive techniques to progress. Thus
investigations which help determine factors that are able to influence aspects of
oocyte development are important.
5.2 AIM
The localisation of Dnmtlo is highly regulated with developmental stage in both the
oocyte and early embryo. Thus, any alteration of the timing of translocation between
the cytoplasm and nucleus may have an impact on the DNA methylation status and
hence developmental competence of the oocyte or pre-implantation embryo. As
discussed in Section 4.4.2, exposure to high concentrations of androgens and
oestrogens in culture resulted in alterations to global levels of oocyte DNA
methylation. Potentially, this observation could be the result of inappropriate
localisation of Dnmtlo leading to aberrant methylation of the oocyte genome. The
aim of this study is to investigate whether raised levels of androgens and oestrogens
influence the translocation of Dnmtlo in the developing oocyte and could thereby
affect global methylation levels and subsequent development.
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5.3 MATERIALS AND METHODS
The study required investigation of the localisation pattern of Dnmtlo after exposure
to raised androgens and oestrogens in culture. However, there is no antibody
available that just detects the Dnmtlo protein. Instead, the study used the PATH52
antibody (Carlson et al., 1992). The epitope that the PATH52 antibody binds to is
common to both Dnmtls and Dnmtlo proteins (Carlson et al., 1992; Howell et al.,
2001; Ratnam et al., 2002). Although Dnmtls protein is not normally found in
oocytes the rnRNA transcripts are present. In order to check that any Dnmtl
recognised by the PATH52 antibody was indeed due to expression of the Dnmtlo
protein, a second antibody UPT82, that only detects Dnmtls protein, was also used
(Ratnam et al., 2002). Antibodies were stored at 4°C in an undiluted state. Although
the initial aim was to carry out an analysis of Dnmtlo after culture with all the
treatment groups previously described in Table 4.1, time constraints meant that only
an assessment of the A+E treatment group was able to be carried out.
5.3.1 Follicle Culture
Pre-antral follicles were dissected from 3 week old F1 ovaries and cultured for 5
days as described in Sections 2.4 and 2.5. A small number (n=21) of pre-antral
follicles were not cultured; instead these were ruptured immediately after dissection
and these Day 0 oocytes were then fixed for immunohistochemistry as detailed in
Section 2.6.1. Cultures were carried out as previously described, in Section 2.7. For
the experimental group, the basic culture medium was supplemented after filtration
with Arimidex and DES, both solubilised in ETOH, to give a final concentration of
0.1pm and 4nmol respectively. Control follicles were cultured in the standard
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medium with ETOH added. These groups were the same as the control and A+E
treatment groups described in Table 4.1. The basic culture medium was freshly
made up as required and the supplementation with steroids and ETOH was carried
out immediately prior to the media being dispensed into the culture wells. The
experiment was repeated on seven separate occasions with follicles obtained from a
minimum of three 3 week old F1 mice being used in each replicate.
5.3.2 Dnmtlo and Dnmtls Immunohistochemistry
Follicles were ruptured and oocytes recovered and fixed as previously described
(Section 2.6.1). All steps were carried out at room temperature. Oocytes were
washed in PVP/PBS (3mg/ml, Sigma-Aldrich, UK) for 15 minutes prior to
penneabilisation in Triton X-100 (0.1% in PBS, Sigma-Aldrich, UK) for a further 15
minutes. The PVP/PBS wash was repeated and oocytes transferred to blocking
solution (BS) for 15 minutes (0.1% BSA, 0.01% Tween 20 in PBS, Sigma-Aldrich,
UK). Incubation with the PATH52 antibody (1:1000 dilution in BS; gift from T.
Bestor) was carried out for 1 hour followed by two washes of 15 minutes each in BS.
The secondary antibody used was donkey anti-rabbit FIT-C (Jackson Immunotech,
USA) diluted 1:500 in BS for 1 hour in the dark. The final step was a 1 hour wash in
BS with oocytes being mounted on positively charged Superfrost slides (VWR
International Ltd, UK). After oocytes were placed on the slides excess liquid was
removed prior to the addition of vectashield (Vector Laboratories, USA) and the
coverslip (thickness 1, BDH, UK). Some oocytes from each treatment group (Day 0
n= 10; Control n= 32 ; A+E n= 24) were allocated to the negative control group. The
same immunohistochemistry protocol was carried out on these negative controls with
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the exception of the primary antibody step. Instead of incubation with the primary
antibody they were transferred into a fresh BS drop.
As the PATH52 antibody described above cannot discriminate between Dnmtls and
Dnmtlo a further immunohistochemical assessment was required to demonstrate the
exclusive presence of Dnmtlo. The UPT82 antibody, which only detects the Dnmtls
protein, was used to stain oocytes isolated from follicles exposed to A+E in culture
(gift from R. Chaillet). All steps were carried out at room temperature. After fixing,
in freshly made 4% PFA, oocytes were blocked and permeabilised for 1 hour in
blocking buffer (3% BSA, 0.1% Triton X-100 in PBS). Oocytes were transferred to
primary antibody, UPT82 (1:100 in blocking buffer), and left overnight at 4°C. To
provide a negative control for the staining procedure a number of oocytes (n=3) were
not incubated with primary antibody and were instead transferred to a fresh drop of
blocking buffer. Other than the omission of the primary antibody the
immunohistochemistry protocol for these negative control oocytes was normal. The
following day oocytes were washed three times for 5 minutes per wash in blocking
buffer before being moved to the anti-rabbit IgG alexa fluor secondary antibody
(1:250 in blocking buffer; Molecular Probes, Invitrogen, UK) and left for 5 hours at
4°C in the dark. Finally three 5 minute washes in blocking buffer were carried out
before oocytes were mounted on positively charged slides in vectashield mounting
medium (Vector Laboratories, UK). All antibodies were stored in their undiluted
state at 4°C. The PVP/PBS, Triton X-100, BSA and Tween 20 were all stored at 4°C
for up to one month. The BS and blocking buffer were only made up as required and
when appropriate the antibodies added immediately prior to use. After staining all
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slides were stored at 4°C wrapped in foil and confocal images were obtained within 6
hours to prevent deterioration of the fluorescent signal.
All imaging was carried out using the Leica upright TCS-NT confocal microscope
(Leica Microsystems UK Ltd, UK) as described in Section 2.9. The image to be
obtained for analysis was the section of the oocyte in which the nucleolus was at its
largest diameter as determined by a visual assessment. If no nucleolus was visible
upon scanning through the entire depth of the oocyte, then the image selected for
analysis was that in which the oocyte diameter was at its greatest. A single image of
each oocyte at this point was captured using the confocal microscope. The negative
controls were also assessed on the confocal microscope (Day 0 n= 10; Control n= 32;
A+E n= 24).
5.3.3 Image Analysis
While growing oocytes have Dnmtlo in both the cytoplasm and the nucleus, the fully
grown oocyte in a Graafian follicle has strong staining for Dnmtlo throughout the
cytoplasm but an unstained nucleus (Mertineit et al., 1998). The criteria used to
assess the Dnmtlo localisation pattern in the current study were determined using
these previous observations from Mertineit et al. (1998). The criteria used in this
study are based on the hypothesis that Dnmtlo would only be able to lay down DNA
methylation while localised to the GV, as once sequestered in the cytoplasm it would
no longer have access to the oocyte DNA.
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The staining pattern of each oocyte was assessed and categorised according to the
criteria detailed in Table 5.1 below. Images from seven separate cultures were
assessed using a blind analysis (Day 0 n= 11; Control n=76; A+E treatment n=72).
Table 5.1Description of immunohistochemistry staining categories
Group Description of Staining
GROUP 1 Fully Stained (no GV or nucleolus visible)
GROUP 2 Fully stained GV but unstained nucleolus
GROUP 3 Partially Stained (GV still visible)
GROUP 4 Unstained GV
5.3.4 Statistical Analysis
The distribution of oocytes between each of the localisation groups after control and
A+E treatment were statistically analysed using the chi-square test.
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5.4 RESULTS
5.4.1 Dnmtlo and Dnmtls Immunohistochemistry
To determine whether Dnmtl o was the sole variant present in the oocytes after
exposure to A+E they were incubated with the UPT82 antibody. There was no
positive oocyte-staining with this antibody, demonstrating that no Dnmtls was
present in the oocytes (Figures 5.1 A). The cumulus cells acted as a positive control
for this immunohistochemistry protocol with very strong staining evident (Figure
5.1 A). All of the oocytes from Day 0 pre-antral follicles (n=ll) that were stained
with PATH52 had a Group 3 localisation pattern where the GV was visible but
partially stained (Figure 5.1C). Several patterns of staining were observed in
cultured oocytes using the PATH52 antibody (Figures 5.1D-F). There was a very
small number of oocytes (n=6) which were entirely stained with no nucleolus evident
(Group 1, Figure 5. ID). A higher number of oocytes had both cytoplasmic and
nuclear staining while only the nucleolus remaining unstained (Group 2, Figure
5. IE). Other oocytes had some partitioning of the stain similar to that of the oocytes
from uncultured follicles, such that the germinal vesicle had less staining than the
cytoplasm: these were determined as having a group 3 localisation pattern (Figure
5.IF). When oocytes were analysed according to the criteria described in Table 5.1 it
was found that there were no oocytes from either control or A+E cultures which had
the Group 4 localisation pattern of an entirely unstained GV.
A total of 76 oocytes from control cultures and 72 from A+E supplemented cultures
were analysed. The majority of control oocytes (75%) had a staining pattern
consistent with Group 2, where the GV was completely stained and the nucleolus
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was visible (Figure 5.2). In contrast, only 50% of oocytes exposed to A+E during
the culture period had a Group 2 localisation pattern (Figure 5.2). The proportion of
oocytes with partially stained GVs (Group 3) was also found to differ between the
treatment groups. Only 18% of controls had a partially stained GV while 49% of
oocytes exposed to A+E in culture fell into this category (Figure 5.2). A chi-square
test was used to determine whether the proportion of oocytes with each localisation
pattern varied between treatments, a significant difference was found (P=0.0003).
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Figure 5.1:- A) Oocyte from A+E treated follicles cultured for 5 days,
stained with UPT82 antibody which detects only Dnmtls staining. The
cumulus cells are strongly stained while the oocyte is unstained. B)
Transmitted light image of the oocyte in A. C) Oocyte recovered from pre-
antral follicle on Day 0 of culture and stained with PATH52 antibody to
detect Dnmtl (both somatic and oocyte variants) D-E) Oocytes cultured for 5
days and then stained with PATH52. Examples of staining D) Group 1, no
nucleolus visible E) Group 2, unstained nucleolus F) Group 3, with GV
evident All scale bars represent 10pm.
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Figure 5.2:- The graph shows the percentage of oocytes in each staining
pattern group according to treatment. Blue bars represent oocytes from
control cultures (n=76); red bars represent oocytes from cultures where
oocytes were exposed to high androgen and oestrogen in combination (A+E)
(n=72). The experiment was repeated on seven separate occasions with
follicles obtained from a minimum of three 3 week old F1 mice being used in
each replicate, yl test. P=0.0003.
Group 1. no nucleolus visible
Group 2, unstained nucleolus
Group 3, with germinal vesicle evident
Group 4, unstained germinal vesicle
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5.5 DISCUSSION
When oocytes from Day 5 cultures were stained with PATH52, which detects both
Dnmtls and Dnmtlo, the staining pattern obtained matched previously published
observations of Dnmtlo localisation in the growing oocyte (Mertineit et al., 1998;
Cardoso & Leonhardt, 1999). In growing oocytes intense staining for Dnmtlo is
present throughout both the nucleus and cytoplasm (Mertineit et al., 1998; Cardoso
& Lconhardt, 1999). To ensure that the exposure of oocytes to raised steroids did not
influence which of the splice variants was translated in the oocyte, the UPT82
antibody which only detects the Dnmtls protein was used. The results from this
clearly showed that no Dnmtls protein was present in the oocytes regardless of
treatment. Thus, any change to the localisation pattern was purely due to alterations
in Dnmtlo rather than aberrant translation of the somatic form.
When oocytes from pre-antral follicles recovered on Day 0 of culture were analysed
they all had Dnmtlo localised to the cytoplasm with partial staining of the GV
(Group 3). Inclusion of Day 0 in vivo oocytes was not intended as a direct
comparison to the day 6 cultured oocytes. The Day 0 oocytes were stained to
provide information as to the localisation of Dnmtlo prior to the culture period and
to act as a positive control for the staining protocol. In growing oocytes Dnmtlo is
reported to be present in both the cytoplasmic and GV compartments of the oocyte
while in more mature oocytes there is an active sequestering of the Dnmtlo protein
to the cytoplasm (Mertineit et al., 1998; Cardoso & Leonhardt, 1999). When these
previously reported dynamics ofDnmtlo translocation are considered the proportion
of Day 5 oocytes with completely stained GVs are somewhat unexpected.
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When comparisons were made between the staining patterns observed after culture
there was a significant difference in distribution between the controls and A+E
treatment group (P=0.0003). For Dnmtl o to methylate the oocyte genome it would
need to be localised to the GV at the appropriate time point. When the control
cultures were analysed the majority of the oocytes (75%) had a completely stained
GV. In contrast, only 50% of oocytes which were exposed to high steroid levels in
culture were categorised as having a completely stained GV. A further 49% have a
staining pattern where the GV was visible and therefore less stained than the
cytoplasm. This change in localisation suggests that the process of sequestering the
Dnmtlo to the cytoplasm had been initiated in the High A+E group. This
translocation of Dnmtlo protein to the cytoplasm and exclusion from the GV is
correlated to increased developmental maturity of the oocyte. Thus, the oocytes
exposed to raised A+E levels during culture may have accelerated maturation. As
this is the group with the poor IVF result, this is, on the face of it, a surprising result.
The change in Dnmtlo localisation may, however, represent impaired
synchronisation of the nuclear and cytoplasmic maturation processes. As such, the
previously observed reduction in developmental competence during IVF described
by Murray et al. (2005) may be due to the precocious sequestering of Dnmtlo to the
cytoplasm.
Within this study an image of a single oocyte section was assessed to determine the
localisation pattern of Dnmtlo. In retrospect, the inclusion of merged Z-stack
images and a nuclear counterstain could have provided further information and
should be employed in future studies. It is possible that the additional information
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resulting from nuclear counterstaining could have been used to pinpoint the stage of
oocyte development. This may have allowed further assessment of whether the
differences between the control and A+E treatment groups were due to any subtle
changes to the timing of oocyte development. Although the approach to image
analysis used in this study did not include Z-stack or counterstained images this does
not detract from the overall findings.
When considering the results obtained in these experiments the results presented by
Shi & Haaf (2002) need to be considered. One treatment that this group investigated
was the addition of an ETOH derivative, acetaldehyde, to mouse embryos in culture.
After exposure to acetaldehyde a large proportion of embryos were found to have
abnormal DNA methylation patterns, as assessed by staining with anti-5-
methylcytosine antibody (Shi & Haaf, 2002). The majority of these abnormally
methylated embryos had undergone a loss of DNA methylation. This acetaldehyde
treatment also affected embryo development with reduced blastocyst development
reported for both the mouse strains used in the investigation, with 100% of the NMRI
strain embryos failing to reach the blastocyst stage of development (Shi & Haaf,
2002). Within the follicle culture system described in this chapter the DES and
Arimidex were solubilised in ETOH, this aspect of the treatment protocol could have
introduced an additional factor which is capable of causing a change to the
methyltransferase activity of the oocyte. However, the concentration of ETOH used
in this study was only 4nmol compared to the 0.5mM of acetaldehyde added in the
Shi & Haaf (2002) study. The previous study did not investigate the range of
acetaldehyde doses over which the embryo DNA methylation dynamic was sensitive
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to alteration. There is no conclusive evidence that the lower dose of ETOH used in
the current study would be sufficiently high enough to interfere with the DNA
methyltransferase activity of the oocyte. Any effect of the ETOH was controlled for
in this study through the addition of 4nmol ETOH to the control culture medium.
Thus, the significant difference in Dnmtlo localisation described within this chapter
can be attributed to culture in the presence of raised A+E rather than simply a result
of ETOH being metabolised to acetaldehyde.
A previous investigation into the translocation of Dnmtlo found co-localisation with
annexin V a finding that may represent an interaction between these two proteins
(Doherty et al., 2002). This possibility is supported by the fact that part of the N-
terminus of Dnmtl was identified as an annexin V binding protein (Ohsawa et al.,
1996). As exposure to raised androgens and oestrogens in culture has a significant
effect on the localisation pattern of Dnmtlo it may be that the steroids illicit this
effect through alteration of the annexin V sequestering mechanism.
5.5.1 Further Work
The natural progression in this investigation would be to carry out cultures using the
treatment groups in which the androgens or oestrogens are raised separately (as
described in Table 4.1). This would allow more information on the role of each
steroid on Dnmtlo translocation to be established.
The results described within this chapter demonstrate that there are differences in the
translocation of Dnmtlo after steroid exposure. Complete disruption of the Dnmtlo
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promoter, which prevents Dnmtlo protein accumulating in the oocyte during growth
results in normal oocyte methylation levels but is embryonic lethal during later
development (Howell et al., 2001). It would therefore be of relevance to extend the
scope of this study to investigate pre-implantation embryonic development. If
changes to annexin V are involved in the altered localisation pattern of Dnmtlo
observed in oocytes after exposure to raised steroids this may also have an effect in
the early embryo. Dnmtlo has been shown to remain localised to the cytoplasm at
all the pre-implantation stages with the exception of the 8-cell embryo, when it
transiently translocates to the nucleus. The timing of this translocation is not
controlled by any of the mechanisms previously investigated by Doherty et al. (2002)
resulting in the hypothesis that translocation occurs at a time point determined by
fertilisation. Annexin Visa calcium-dependent phospholipid binding protein,
raising the possibility that the calcium waves occurring immediately after
fertilisation could play a role in its binding ability and cellular function. If the
annexin V within the oocyte is influenced by exposure to raised steroids there may
be an impact on the timing of the embryonic translocation of Dnmtlo. Additionally,
annexin V has been identified as an inhibitor of protein kinase C activity, one of the
proteins identified as mediating formation of the second polar body after fertilisation
(Shibata et al., 1992; Schlaepfer et al., 1992; Dubois et al., 1998). Thus, further
investigation of the function of annexin V within the oocyte may reveal a mechanism
by which hormonal signals could impact on DNA methylation levels and
developmental competence of the oocyte and early embryo.
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Chapter 6
Examination of reproduction in Mbd2~ ~ mice
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6.1 INTRODUCTION
Several members of the Mbcl protein family are involved in the repression of
methylated genes, as discussed in Section 1.12.3. The existence of several Mbd
proteins has complicated the elucidation of their physiological functions. Mbd2 and
Mbd3 are very similar proteins sharing 70% identity: the identical gene structure
suggests they arose from a gene duplication event (Hendrich et al., 1999).
Determination of each protein's role was complicated by the in vivo interaction
which exists between these two members of the Mbd family. In the investigation of
the relationships between these two proteins gene deletion mice have been created.
The Mbd2~'~ animals are capable of transcribing the first two exons of the gene, the
transcript of which can be translated but terminates within the methyl binding
domain region (Hendrich et al., 2001). The regions of the Mbd2 protein present in
Mbd2''~ mice are not capable of binding to methyl groups and are lacking the regions
responsible for repression as these are further downstream (Boeke et al., 2000).
While Mbd3~'~ is embryo lethal, the Mbd2''~ mice are viable although they have some
maternal behavioural abnormalities (Hendrich et al., 2001).
Mbd2''~ mice have normal global methylation levels and normal methylation
dependent silencing of both imprinted genes and IAPs (Hendrich et al., 2001).
Although Mbd2~'~ mice appeared phenotypically normal, interesting observations as
to their reproductive abilities were made. Mbd2~'~ pairs had a significantly lower
litter size than heterozygotes. On further investigation this reduction in litter size
was found to be a trait of the female Mbd2~'~ mice with the paternal genotype having
no impact on litter size (Hendrich et al., 2001). In addition to the reduced litter size,
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there is also a reduction in the size of offspring produced by Mbd2''~ females
(Hendrich et al., 2001). When pups from these Mbd2~'~ females were fostered onto
wildtype females the weight phenotype was rescued (Hendrich et al., 2001). Further
investigation of the null mutant females identified problems with an important aspect
of maternal behaviour; they were slower at pup retrieval. Thus, the lower pup weight
seems to be due to the impaired maternal behaviour of the Mbd2~'~ females (Hendrich
et al., 2001). Although this aberrant maternal behaviour explains the reduced weight
of pups from Mbd2~'~ females it does not explain the lower litter size obtained from
these animals. To date, the only apparent effects of knocking out the Mbd2 gene
seem to be the reduced litter size and the behavioural defects observed. Further
investigation of the maternal behavioural defects has been carried out through
analysis of the imprinted Pegl and Peg3 genes which are involved in nurturing
behaviour. There appeared to be no defect in the expression of these or any other
imprinted genes in the adult Mbd2~'~ animals (Hendrich et al., 2001).
To date, there has been no investigation as to the cause of the reduced litter size. The
only assessment on the oocytes from these mice examined whether maternal or
paternal inheritance of the null allele affected the active demethylation of the
paternal genome immediately after fertilisation (Santos et al., 2002): there appeared
to be normal demethylation of the male pronucleus in both reciprocal crosses
suggesting that Mbd2 is not an active demethylase as had previously been proposed




The aim of this chapter is to study the effect of Mbd2 on female reproduction with
regard to litter size utilising the Mbd2''~ mouse. The specific aspects which will be
investigated are the number of oocytes ovulated in response to superovulatory
gonadotrophins and the developmental competence of those oocytes during IVF.
Analysis of these parameters will assist in the determination of whether the reduced
litter size is a result of reduced ovulation number or problems which become evident
during the pre-implantation stages of development. It would be hypothesised that if
Mbd2 plays a role in supporting the normal development of follicles to ovulation that
the Mbd2~'~ females would have a reduced number of oocytes present in the oviduct
after ovulation. Likewise the lack of Mbd2 could also account for the reduced litter
size by reducing the developmental capacity of the pre-implantation embryo.
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6.3 MATERIALS AND METHODS
6.3.1 Transgenic Mouse Colony
Originally five Mbd2~'~ (C57Black/6J congenic background) pairs of mice were
obtained to form the basis of a new breeding colony in the Medical Faculty Animal
House (MFAA) (gift from Brian Hendrich). Although Mbd2~'~ pairs formed the basis
of a successful breeding colony at a previous site (Hendrich, personal
communication) this was not found to be the case in the MFAA unit. At this location
very few pregnancies were achieved and none of the small number of offspring
survived to adulthood. To overcome this Mbd2~'~ animals were paired with
C57Black/6J mice with the intention of obtaining Mbd2+'~ offspring which could then
be used as the breeding stock for the new colony. Pups which survived to adulthood
were obtained from those pairs which consisted of a C57Black/6J female with an
Mbd2~j~ male. The reciprocal cross only resulted in a small number of pregnancies of
which few offspring survived. Adequate numbers of offspring were obtained to
allow Mbd2+I'l Mbd2+I' breeding pairs to be set up. However although pregnancies
were achieved the pups were of low weight and there was a high rate of death with
particularly large numbers lost at weaning. Genotyping results of those offspring
which survived past weaning found that almost no Mbd2~'~ females were surviving.
Those that did were small for their age and had a very limited response to
superovulatory doses of gonadotrophins at 8 weeks of age. Only two Mbd2~'~
females survived long enough to allow an assessment of ovulation at increased age
and body mass. This situation continued until the MFAA unit closed. At this point
the Mbd2~'~ colony was re-derived in a new animal facility. Mbd2+/'/ Mbd2+I~
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breeding pairs were set up with these re-derived animals, from which viable
offspring suitable for both experimental and replacement stock were obtained.
6.3.2 Genotyping of Transgenic Mouse Colony
Ear punches were taken when pups were between 3-4 weeks of age to provide a
tissue sample for genotyping. 75pl of "hot shot" alkaline lysis buffer (see below)
were added to each sample and heated to 95°C for 30 minutes. Samples were cooled
before 75pl of neutralising buffer (see below) were added.
"Hot Shot" Alkaline Lysis Buffer Neutralising Buffer
25nrM NaOH 40mM Tris-HCl
0.2mM EDTA pH12
Constituents of each buffer were dissolved in water without adjustment of the pH.
Buffers were stored at room temperature until required. All constituents for these
buffers were obtained from Sigma-Aldrich, UK.
Primers which could distinguish between the wild type and mutant Mbd2 alleles
were used to establish the genotype of each animal. Primers (Eurogentec, Belgium)
Mbd2P62 and EnPl (see sequence below) were used to identify the mutant allele by
the production of a 170bp PCR product while the 240bp product given by primers
Mbd2P49 and Mbd2P61 (see sequence below) showed the presence of the wild type
allele. Primers were dissolved in autoclaved distilled water to give a stock
concentration of lOOpM, aliquoted and frozen at -70°C to prevent freeze/thawing.
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Primer Sequences (personal communication from Brian Hendrich)
KO allele - 170bp product
Mbd2P62 TTGTGGTTGTGCTCAGTTC
EnPl TCCGCAAACTCCTATTTCTG
Wild Type allele - 240bp product
Mbd2P49 AAGAACAAGCAGAGACTCCG
Mbd2P61 ACGCTGGCCTAGTGCCGTGC
These primers were used in a multiplex PCR using the master mix shown in Table
6.1. The PCR protocol involved a denaturing step of 94°C for 10 seconds followed
by annealing at 56°C for 10 seconds and an elongation step of 72°C for 40 seconds.
These steps were repeated for a total of 35 cycles before a final extended elongation
step of 72°C for 2 minutes was carried out. PCR products were assessed using gel
electrophoresis and visualisation as described in Section 2.8.1.
Table 6.1Table listing the components, volume and final concentration of the PCR








(200mM Tris-HCl (pH 8.4), 500mM KC1) Promega, UK
2.5 IX
MgC12 (50mM) Promega, UK 0.6 1.2mM
dNTP mixture (5mM each) Promega, UK 1.0 0.2mM each
Mbd2P62 Primer (lOOpM) Eurogentec, UK 0.2 0.8pM
EnPl Primer (lOOpM) Eurogentec, UK 0.2 0.8pM
Mbd2P49 Primer (lOOpM) Eurogentec, UK 0.1 0.4pM
Mbd2P61 Primer (lOOpM) Eurogentec, UK 0.1 0.4pM
Platinum Taq Polymerase (5U/pl) Invitrogen, UK 0.2 1U
Autoclaved distilled H2O ~ 19.1 ~
DNA Sample ~ 1.0 ~
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6.3.3 Investigation of oocyte competence and embryo development of Mbd2~'~
mice using IVF
Between 7-8 weeks of age the Mbd2~'~ females and their Mbd2H+ female siblings
were superovulated, according to the protocol described in Section 2.3. Ovaries and
oviducts were removed and placed into warmed dissecting medium as described in
Section 2.2 and 2.4. The ovulated oocytes were recovered from the isolated oviducts
as detailed in Section 2.6.2 before being fertilised in vitro and the subsequent
embryos cultured to the blastocyst stage (as described below in Section 6.3.3.3). If
there was no Mbd2+I+ female present in the litter then a Mbd2+I~ sibling and an
additional age-matched Mbd2+I+ female were used as experimental controls.
Analysis of oocyte number after superovulation was repeated four times while three
experimental repeats of the IVF were carried out.
6.3.3.1 FVF
Basic stock solutions A, B, C and D for KSOM and T6 were made according to the
protocol (see Appendix A) and stored at -70°C. Before use they were thawed,
vortexed and spun down in a mini-centrifuge. When required both KSOM and T6
were freshly made up using the relevant basic stock solutions, according to the
volumes in table 6.2 below. The final osmolarity of KSOM was 254 ± 5mOsmKg"'
while the T6 final osmolarity was 287 ± 5mOsmKg"'. Once the osmolarity of the
media were within the acceptable range the BSA was sprinkled on top of the media
and left until it had dissolved, lmgml"1 of BSA (Fraction V fatty acid free tissue
culture grade, Sigma-Aldrich, UK) was dissolved into the KSOM while ISmgmF1 of
BSA (Fraction V tissue culture grade, Sigma-Aldrich, UK) was dissolved into the
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T6. 6 well non-tissue culture treated plastic plates (Iwaki) were used for the IVF. T6
medium was used for the sperm preparation and fertilisation drops while KSOM
drops were prepared for transferring the embryos into. Media were covered with 5ml
silicon oil (Merck) to prevent evaporation and the trays incubated (37°C in a
humidified 5% CO2, 95% air atmosphere incubator, Thermo Electron Corporation,
UK).







Hospital Grade Water 7.8 7.8
6.3.3.2 Sperm preparation
Two 12 week old F1 male mice were killed by cervical dislocation and an abdominal
incision made. The testes were removed and placed in warmed dissecting medium.
The vas deferens and caudis epididymis were isolated and transferred into a drop of
T6. A needle was used to apply pressure to the tube to displace the sperm and the
remaining tissue then discarded leaving the sperm in the T6 medium. It was then left
for 3-4 hours in the incubator to allow the sperm to undergo capacitation.
6.3.3.3 Fertilisation & Embryo Development
Females underwent superovulation as described in section 2.3 and the oocytes
recovered as detailed in Sections 2.4 and 2.6.2. Oocytes were then transferred
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through T6 wash drops and placed in the fertilisation drop. Sperm were added to this
fertilisation drop along with the oocytes, they were then incubated (37°C in a
humidified 5% CO2, 95% air atmosphere incubator, Thermo Electron Corporation,
UK) for 4-5 hours. All oocytes were moved into KSOM and incubated for a further
12 hours after which time all 2-cell embryos were moved into freshly prepared drops
of KSOM, 2pl per embryo, and returned to the incubator. This system was able to
support embryo development for 6 days to the hatching blastocyst stage with the
number of 2-cell embryos and blastocysts being visually assessed and recorded.
6.3.3.4 Statistical Analysis
The number of oocytes retrieved after superovulation were displayed as mean ± SEM
and were analysed using ANOVA. Both fertilisation rate and the percentage of 2-
cell embryos developing to the blastocyst stage were analysed using the chi-squared
statistical test. The F1 (C57BL/6J x CBA background) animals were acting as
controls to confirm the IVF system was working rather than as experimental control
group. F1 females have been used in previous IVF studies in the laboratory so the
performance of their oocytes and embryos in this system are well understood and
offer a way of checking the performance of the IVF protocol independently of the
animals of experimental interest. Thus, the data obtained from the F1 controls were
not used in the statistical analysis.
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6.4 RESULTS
6.4.1 Investigation of oocyte competence and embryo development of Mbd2~'~
mice using IVF
6.4.1.1 Original MFAA Colony
Only a single oocyte was recovered after superovulation of 8 week old Mbd2~'~
females (n=2) (Figure 6.1 A). This oocyte failed to undergo successful fertilisation,
as determined by its failure to develop into a 2-cell embryo. As the Mbd2~'~ females
were smaller than their Mbd2+I+ siblings at 8 weeks of age the experiment was
repeated using 15 week old Mbd2" females when the size difference was less
marked. After superovulation 15 ± 7 oocytes were recovered from Mbd2+,+ animals
while 19 ± 7 oocytes were obtained from the Mbd2~'~ females (Figure 6.IB).
Inadequate numbers of females were available for any statistical analysis to be
earned out on these results.
6.4.1.2 Re-derived Colony
There was not a statistically significant difference in the number of oocytes
recovered after superovulation from each genotype (Figure 6.2). Interestingly, there
does appear to be a trend towards the Mbd2~'~ females having an ovulation rate which
is greater than Mbd2+I+ animals. The mean number of oocytes for the Mbd2+I+
females was 11.2 ± 2.3, while for Mbd2~'' females a mean of 14.7 ± 3.67 oocytes
were recovered. The Mbd2+,~ females have the smallest number of oocytes in
response to superovulation, with an average ovulation number of only 6.5 ± 2.5. As
these Mbd2+I~ animals were only used in cases where there was no other sibling
control available, only a small number underwent superovulation (n=2).
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Regardless of genotype, there was no difference in the percentage of oocytes
recovered which underwent fertilisation (Figure 6.3). All genotypes had a
fertilisation rate between 75-84%, which compared well with the 86% fertilisation
rate achieved by the F1 system controls. When the percentage of 2-cell embryos
which achieved the blastocyst stage was considered there was no significant effect of
genotype (Figure 6.4). However, there was a trend whereby the ability of embryos to
develop to the blastocyst stage varied with maternal genotype, with embryos from














Mbcl2+/+ Mbd2' F1 control
Mbd2+ + Mbd2~'~ F1 control
Figure 6.1Number of oocytes recovered after superovulation of female
Mbd2+/+ and Mbd2''~ offspring from original MFAA colony. Values are mean
± SEM (except Mbd2~'~ in panel A, value given represents actual number of
oocytes recovered as n=l). A) Graph shows the average number of oocytes
recovered after superovulation, demonstrating the very poor response to
exogenous gonadotrophin administration by the 8 week old Mbd2~'~ (n=2),
Mbd2+ ' (n=2) and F1 (n=2) females. Only one run of this experiment was
carried out. B) Graph shows the average number of oocytes recovered after
superovulation of 15 week old Mbd2~'~ (n=2), Mbd2+/+ (n=2) and F1 (n=2)
females. The data represents one experimental run.
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Figure 6.2:- The number of superovulated oocytes recovered by genotype.
Values are mean ± SEM. There is no significant difference in oocyte number
between the groups. Four experimental replicates were carried out. The
number of females of each genotype used was as follows: Mbd2" n=8;
Mbd2+/" n=2; Mbd2+/+ n=9.
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Figure 6.3:- The fertilisation rate by genotype and F1 experimental controls.
The graph shows the percentage of recovered oocytes which developed into
2-cell embryos after IVF. There is no significant difference between the
groups (F1 controls are not included in this statistical analysis). This
experiment was repeated on three separate occasions. The number of females
of each genotype used was as follows: Mbd2" n=7; Mbd2 "n=2; Mbd2++




Figure 6.4:- The percentage of 2-cell embryos which developed to the
blastocyst stage, according to maternal genotype. There is no significant
difference between the groups (F1 controls are not included in this statistical
analysis). This experiment was repeated on three separate occasions. . The
number of females of each genotype used was as follows: Mbd2~'~ n=7;
Mbd2+" n=2; Mbd2~T'+ n=7 and F1 n=9.
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6.5 DISCUSSION
Although the original MFAA breeding colony did not provide enough Mbd2~''
females for a comprehensive assessment of oocyte quality and early embryo
development the observed breeding problems are of relevance. The effect of the
environment on the reproductive potential of the colony was considerable. Previous
studies have established that environmental factors can influence epigenetic
regulation of gene expression (Wolff et al., 1998; Tremolizzo et al., 2002; Jaenisch
& Bird, 2003). This is of importance when any strain of mice are being used
experimentally but when an epigenetic mechanism such as genomic imprinting and
DNA methylation is being considered it is perhaps even more relevant.
The data reported here does not support an obligatory role for Mbd2 in several
aspects of female reproduction. Regardless of genotype the ovulation rate,
fertilisation rate and the percentage of fertilised oocytes progressing to the blastocyst
stage did not alter significantly. As previously mentioned there is thought to be a
certain degree of redundancy within the Mbd family of proteins (Section 1.12.3).
Thus, these IVF results from the Mbd2~'~ mice do not conclusively demonstrate that
Mbd2 has no role in oocyte maturation or embryo development. It is possible that
other Mbd proteins are able to compensate for its absence.
In addition, it should be remembered that oocyte quality, fertilisation and pre-
implantation embryo development do not represent all aspects of successful
reproduction. No assessment as to the ability of these embryos to implant in the
uterus or their subsequent resorption rate was made in this study. As the blastocyst is
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the most advanced stage of embryo development that can be supported in vitro this is
often used as the experimental endpoint. However, the ability to progress to this
developmental stage does not necessarily predict that embryos would be able to
successfully implant and progress through normal post-implantation development.
As could be seen in the early breeding attempts of the original knockout colony
(where the Mbd2~l'IMbd2~l~ pairings produced almost no viable young) there was a
substantial reproductive problem with these mice over and above that reported by the
previous Mbcl2~'~ studies which identified a reduced litter size. Thus, this offered
confirmation of a potential correlation between a lack of functional Mbd2 and poor
reproductive performance. It was only when Mbd2+l'IMbd2Jrl' pairings were
established in the new animal facility that adequate numbers ofMbd2~'~ females were
obtained to allow any kind of study of reproductive parameters to be assessed. Thus,
investigations on unstimulated females were not carried out as the poor reproductive
ability of these animals severely limited the likelihood of obtaining adequate
numbers of oocytes which could subsequently be fertilised in vitro. The use of
superovulation ensured that a maximal amount of information could be obtained
from the small number of suitable females that became available during the period of
study. Had more time and resources been available then a natural progression for
this study would have been to assess the same reproductive parameters in
unstimulated females. Although, the use of superovulatory gonadotrophins means
that drawing direct comparisons between the previous studies and the results from
the current study is difficult it does provide important and relevant information as to
the role of Mbd2 in female reproduction. Superovulation over-rides some aspects of
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the natural selection processes within the ovary allowing more follicles to develop
and escape atresia. The current study shows that the lack of Mbd2 does not result in
a response to superovulation that is significantly different to the control mice used in
the investigation. Although there may be some aspect of follicle development or pre-
implantation developmental potential that is impaired in the absence of Mbd2 and
has been overcome by the high levels of exogenous gonadotrophins the study
demonstrates that female murine reproduction can function normally in the absence
of Mbd2.
6.5.1 Further Work
The conclusions that there are no differences in any of the fertility parameters
assessed through IVF all relate to stimulated cycles. In contrast the observations that
one aspect of the Mbd2''~ female phenotype is a reduced litter size was made after
natural matings from unstimulated cycles. Therefore, to fully determine the effects
of Mbd2~'~ on female reproduction it would be important to analyse unstimulated
ovulations. The same parameters which were assessed during the IVF procedure
could be investigated; number of oocytes ovulated, number of 2-cell and later stage
embryos flushed and an additional count of implantation sites could be carried out.
A recent paper examined the helper T-cell differentiation in Mbd2~'~ mice. This study
found there were differences in the cytokines produced by this transgenic mouse as
regards the Thl and Th2 profiles (Hutchins et al., 2002). This could have
implications for both an understanding of control of the immune system and
potentially for implantation research. If implantation of the blastocyst is to
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successfully occur there must be maternal immune tolerance of the allogenic fetus
and placental tissues. It is thought that the presence of a particular cytokine profile
consistent with a Th2 response is beneficial to developing and maintaining this
immune tolerance. It may be that this is one mechanism which implantation is
allowed to progress without interference from the maternal immune system. Thus, if
the in vitro observations by Hutchins et al. (2002) which identified altered helper T-
cell differentiation and subsequent changes to cytokine production are replicated in
vivo it could have implications on embryo implantation. This may play a role in the
reduced litter size phenotype observed in the Mbd2~'~ females. If immune tolerance is
not initiated although successful blastocyst development maybe obtainable
implantation rates may be reduced. Further examination of the Mbd2~'' females
include analysis of the process of implantation and the cytokine and T-cell profile






The factors influencing mammalian oocyte maturation have been the subject of
extensive investigations, in domestic and laboratory species as well as humans. The
complex interplay of genetic and environmental factors that can affect the oocyte and
subsequent embryo means that the factors which affect the process of oocyte
maturation are hard to detennine. Studies within this field have also been limited by
the difficulty of assessing both gamete and early embryo quality, particularly in the
clinical setting. Although basic morphological assessments are routinely used to
determine quality, the molecular markers that characterise a developmentally
competent oocyte or embryo are less well defined.
The relatively new field of genomic imprinting in reproduction and early embryo
development is rapidly developing. Several recent studies have highlighted a
potential correlation between the use of ART and an increase in imprinting disorders
(Cox et al. 2002; DeBaun et al. 2003; Gicquel et al. 2003; Maher et al. 2003;
Orstavik et al. 2003; Li et al., 2005). These findings demonstrate the importance of
understanding the processes involved in gamete maturation and embryo
development. Although human oocytes and embryos can be used in experimental
studies only small numbers are available and the strict legal and ethical requirements
of such work limit the range of investigations that can be carried out. Due to this
limited supply of human material the use of other mammalian gametes and embryos
are being used to elucidate the principles of genomic imprinting, DNA methylation
and the control of gene expression. The studies described within this thesis have
used the murine model to study the effects of steroids on oocyte maturation. The use
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of a mouse model provides several benefits over other available species. Mouse
follicles can be isolated from the ovary during pre-antral follicular development and
can reach the Graafian stage in vitro. This culture model allows the effects of
specific factors on oocyte maturation to be analysed in a more controlled
environment than can be achieved using in vivo studies. An additional benefit of
utilising mice in such studies is that transgenic mice can be created to investigate the
role of a particular gene and protein. Equivalent studies in the human rely on the
occasional mutations that occur in disease states. Although it is known that not all
data acquired using alternative mammalian species will be applicable to humans they
provide a useful platform for future human studies.
Utilising a whole follicle culture system, the effects of altered steroid environment
were investigated. In the presence of raised concentrations of A+E there was a
significant increase in global oocyte DNA methylation levels. In contrast there was a
significant reduction in DNA methylation when the oocytes were exposed to
increased levels of A alone during the period of maturation. These two results had
an inverse correlation to the previously described fertilisation rates of steroid treated
oocytes that have been reported by our laboratory. It should also be considered that
the addition of Arimidex will have the dual effect of raising androgen levels while
decreasing the concentration of oestrogen due to the inhibition of the aromatase
enzyme (as discussed in Section 1.15, Figure 1.1 OB). Thus, the two treatment groups
in which a significant change to DNA methylation levels were observed both had
reduced levels of endogenous oestrogens (although in the A+E group there was the
addition of DES). Further assessment of DNA methylation levels after culture with
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alternative preparations that alter androgen and/or oestrogen levels would allow a
more comprehensive assessment of which changes to the steroidal environment were
eliciting this effect. Exposure to E alone in culture did not alter the global DNA
methylation levels from those seen in the control group: in contrast oocytes from this
treatment group had a significantly lower fertilisation rates. Although it is possible
that the altered fertilisation rates occur as a direct result of the alterations to the DNA
methylation, at present it is not evident whether the change in DNA methylation
levels explains the altered embryo development or ifboth of these are separate
effects of the steroids. These observations could represent a loss of synchronisation
between the maturation of the oocyte and the surrounding follicular cells. The
signalling between the oocyte and the cells of the follicular compartment ensures that
the oocyte undergoes the synchronised nuclear and cytoplasmic maturation which are
required if the oocyte is to become developmentally competent. These alterations to
DNA methylation levels could represent an effect of steroid exposure to the
transcription of one of the Dnmt genes in the ovary. Although this possibility was
investigated, the widely differing results between experimental runs did not allow
any conclusion to be drawn. An investigation ofDnmt and Mbd expression in the
oocyte after exposure to raised steroids would allow further analysis of this
possibility.
Oocytes are routinely recovered after superovulation in the fields of both ART and
research. At the time of gonadotrophin administration there will be follicles at
different stages of development and atresia present in the ovaries. Thus, it would be
predicted that the superovulatory hormones would have differing effects on the
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follicles depending on their developmental stage. For the vast majority of
developing follicles, superovulation acts to rescue those subordinate follicles which
would otherwise have become atretic. Thus, an understanding of the effects of
hormonal exposure on different follicular developmental stages is of consequence to
ART. Within both clinical and research settings superovulated oocytes are often
considered as being entirely comparable to oocytes which develop in vivo and
undergo ovulation without induction. The results presented within Chapter 4 of this
thesis suggest that there are differences in the global DNA methylation levels of
oocytes recovered after superovulation and those from natural (unstimulated)
ovulations. This is not to say that the one replicate demonstrating a significant
difference in DNA methylation level between superovulated and naturally ovulated
oocytes alone is adequate data to determine an effect of superovulation on DNA
methylation levels. Rather, the fact that all three replicates of the experiment gave
such different results is in itself a suggestion that perhaps superovulation has an
impact on the dynamics of DNA methylation in the oocyte.
The responses observed after in vitro culture may not parallel the effects that would
be observed after in vivo exposure to raised steroid levels. Although the pre-antral
follicles dissected out for use in culture all appeared to be of a healthy morphology, it
is possible that some of the isolated follicles were in the early stages of atresia. Late
pre-antral follicles were used in these in vitro studies as the selection processes
which determine dominant and subordinate follicles are not yet thought to be
underway. However, a complete lack of follicular selection at these stages of
development has yet to be conclusively proven. Bearing in mind that the early stages
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of follicular atresia are not evident through a purely visual assessment it is possible
that the culture conditions rescue some follicles which would otherwise have been
destined to die through atresia. However, the effects of any molecular changes
occurring during early selection and atresia may not be entirely reversible. Taking
this into account it is plausible that some of the oocytes in each treatment group
would in fact have been retrieved from follicles that had been rescued from the
atretic pathway. It may be the case that these follicles and their oocytes would
respond differently when exposed to raised steroid levels in culture than those in
which no atretic signalling pathways had been initiated.
When Dnmtlo localisation patterns were investigated, a greater proportion of the
A+E treated oocytes were assessed as having reduced GV localisation of the protein
than was seen in the Control group. While the majority of the Control oocytes had a
completely stained GV, many of the A+E oocytes had only a partially stained GV. A
simple interpretation of this difference in localisation pattern would be that the A+E
oocytes would have reduced DNA methylation levels due to a reduction in the level
of the methylase enzyme present in the GV. However, when A+E treated oocytes
were assessed they were found to have a significantly higher level ofDNA
methylation than the controls. Initially, these two results may appear to be
contradictory but on further consideration this may not be the case. The analysis of
the Dnmtlo localisation pattern reported in Chapter 5 was carried out at only one
time point during oocyte maturation. The altered localisation pattern may in fact
represent an accelerated translocation of the Dnmtlo protein, as opposed to a failure
of the protein to become localised to the GV. Further information on the effect of
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steroids on the localisation of Dnmtlo could be obtained by undertaking a time-
course experiment. It should also be borne in mind that the actual role of Dnmtlo
within the oocyte has yet to be elucidated. There is conflicting data as to whether it
plays a role in DNA methylation during oocyte maturation or acts exclusively during
the 8-cell stage of embryo development.
The investigation into the small litter phenotype of the Mbdl" female mice did not
yield any significant results when ovulation number, fertilisation rate or blastocyst
development were assessed. These results could be interpreted as demonstrating that
the Mbd2 protein does not play a role in these reproductive processes and that the
phenotype of small litter size is the result of a separate effect of Mbd2, perhaps on
implantation. It could, however, be that the loss of Mbd2 does have a negative
impact on one of the investigated parameters but that this effect can be compensated
for by the administration of exogenous superovulatory gonadotrophins.
7.2 Future Work
As well as the laying down of DNA methylation patterns in the gametes, the
appropriate demethylation of the parental genomes after fertilisation is required for
normal embryo development to proceed. There are two steps involved in this
process, the rapid, active demethylation of the paternal genome immediately after
fertilisation and the slower, passive demethylation of the maternal genome. Work by
Beaujean et a!. (2004c) established that the active process of demethylation is
controlled primarily by the oocyte. Thus, it is plausible that impaired oocyte
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maturation may impair the capability of the oocyte cytoplasm to exert this
demethylating activity. It would be worthwhile to investigate whether steroids affect
the oocyte in a way which impairs its ability to demethylate the paternal genome. In
conjunction with this analysis of paternal demethylation, the remodelling of the
chromatin should also be analysed as these two processes are linked. The process of
passive demethylation is also important with the DNA methylation levels of embryos
obtained as a result of somatic cell nuclear transfer being aberrantly high, potentially
through a reduction in the amount of passive demethylation occurring (Dean et al.,
2001). Oocytes obtained from follicles exposed to the culture conditions described
in Section 4. 3.3 could be subjected to IVF and then fixed. The assessment of the
DNA methylation levels of both the maternal and paternal genome at several time
points after fertilisation would allow both the initial process of active demethylation
and the later passive demethylation of the maternal genome to be evaluated.
An important progression of this study would be to carry out embryo transfers to see
whether the exposure to androgens and/or oestrogens during oocyte maturation had
any impact later in development. As not all modifications to the oocyte or early
embryo result in immediate failure of development more long-term analysis of the
embryo and subsequent offspring is desirable. Although alterations to global DNA
methylation levels were identified in this study it may be that abnormally hyper- or
hypo-methylated oocytes are capable of normal development after fertilisation.
There may be mechanisms within the oocyte or early embryo which allow correction
of DNA methylation levels. Alternatively, the normal process of demethylation and
reprogramming that occur after fertilisation may compensate for the altered DNA
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methylation levels observed. During early pre-implantation development there is
demethylation of repeat regions and other non-imprinted sequences, while the
imprinted genes are protected and maintain their methylation patterns. The fact that
previous 1VF data after steroid exposure found that the ability of the embryos to
reach the blastocyst stage was not affected may suggest that the altered methylation
is not occurring at the imprinted genes but in the non-imprinted sequences which
ordinarily undergo epigenetic reprogramming, and are therefore reset, during early
stages of embryo development.
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7.3 Clinical Impact
The rate of pregnancy success after ART is currently stalled at approximately 20-
25%. Any investigations which lead to an improved understanding of oocyte quality
and the factors which have an impact on developmental competence of gametes or
pre-implantation embryos could be beneficial to the field of assisted reproduction.
Oocytes used in ARTs are exposed to an altered hormonal environment due to the
administration of exogenous gonadotrophins, which will in turn cause an increase in
intra-follicular androgens and oestrogens. Evidence presented within this thesis
demonstrates that exposure to raised steroids can influence the DNA methylation
levels of the oocyte genome. As correct DNA methylation is vital for normal gene
expression and embryo development it is possible that impaired methylation is a
contributing factor in the low rate of pregnancy achieved after ART. Improvements
in ARTs could increase the success rates and the chances of a "take-home" baby
resulting from each cycle. Additionally, an understanding of the mechanisms
involved in developmental competence could ultimately allow only one embryo to be
transferred, thus reducing the level of multiple pregnancies resulting from ART.
This is of particular interest in the clinical field as a multiple pregnancy is associated
with higher risks for both mother and baby.
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7.4 Conclusion
One of the main limits on research in this field is a lack of knowledge on what
constitutes a "normal" oocyte. Many studies utilise superovulated oocytes in their
research but this thesis raises questions as to how physiological the DNA
methylation status of these oocytes actually is. The results presented within this
thesis add support to the hypothesis that the presence of androgens and oestrogens at
higher than physiological concentrations have an impact on oocyte maturation. This
study is the first to demonstrate that global DNA methylation levels of oocytes can
be altered by exposure to raised steroid levels. There is an increasing body of
evidence supporting the concept that altered environmental conditions can have an
impact on oocyte quality and the subsequent development of an embryo. However,
the specific environmental factors and the mechanisms through which they exert
their effects are unclear. This thesis demonstrates a correlation between altered
steroidal exposure of the oocyte and changes to DNA methylation levels during
oocyte maturation, potentially through altered Dnmtlo localisation. The implications
of this finding are far reaching, both in the clinical and research setting.
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Common to both KSOM
& T6 constituents
100ml of xlO stock








g 100ml"1 Final Cone.(mM)





g 100ml"1 Final Cone.(mM)
Na pyruvate 0.055 0.47
Solution D
Common to both KSOM
& T6 constituents
100ml of xlO stock
g 100ml"1 Final Cone.(mM)
CaC12 2H20 0.252 1.71
Stocks of A, B, C and E were stored at -70°C for 6 months while stocks of D were
stored at -70°C for 3 months.
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APPENDIX C: - NOW2004, Edinburgh, 2004
Platform Presentation, Awarded Session Prize
Mouse oocytes exposed to raised androgen and oestrogen levels in vitro exhibit
increased DNA methylation.
Swales A.K.E. & Spears N.
SBCLS, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD, UK.
If normal embryo development is to progress after fertilisation, the oocyte must have
undergone coordinated nuclear and cytoplasmic maturation. As part of this maturation it is
vital that epigenetic reprogramming occurs, involving the addition of methyl groups to the
DNA of imprinted genes. Studies have found that errors in imprinting are commonly seen
after oocytes or embryos have been exposed to a period of time in culture, which can result
in disorders such as large offspring syndrome. Although effects on imprinting have been
identified, the aspects of the culture system responsible have yet to be identified. Further
studies in this area could be beneficial for both Assisted Reproductive Techniques and
cloning. Preantral follicles were cultured in either control media or media with raised
levels of androgens and oestrogens. Steroid levels were altered using Arimidex (an
aromatase inhibitor which will increase androgens by preventing their conversion to
oestrogen) and Diethylstilboestrol (DES, a synthetic oestrogen). Previous unpublished
results from this lab demonstrated impaired developmental competence of oocytes cultured
using this regime. After 5 days in culture, follicles were ruptured and the oocytes
recovered. Methyl groups on the oocyte DNA were stained using immunocytochemistry:
images were obtained using a confocal microscope and then analysed. Oocytes exposed to
raised levels of androgens and oestrogens during the culture period had a significantly
raised level of global methylation compared to controls (P=0.0015). The increase in global
methylation identified could represent incorrect methylation of imprinted genes. This
result proves that an in vitro environment high in both androgens and oestrogens can affect
the maturation of the oocyte.
Acknowledgements: Thanks to Nathalie Beaujean for her time and advice and Linda
Wilson for help with the confocal work and image analysis.
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APPENDIX D: - Xlth Ovarian Workshop, Vancouver, 2004
Title of poster
Mouse oocytes exposed to raised androgen and oestrogen levels in vitro exhibit
increased DNA methylation.
Objective
If normal embryo development is to progress after fertilisation, the oocyte must have
undergone coordinated nuclear and cytoplasmic maturation. As part of this
maturation it is vital that epigenetic reprogramming occurs, involving the addition of
methyl groups to the DNA of imprinted genes. Studies have found that errors in
imprinting are commonly seen after oocytes or embryos have been exposed to a
period of time in culture, which can result in disorders such as large offspring
syndrome. Although effects on imprinting have been identified, the aspects of the
culture system responsible have yet to be identified. The aim of this study was to




Preantral follicles were cultured in either control media or media with raised level of
androgens and oestrogens. Steroid levels were altered using Arimidex (an aromatase
inhibitor which will increase androgens by preventing the conversion of androgen to
oestrogen) and Diethylstilboestrol (DES, a synthetic oestrogen). After 5 days in
culture, follicles were ruptured and the oocytes recovered. Methyl groups on the
oocyte DNA were stained using the 5-methyl cytosine antibody in
immunocytochemistry: images were obtained using a confocal microscope and then
analysed.
Results
Oocytes exposed to raised levels of androgens and oestrogens during the culture
period had significantly increased global methylation compared to controls
(PO.OOOl).
Conclusions
The increase in global methylation identified could represent incorrect methylation of
imprinted genes. This result proves that an in vitro environment high in both androgens
and oestrogens can affect the development of the oocyte. Further studies in this area could




APPENDIX E:- SSR Abstract, Vancouver, 2004
Platform Oral Presentation
MOUSE OOCYTES EXPOSED TO RAISED ANDROGEN AND OESTROGEN
LEVELS IN VITRO EXHIBIT INCREASED DNA METHYLATION.
Swales A.K.E. & Spears N.
University of Edinburgh, Edinburgh, UK.
If normal embryo development is to progress after fertilisation, the oocyte must have
undergone coordinated nuclear and cytoplasmic maturation. As part of this maturation it is
vital that epigenetic reprogramming occurs, involving the addition of methyl groups to the
DNA of imprinted genes. Studies have found that errors in imprinting are commonly seen
after oocytes or embryos have been exposed to a period of time in culture, which can result in
disorders such as large offspring syndrome. Although effects on imprinting have been
identified, the aspects of the culture system responsible have yet to be identified. Further
studies in this area could be beneficial for both Assisted Reproductive Techniques (ARTs) and
cloning. Preantral follicles were cultured in either control media or media with raised level of
androgens and oestrogens. Steroid levels were altered using Arimidex (an aromatase inhibitor
which will increase androgens by preventing the conversion of androgen to oestrogen) and
Diethylstilboestrol (DES, a synthetic oestrogen). Previous unpublished results from this lab
demonstrated impaired developmental competence of oocytes cultured using this regime.
After 5 days in culture, follicles were ruptured and the oocytes recovered. Methyl groups on
the oocyte DNA were stained using the 5-methyl cytosine antibody in immunocytochemistry:
images were obtained using a confocal microscope and then analysed. Oocytes exposed to
raised levels of androgens and oestrogens during the culture period had significantly increased
global methylation compared to controls (P<0.0001). The increase in global methylation
identified could represent incorrect methylation of imprinted genes. This result proves that an
in vitro environment high in both androgens and oestrogens can affect the maturation of the
oocyte.
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Abstract
Genomic imprinting is the parent-of-origin specific gene expression which is a vital mechanism through hoth development
and adult life. One of the key elements of the imprinting mechanism is DNA methylation, controlled by DNA methyltransfer-
ase enzymes. Germ cells undergo reprogramming to ensure that sex-specific genomic imprinting is initiated, thus allowing
normal embryo development to progress after fertilisation. In some cases, errors in genomic imprinting are embryo lethal
while in others they lead to developmental disorders and disease. Recent studies have suggested a link between the use of
assisted reproductive techniques and an increase in normally rare imprinting disorders. A greater understanding of the mech¬
anisms of genomic imprinting and the factors that influence them are important in assessing the safety of these techniques.
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What is genomic imprinting?
Genomic imprinting is the parent-of-origin specific gene
expression and is determined by epigenetic modification of
genes, such that gene transcription is altered while the
actual gene sequence remains unchanged. Genomic
imprinting results in only one inherited copy of the relevant
imprinted gene being expressed in an embryo. For pater¬
nally imprinted genes, the paternal allele is epigenetically
modified to prevent transcription, ensuring that the embryo
has only mono-allelic expression from the maternally
inherited copy. The opposite is true of maternally imprinted
genes, when only the copy inherited from the father is
expressed. The fact that particular genes are differentially
expressed, according to their parent-of-origin, means that
during development the parental genomes are functionally
non-equivalent (Surani 1998). Genomic imprinting is vital
for normal gene expression patterns in an individual, with
errors sometimes resulting in inappropriate gene transcrip¬
tion or repression. Within the mouse genome, approxi¬
mately 80 imprinted genes have so far been identified
(Beechey ct al. 2005). It is likely that there will be a similar
number of imprinted genes in humans, although fewer
have been found to date. Except where stated, this review
refers to work on the mouse, as this species has been by far
the most extensively studied species.
Within the mammalian genome, the majority of cyto-
sine residues found as CpG dinucleotides (i.e. those cyto-
sines positioned next to a guanine residue) have a methyl
group added to their carbon 5 position (Costello & Plass
200I). It is this addition of the methyl group, referred to as
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DNA methylation, that is proposed as the key mechanism
(certainly the best studied mechanism) regulating imprint¬
ing. It is important to point out, however, that the majority
of methylated DNA in the genome is not concerned with
genomic imprinting. Heavy methylation of DNA results in
a more condensed structure which is resistant to transcrip¬
tion. Thus, if an animal inherits a methylated copy of a
gene from its mother and a non-methylated copy from its
father, the maternal copy will have its transcription
repressed leaving the paternal copy as the only active
gene. DNA methylation is an epigenetic modification
which can be inherited in a stable manner but is also
reversible, allowing gender specific patterns to be initiated
in germ cells.
Why did genomic imprinting evolve?
The most commonly proposed theory explaining the
development of genomic imprinting is the genetic conflict
or parental investment theory (Moore & Haig 1991). This
theory arose from the observation that many imprinted
genes are implicated in the growth and development of
the mammalian fetus or placenta. In addition to this,
imprinted genes have been shown to exhibit directionality
in their actions; that is the majority of the paternally
expressed genes, such as lgt'2 and Peg3, promote fetal
growth and nutrient uptake while in contrast the mater¬
nally expressed genes, such as lgt'2R and Cnas, tend to
curb fetal growth (Reik & Dean 2001, Tycko & Morison
2002). Females who could restrict fetal growth and
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produce more offspring from their limited resources
would, in the long term, be more successful. In contrast,
males would derive long-term benefit from their progeny
being larger and stronger even if they achieved this to the
detriment of the mother by utilising more maternal
nutrients.
An alternative theory to account for the presence of
imprinted genes within the genome is the evolvability
model (Beaudet & Jiang 2002). This predicts that species
which have genomic imprinting are more able to evolve
in response to environmental pressures, as they can
induce rapid changes by altering which of the two alleles
is silenced and which is expressed. An individual organ¬
ism can carry an allele which promotes growth that, while
imprinted, has no phenotypic effects. Thus, if increased
growth becomes advantageous, the relevant allele is
already present in the gene pool: by rapid reversal of the
imprinting, the allele can be expressed. There is also the
'ovarian time bomb' concept which proposes that geno¬
mic imprinting evolved to protect the female from ovarian
disease: Varmuza & Mann (1994) hypothesised that
imprinting could limit the level of growth and develop¬
ment of any parthenogenetic embryos within the ovary,
thereby preventing malignant trophoblast formation.
How are DNA methylation patterns regulated?
DNA methyltransferases (Dnmts) carry out methylation of
DNA; these can be broadly divided into Dnmtl, Dnmt2
and Dnmt3 families. The three families of Dnmts are
related, albeit distantly, and are believed to have diverged
from their common ancestors prior to the separation of the
animal and plant kingdoms (Howell et al. 2001). Members
of both the Dnmtl and Dnmt3 families have been ident¬
ified as having active transmcthylase activity and their
functions have been partially elucidated, with the Dnmt3
family being primarily concerned with laying down new
methylation patterns while the Dnmtl family appears to
be mainly involved in the maintenance of these patterns
during cell division. Initial studies on Dnmt2 did not find
any active methylation function for this protein but more
recent research has challenged this concept, with work by
several groups finding that this enzyme can act as a meth-
yltransferase which targets a very specific DNA sequence,
explaining the low level of identifiable activity (Liu et al.
2003, Hermann et al. 2003, Tang et al. 2003). Although
capable of binding to methylated DNA, the definitive
binding specificity of Dnmt2 has yet to be determined
(Hermann et al. 2003). Colding & Westhusin (2003) have
shown that Dnmt2 is actually the most prevalent Dnmt in
the bovine adult ovary and testis.
Laying down of methylation patterns
To allow reprogramming of the germ cell, the genome
must undergo demethylation (as described later). Once
the initial imprints have been removed the appropriate
new pattern must be established, thus ensuring that the
paternal- and maternal-specific imprints are laid down in
the sperm and oocyte respectively. The enzymes which
are capable of laying down the new methyl groups onto
previously unmethylated DNA are from the Dnmt3 family.
Members of this family which have active transmethylase
activity are Dnmt3a and Dnmt3b, which share a high
degree of sequence homology but have been shown to
have different expression patterns and timing through
development. The third member of this family, Dnmt3l,
shares sequence homology with the other enzymes but is
missing the catalytic domain needed to add methyl groups
onto DNA. After both examining the localisation of this
protein and using mice with a disrupted Dnmt3l gene, a
role in the establishment of maternal imprints in the
oocyte has been hypothesised for this enzyme, as dis¬
cussed below.
Maintenance of methylation
When a methyl group is added onto already hemi-
methylated DNA during cell replication (necessary if the
daughter cells are to maintain the methylation pattern of
the cell undergoing mitosis), the process is termed main¬
tenance methylation. Dnmtl has the primary responsibil¬
ity for maintaining the methylation status of DNA. The
most common form of this methyltransferase is that found
in all somatic cells, Dnmtls, and has been shown to be
vital for development. In addition, there are two splice
variants identified which are specific to the germ cells and
early embryo. Dnmtl p is found in pachytene spermato¬
cytes whilst Dnmtlo is only identifiable in the oocyte and
pre-implantation embryo. It is not until embryonic day 7
(E7) that the embryo is capable of producing full-length
Dnmtl s protein.
Interestingly, although Dnmtl has been identified as the
main maintenance methylase in vivo, studies in vitro have
shown that this enzyme has a higher de novo methylase
activity than either Dnmt3a or Dnmt3b. In vivo, Dnmtl
de novo methylase activity has yet to be found, but the
possible implications of this in vitro activity should be
borne in mind (Howell et al. 2001).
How does methylation lead to repressed gene
transcription?
There are two main mechanisms by which the methylation
of DNA can prevent the transcription of genes. The first of
these is by the methyl group causing direct interference
preventing particular transcription factors from binding to
methylated DNA (Iguchi-Ariga & Schaft'ner 1989). The
second mechanism results from methyl-binding domain
proteins (MBDs) binding to methylated DNA.
Of the MBDs identified to date, MBD1 to MBD3 and
methyl CpG-binding protein 2 (MeCP2) are involved in
transcriptional repression (Nan et al. 1997, Fujita et al.
1999, Ng et al. 1999), while MBD4 is thought to have a
role as a mismatch repair protein (Hendrich et al. 1999).
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MBD1 and MeCP2 both contain transcriptional repression
domains which act via histone deacetylases (HDACs).
HDACs cause local deacetylation of the histone tails
which, in turn, results in remodelling of the chromatin
into a more condensed structure that is resistant to tran¬
scription (Taunton eta/. 1996). MBD1 mediates transcrip¬
tional repression through recruitment of a histone
methylase capable of binding HDACs (Ng ct al. 2000,
Fujita el al. 2003), while MeCP2 acts to bind a co-repres-
sor complex containing an HDAC (Jones et al. 1998, Nan
el al. 1998), although MeCP2 has also been shown to
cause transcription repression in the absence of HDAC
activity (Nan ct al. 1998, Yu et al. 2000). MBD2 and
MBD3 are both components of a large protein complex,
MeCPI (Feng & Zhang 2001). MeCPI binds methylated
DNA in a non-sequence-specific manner. The binding of
MeCPI to methylated DNA is due to the presence of
MBD2 in the complex (Ng el al. 1999). Interestingly, the
mammalian form of MBD3 appears not to bind directly to
methylated DNA (Hendrich & Bird 1998). The MeCPI
complex binds methylated DNA less tightly than MeCP2,
which suggests that long-term transcriptional repression
may be maintained by the permanent binding of MeCP2,
with more transient transcriptional silencing determined
by the binding of the MeCPI complex (Ng et al. 1999). In
addition to the MBD family, there is a further binding pro¬
tein termed Kaiso which is capable of methylation-depen-
dent repression of gene transcription. Although it is not an
MBD-containing protein, it is capable of binding to meth¬
ylated DNA via its zinc finger (Prokhortchouk el al. 2001).
Kaiso has been shown to be a vital component of amphi¬
bian development; blocking translation of this protein is
lethal (Ruzof et al. 2004) but the extent of its role in mam¬
malian systems has yet to be established. Methylation-
dependent transcriptional repression is covered by many
good reviews such as Wade (2001) and Li (2002).
Transgenic studies show that mice lacking MBD1 have
no observable phenotype, although problems within the
nervous system are evident at the molecular level (Zhao
cl al. 2003). Mbd2 knockout (KO) mice are also viable,
although they exhibit impaired maternal behaviour (Hen¬
drich cl al. 2001). Mbd3 null mutations are embryo lethal
(Hendrich ct al. 2001). The abnormal phenotype of Mecp2
KO mice develops from several weeks of age and is lethal
by 8 weeks of age, with all known abnormalities having
their origin in the nervous system (Guy et al. 2001). The
fact that Mbdl, Mbd2 and Mbd3 KO mice have no appar¬
ent phenotype outside of the nervous system suggests that
there is a degree of redundancy within the MBD-mediated
system of transcription control. Although a double KO of
Mbd2 and Mccp2 has demonstrated that both these pro¬
teins function in separate pathways, this does not rule out
co-operation between other members of the MBD family
(Guy ct al. 2001).
Genomic imprinting in germ cells and embryos
Primordial germ cells
When primordial germ cells (PGCs) are first seen in the
mouse embryo at E7 they, and the surrounding somatic
cells, carry the maternally and paternally inherited
imprinting patterns. This DNA methylation pattern is
maintained in PGCs as they migrate to the developing
gonad. Coincident with their arrival in the gonadal ridge,
the mouse PGCs begin to undergo global demethylation
from around E11.5 to remove their inherited imprinting
pattern. During this period, DNA methylation of the
somatic cells is maintained (Fig. 1). Demethylation of
germ cells is clearly vital if the correct sex-specific epige-
netic information is to be subsequently laid down during
oocyte and sperm maturation. Demethylation is complete
by El 3—14, correlating to the period when the male
and female mouse PGCs begin to enter mitotic and
meiotic arrest respectively. It has been suggested that
mitotic/meiotic arrest might necessarily follow demethyla¬
tion because replication of unmethylated DNA has an
increased risk of unrepressed retro-transposons moving
and causing mutations (Walsh et al. 1998). The time at
which this demethylation occurs, and also the amount of
methylation lost, appears to be identical regardless of the
gender of the embryo (Hajkova et al. 2002). Whether the
loss of methylation occurs by a passive or active mechan¬
ism or a combination of both is not yet known, although
the speed with which this occurs would suggest involve¬
ment of an active mechanism.
Oocyte development
In female embryos, the gonad forms as an ovary with
germ cells forming primordial follicles. As long as the pri¬
mordial follicle and the oocyte contained within it are not
activated to enter the growing population, the methylation
level of the oocyte genome remains low and unchanged.
It is during the growth phase of the oocyte that the
maternal imprints are laid down on the genome (Fig. 1).
The imprints are not all established at the same time;
instead, each imprinted gene has a specific time at which
it will become methylated (Fig. 2). Obata & Kono (2002)
analysed parthenogenetic embryos created by nuclear
transfer of oocyte nuclei from different stages of follicle
development, with the aim of establishing the timing of
the maternal imprinting within the oocytes, and showed
that Snrpn, Znfi27 and Ndn genes are imprinted early in
follicle development during the primordial to primary fol¬
licle stages, whilst imprinting of Peg3, lgt'2r and p57K'p~
happens at the secondary follicle stage. There are also
genes which become imprinted at even later stages of fol¬
licle development, including Pegi/mest during tertiary to
early antral • stages and Impact which only becomes
imprinted in the oocyte within an antral follicle (Obata &
Kono 2002). A further study by Lucifero et al. (2004)
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Figure 1 The maternal (pink shaded region) and paternal (blue shaded region) imprints are laid down during germ cell development so that by
the time the oocyte and sperm are fully mature the correct pattern of DNA methylation is present on the genome (female imprints, pink ovals;
male imprints, blue ovals). After fertilisation (yellow-shaded area), both parental genomes undergo global demethylation of non-imprinted
sequences: imprinted genes are protected from this process. During early embryo development the imprinted genes of both the somatic and
PGC retain the parental imprints. From El 1.5 the primordial germ cells begin to undergo demethylation to erase the inherited parental imprints,
but the somatic cells of the embryo maintain the parental imprints through embryo development and into adulthood. The process of PGC
demethylation is complete by E13. Subsequent reprogramming of the germ cells occurs when the gender-specific imprinting patterns are once
more laid down.
1or5dpp 10dpp 15dpp 25dpp Mil
Figure 2 Methylation levels of individual imprinted genes and non-imprinted regions of the genome were assessed over the period of oocyte
growth and development. These results demonstrate the gene-specific nature of methylation of the genome, with some genes imprinted early on
in follicle development while others are imprinted much later, dpp, days post partum; Mil, Metaphase II; IAP, intracisternal A particles;
Reproduced from Lucifero et a/. (2004) with permission from Oxford University Press.
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investigated the methylation of imprinted genes by dissect¬
ing follicles from ovaries of different postnatal ages and
examining the oocytes. This confirmed the earlier Obata
& Kono, 2002 study in that Peg3, Igf2r and Snrpn began to
gain methylation earlier in development than Pegl. By the
early antral stages, some differentially methylated regions
(OMRs) were fully methylated in all genes other than
Peg/, while it was not until oocytes were fully mature that
Peg/ appeared to undergo rapid de novo methylation.
Thus, the imprinting pattern of the oocyte is not fully laid
down until it is within a mature follicle ready to ovulate.
This has clear implications for assisted reproductive tech¬
niques (ARTs), where follicle and oocyte maturation is
usually artificially stimulated; any such process must sup¬
port the correct completion of oocyte imprinting.
Over the period of oocyte growth, the general level of
DNA methylation increases as both the appropriate
maternal pattern of imprinting is laid down and non-
imprinted sequences also become methylated (Fig. 3). The
Dnmt involved has yet to be identified, although it has
been suggested that one or more members of the Dnmt3
family could be responsible. Dnmt3a, 3b and 31 are all
expressed during postnatal oocyte growth. Dnmt3l is
expressed at a higher level than either Dnmt3a or Dnmt3b,
although all three have maximal expression levels occur¬
ring at approximately the same stage of oocyte develop¬
ment (Lucit'ero et al. 2004). Dnmtl s protein is not found in
either growing oocytes or in pre-implantation embryos.
Instead, an alternatively spliced, more stable transcript,
Dnmtlo, is expressed at these stages. In the growing
oocyte, Dnmtlo is found in both the cytoplasm and the
germinal vesicle (Fig. 4), but once the oocyte is fully
matured, it is localised to the cytoplasm where it is stored
until it is required during later embryo development (Carl¬
son eta/. 1992, Mertineit eta/. 1998). Since Dnmtlo trans¬
lation only occurs early in oocyte development, the
stability of this form of Dnmtl is clearly important.
Dnmt3l does not have the active transmethylase activity
which is a characteristic of the other Dnmt3 family
proteins, Dnmt3a and 3b. However, Hata ef a/. (2002)
found that Dnmt3l expression was vital if normal maternal
imprints were to be laid down in the oocyte and that this
function may be mediated through its ability to bind and
co-localise with both Dnmt3a and 3b. Mice with a dis¬
rupted Dnmt3l gene are sterile. Males produce no mature
sperm (see below); females undergo apparently normal
oocyte growth and the resulting oocytes can be fertilised,
but the absence of maternal Dnmt3l is embryo lethal to
heterozygote offspring by E9.S (Bourc'his et al. 2001).
Interestingly, a conditional KO with disrupted Dnmt3a in
the germ cells has an almost identical phenotype to the
Dnmt3l 7 mouse (Kaneda et al. 2004): when females
whose oocytes lacked Dnmt3a were crossed with wild-
type males all offspring died by E11.5, with embryos lack¬
ing methylation on the normally methylated maternally
imprinted genes (resulting in inappropriate gene
expression). This study demonstrates the essential role of
Dnmt3a in the establishment of maternal imprints. Kaneda
et al. (2004) also investigated the role of Dnmt3b using a
conditional KO; these animals were found to be phenoty-
pically normal and were able to produce viable offspring.
Sperm development
As with the oocyte, new imprints are laid down as sperm
develop (Fig. 1), with the increase in DNA methylation
levels not just attributable to the establishment of paternal
imprints but also the methylation of other non-imprinted
sequences, such as intracisternal A particles (lAPs) becom¬
ing methylated (Walsh et al. 1998). The paternally
expressed (i.e. maternally imprinted) human MEST/PEG1
gene is demethylated during fetal life and then remains
unmethylated through all stages of sperm development in
adult life. Ueda et al. (2000) analysed the methylation
level of an imprinted gene, HI9, in male germ cells and
found that the HI9 imprint is laid down early in germ cell
development before meiosis occurs. The same result was
found in humans, with the HI9 gene becoming methyl¬
ated before meiosis at the spermatogonia! stage of devel¬
opment (Kerjean et al. 2000). In general, though, there is
less information about the laying down of imprinting
patterns during sperm development compared with what
is known about imprinting in oocytes.
The resumption of mitotic division of male germ cells at
puberty coincides with an increase in the level of Dnmtl
within the spermatocytes. During the early stages of
Day 0 ~ I Day 2 — I Day 4 — I Day 6
Figure 3 Global methylation level of the oocyte increases over the period of growth and development associated with follicle development from
pre-antral stages to full maturity. Contocal images showing oocytes stained with 5-methyl-cytosine antibody (Eurogentec, Seraing, Belgium) and
an FITC fluorescent secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA). Late pre-antral follicles were dissected from 3-week-
old mouse ovaries and cultured as in Spears et al. (1994), with follicles developing to the Graafian stage over a 6-day period. Follicles were
removed from culture and oocytes recovered on days 0, 2, 4 and 6 of culture before being fixed and stained. White scale bars represent 10 p.m.
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Figure 4 The oocyte expresses only Dnmtlo (and not Dnmtls). Until oocyte maturation is complete, Dnmtlo is localised in the cytoplasm and
germinal vesicle - but not the nucleolus - of growing oocytes. The figure shows an oocyte from a mid-antral (i.e. not yet fully mature) follicle.
(A) Immunocytochemistry using the PATH52 antibody that recognises both Dnmtls and Dnmtlo (kindly donated by T Bestor, Columbia Univer¬
sity). The image shows localisation of Dnmtl in both the cytoplasm and the germinal vesicle of the oocyte, with only the nucleolus remaining
unstained. (B) Immunocytochemistry using the UPT82 antibody which detects only Dnmtls (kindly donated by J R Chaillet, University of
Pittsburgh). The cumulus cells are heavily stained while, as expected, the oocyte remains unstained showing that staining in (A) was specifically
due to Dnmtlo. (C) Transmitted light image of oocyte shown in (B). White scale bars represent 10 p.m.
meiosis the level of Dnmtls in spermatocytes is high but a
reduction in the level of the Dnmtl enzyme has been
observed in pachytene stage spermatocytes (Jue et al.
1995). This is due to the expression of an alternatively
spliced version, Dnmllp, which does not appear to be
translated. Although Dnmtls within the sperm is normally
found in both the nucleus and the cytoplasm, it is concen¬
trated at nuclear foci during some stages of meiosis and it
may be that this correlates with the laying down of
paternal imprints Cue et al. 1995). Dnmt3l is expressed in
the murine testes from El2.5 in non-dividing prospermato-
gonia with peak expression seen at the time of birth, after
which there is a dramatic postnatal reduction in
expression level (Bourc'his & Bestor 2004, La Salle et al.
2004). Dnmt3a expression in the testis is raised before
birth and during early postnatal life, in contrast to the
level of Dnmt3b expression which is lower during
embryonic life and rises postnatally (La Salle et al. 2004).
Mice lacking Dnmt3l have smaller testes, and by adult¬
hood there are virtually no spermatozoa present, resulting
in sterile animals (Hata et al. 2002). Dnmt3l is required if
normal meiosis and silencing of retrotransposons is to
occur (Bourc'his & Bestor 2004). The loss of Dnmt3a
results in a similar although less extreme phenotype than
that seen in the Dnmt3l KO mouse (Hata et al. 2002).
More recently, the male Dnmt3a conditional KO was cre¬
ated, with no germ cell Dnmt3a expression but with
somatic cell levels maintained (Kaneda et al. 2004). Sper¬
matogenesis is severely impaired in these mice so that by
1 I weeks of age there are no spermatozoa in the testis,
demonstrating a vital role for Dnmt3a in this process. Off¬
spring from these conditional KO males have errors in the
methylation of some paternally imprinted genes.
Fertilisation and early embryo development
As shown in Fig. I, the fertilised embryo contains methyl¬
ated DNA, some of which will be located in imprinted
genes (both maternal and paternal) while the majority of
the DNA methylation will be positioned on non-imprinted
sequences (again of both maternal and paternal origin).
Early on in embryo development, the embryo loses its
methylation at the non-imprinted DNA sequences; it now
appears that this DNA methylation is lost in a parent-of-
origin specific order, at least in some species. Imprinted
genes are resistant to these early demethylation processes.
The embryo's germ cells will lose methylation of the
imprinted genes during gonadal development, while
somatic cells maintain these methylation patterns through¬
out embryonic development and, in the main, throughout
the life of the newly formed organism (although imprinted
patterns are lost or altered in some tissues, such as the
liver; McLaren & Montgomery 1999).
In some species (such as the mouse), the paternal gen¬
ome is actively demethylated immediately after fertilisa¬
tion (Oswald et at. 2000). The occurrence and degree of
this demethylation appears to be species specific, and its
regulation is currently unknown. Cross-fertilisation using
gametes from several species of animal has shown that,
although there are sperm characteristics which affect the
degree of demethylation, the main factor determining
whether the paternal genome becomes demethylated is
oocyte specific (Beaujean et al. 2004). In the search for
the factor responsible for this post-fertilisation active
demethylation, MBD2 was proposed as a candidate after
an in vitro study by Bhattacharya ef al. (1999). However, a
subsequent study utilising MBD2 oocytes has found
that the rapid demethylation of the paternal genome still
occurs in its absence (although this result does not elimin¬
ate the possibility of redundancy; Santos et al. 2002). The
maternal genome undergoes passive demethylation which
is slower to occur and is linked to the replication of DNA
in the absence of any maintenance methylase activity.
Although the general trend after fertilisation is for non-
imprinted sequences to undergo demethylation, there
does appear to be some specific incidences of de novo
methylation such as the DMRs of the Dnmtlo gene in the
one-cell to blastocyst stage embryo (Ko et al. 2005).
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Dnmtlo remains localised to the cytoplasm of the
embryonic cells at all pre-implantation stages with
the exception of the eight-cell embryo. During this stage,
(he protein has been shown to translocate to the nuclei,
where it is thought to play a role in maintaining the meth-
ylation level of imprinted genes. Dnmt3a is expressed by
pre-implantation embryos and there is no evidence of the
protein being excluded from the nucleus at any develop¬
mental stage (Ko ct al. 2005). Although Dnmt3b is not
transcribed in the pre-implantation embryo the protein is
present at all stages from the one-cell to the blastocyst
stage; while mainly localised to the cytoplasm, it is not
fully excluded from the nucleus (Ko et at. 2005).
Until recently, embryos which consisted of two maternal
or two paternal genomes were unable to develop to term.
Work examining the competence of parthenogenetic
embryos found they were able to develop at best until
E9.5. By creating an embryo with one set of chromosomes
from a fully grown and the other from a non-growing
oocyte, Kono ct al. (1996) showed that embryo develop¬
ment could be extended to E13.5. It was thought that this
increase in the length of time the embryo survived was due
to the ability of the non-growing oocyte chromosomes
(with, therefore, no female imprints yet laid down) to par¬
tially compensate for the lack of a paternally imprinted set
of chromosomes. Parthenotes which died at E9.5 and E13.5
had incorrect biallelic expression of the normally monoal-
lelic HI 9 gene. The most recent work by Kono et al. (2004)
has resulted in the birth and survival of a viable parthenote.
This was achieved using non-growing oocytes from a trans¬
genic mouse with a 13 kb deletion of H19. The mouse had
H19 expression consistent with that normally seen from
the paternal genome. As H19 in turn influences the
expression of the imprinted lgt'2 gene, the embryo had
monoallelic expression of both HI9 and lgt'2 (from the
wild-type fully grown oocytes only), as would be the case
in normal embryos. The fact that normal embryo develop¬
ment is possible after the female genome is altered to more
closely resemble the genomic imprinting pattern of the
male genome demonstrates the importance of this mechan¬
ism in controlling development, reinforcing the idea that
the presence of mammalian genomic imprinting might act
as a barrier to parthenogenesis (see above).
Errors in genomic imprinting
With genomic imprinting being a basic mechanism clearly
vital for many aspects of development, there are, not sur¬
prisingly, many instances of developmental defects due to
imprinting errors whether occurring naturally or during
human intervention (Table 1).
Assisted reproductive techniques
In recent years, there has been increasing concern that
children conceived with the aid of ARTs could have an
increased occurrence of disorders linked to imprinting
problems. At the turn of the century, two studies (Cox et al.
2002, Orstavik et al. 2003) reported the occurrence of
three children conceived using intra-cytoplasmic sperm
injection (ICSI) with Angelman syndrome (AS), a neuro¬
logical disorder characterised by developmental delay and
seizures, suggesting that the risk of AS may be increased
by the use of ICSI. The fear of such a link was then
increased with three studies that examined patients with
Beckwith-Wiedemann syndrome (BWS) to see if a higher
than expected proportion of these cases came from ART
babies; all studies found a disproportionate number of
such cases (DeBaun et al. 2003, Gicquel et al. 2003,
Maher et al. 2003). BWS is characterised by both pre- and
postnatal overgrowth and defects of the abdominal wall.
Children who had been conceived using ART and suffered
from BWS had the methylation status of their HI9 and
LITI genes established, with only one of the identified
children demonstrating normal methylation patterns on
both these genes. Data suggest that ART results in a three-
to sixfold increase in the incidence of the normally rare
BWS, although some of the studies may in fact be under¬
estimating the true risk (DeBaun et al. 2003).
The cause of the link between ARTs and imprinting dis¬
orders is currently unknown. It could be due to some
aspect of the ARTs involved. There is a wide range of differ¬
ent ARTs which are now routinely used within clinics.
Techniques might expose one or both of the germ cells to
an altered hormonal regime in vivo, a period of time in cul¬
ture or mechanical manipulation. Any such alterations to
the normal environment of the oocyte or sperm could result
in changes to some aspect of their imprinting mechanisms.
Alternatively, it could be due to some error within the germ
cells used, bearing in mind that couples seeking to use
ARTs have reduced natural fertility.
The potential problems do not end with the germ cells;
the pre-implantation embryo is also often exposed to a
period of culture which could again alter the epigenetic
reprogramming known to occur at these early stages. One
such example is abnormal biallelic HI9 expression of
mouse embryos cultured in Whitten's media (Doherty et al.
2000). It is not just in humans and mice that potential pro¬
blems with imprinting have been seen. In large domestic
mammals such as sheep and cattle, large offspring syn¬
drome (LOS) was identified when embryos had been
exposed to some time in culture (Young et al. 1998).
Further investigations into LOS in sheep have identified
changes in the expression level of the imprinted gene,
ICF2R, due to epigenetic changes (Young et al. 2001).
Similar overgrowth problems seen in mice and humans
are often caused by errors in several imprinted genes
including Igf2 and HI9 (Eggenschwiler et al. 1997),
suggesting that other genes responsible for fetal growth
and development could be involved in LOS.
If sperm used for in vitro fertilisation have lowered global
methylation levels there is no alteration in either fertilisa¬
tion rate or in early embryo quality; however, there is a
reduction in pregnancy rate, demonstrating the importance
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Table 1 Diseases and syndromes which result from problems to the imprinting mechanisms or from errors in the imprinting of genes.
Disorder Affected genes Phcnotype Art link?
Angelman syndrome Chromosome 15 - maternal copy, loss Mental retardation, ataxic gait, seizures, sociable Yes
of SNRPN imprinting disposition
Autism Unknown X-linked gene (not always Impaired language development, problems with
connected to imprinting) social and motor skills
Bee kw i t h - W iedema nn synd rome 11 pi 5 region - altered expression of Undescended testes, large newborn, seizures, Yes
IGF2, HI9 and LIT1 abdominal wall defects
Cancer Variable, e.g. IGF2 in lung cancer Tumours
(not always connected to imprinting
ICF (immunodeficiency, centromeric DNMT3B Immune problems, facial anomalies,
region instability and facial growth retardation
anomalies syndrome)
Paraganglioma Paternal mutations SDHA (PGL1) Glomus tumours of the parasympathetic
and PGL2 ganglia mainly in the head and neck region,
tend to be slow growing and benign
Prader-Willi Syndrome Chromosome 15 - paternal copy Undescended tests, mental retardation, short
stature, obesity small hands and feet
Pre-eclampsia Not yet defined Serious complication of pregnancy
Pseudohypoparathyroidism type IA Imprinted GNAS cluster Parathyroid horomone resistance, short
(Albright hereditary osteodystrophy) stature, round face and short hand bones
Pseudohypoparathyroidism type IB Imprinted GNAS cluster Parathyroid hormone resistance localized
to renal system, causing hypocalcaemia
and hyperphosphataemia
Rett syndrome MeCP2 Childhood neurodevelopmental disorder mainly
affecting females. Loss of motor function
and mental retardation
Silver-Russell syndrome Cases which are imprinting Short stature, excessive sweating, triangular face,
related - chromosome 7 inward curving 5th fingers and coloured spots
on the skin
Transient neonatal diabetes An imprinted gene at 6q24. Growth retardation and diabetes which develops
Candidates are ZAC & HYMAI during the first 6 months of life but corrected
by 18 months
Turner syndrome Complete or partial loss of second Affects females - short stature, social problems
X chromosome and ovarian failure
Wilms' tumour IGF2 loses imprinting Childhood kidney tumour
of normal gamete DNA methylation on embryo develop¬
ment and ultimately ART outcome (Benchaib et al. 2005).
There is recent evidence that sperm obtained from males
with low sperm counts due to abnormal spermatogenesis
have incorrect genomic imprinting (Marques et al. 2004),
although such sperm can then be used, for example, in
ICSI. Marques et al. (2004) found that, although the
maternal imprints had been erased from all sperm, the
paternally methylated HI9 gene was under-methylated in
some sperm from the oligozoospermia donors. Any embryo
derived from one of these hypomethylated sperm could
have inappropriate expression of the imprinted HI9 and
IGF2 genes, the effect of which is not known.
Cloning
Studies investigating the failure of cloned animals have
also turned their attention to the role of genomic imprint¬
ing. The fact that many of the errors seen in cloned ani¬
mals have epigenetic causes has been demonstrated by
examining the offspring of cloned mice. These cloned
mice were obese but this trait was not passed onto the off¬
spring, demonstrating that this was not a genetic error but
due to epigenetics. This finding is important as it suggests
that, despite any problem in the cloned animals, it is poss¬
ible that their germ cells are able to correctly undergo
genomic imprint reprogramming (Tamashiro et al. 2002).
In bovine cloned embryos, it has been found that the
levels of methylation in the cells of the embryo are higher
than normal at the four-cell and eight-cell stages.
Although there is initial demethylation of the donor gen¬
ome, passive demethylation does not occur to the level
seen in normal embryos. In addition to a reduction in the
amount of demethylation, there also appears to be inap¬
propriate de novo methylation occurring at early stages of
embryo development (Dean et al. 2001). It is also possible
that errors in the Dnnit enzymes normally present in the
early embryo could account for alterations in methylation
seen in these embryos. Analysis of cloned mouse embryos
shows inappropriate presence of Dnmtls within the pre-
implantation embryo; this transcript of Dnmtl is never
present in normal embryos. It was also observed that at
the eight-cell stage, when Dnmtl o would normally trans¬
locate into the nuclei of embryonic cells, some nuclei
within each embryo were devoid of any Dnmtl transcript,
suggesting that these cells are unable to maintain normal
methylation patterns (Chung et al. 2003).
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Disease
In some cases, imprinting errors can occur which,
although not embryo lethal, cause abnormal physiological
processes and lead to disease. Such diseases can arise
when any imprinted gene becomes hypermethylated or
hypomethylated. Effects are not always limited to the loss
of function of a single gene, as some imprinted genes
affect the expression of other genes, such as H19 and
IGF2. The linked Prader-Willi syndrome (PWS) and AS
are examples of disorders that can occur when correct
imprinting is lost. A loss of a currently unidentified
imprinted gene results in PWS when the deletion is pater¬
nally inherited, whereas the same errors cause AS to
develop when maternally transmitted (Moncla et at.
1999). Other examples of diseases which result after
incorrect imprinting include BWS, Silver-Russell syn¬
drome and transient neonatal diabetes.
Disease can also result from defects in mechanisms reg¬
ulating imprints. One of the key groups of enzymes with a
role in genomic imprinting are the Dnmts which are
responsible for the addition of methyl groups to the DNA.
When problems arise within this aspect of the imprinting
mechanism it can lead to disease in the individual. One
such example is immunodeficiency, centromeric region
instability and facial anomalies syndrome which is a result
of a mutation in DNMT3B (for review see Ehrlich 2003).
Another major component of the imprinting mechanism
is the family of methyl-binding domain proteins. MeCP2 is
a protein which contains a methyl-binding domain. It has
a role in controlling the transcription of imprinted genes
through its ability to bind to methylated DNA. The import¬
ance of this protein for normal development and physio¬
logical function is demonstrated by Rett syndrome which
occurs when MECP2 is mutated (Amir et at. 1999).
There are some diseases with multiple causes which
only in some cases involve errors to the imprinting mech¬
anism or alterations to imprinted genes. Cancer is one such
disease, with some cases of cancer being identified as hav¬
ing a cause linked to genomic imprinting while many other
incidences of the disease occur because of unrelated pro¬
blems. In some instances, human tumour cells have been
found to overexpress one or more of Dnmtls, 3a and 3b,
with the largest upregulation occurring to Dnmt3b (Robert¬
son ct al. 1999). These results support the previous obser¬
vations of abnormal methylation levels seen in tumour
cells. One cancer which demonstrates such raised Dnmt
levels is acute myelogenous leukaemia; it may be that this
overexpression of the Dnmt enzymes accounts for the
hypermethylation and silencing of an important tumour
suppressor gene (Mizuno et al. 2001).
Conclusion
Genomic imprinting is a gene transcription control mech¬
anism which is vital for normal healthy offspring.
Although in recent years there has been a huge volume of
work undertaken to elucidate the mechanisms behind
genomic imprinting there are still many unanswered ques¬
tions. Recent data have demonstrated that there are
species differences in the imprinting mechanism which
still need to be fully explored but could have implications
for the success of cloning attempts. Additionally, knowl¬
edge of genomic imprinting may aid the understanding of
some human diseases and offer potential therapies. The
field of ART will also benefit from a greater understanding
of genomic imprinting, resulting in improved techniques
with an increased success rate and, most importantly, a
safer outcome.
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Abstract
Although there have been extensive studies on the effects of gonadotrophins and
steroids on follicular development, less is known as to the effects these hormones
have on the acquisition of oocyte developmental competence. This study investigates
the effect of altering the gonadotrophin or steroidal environment on follicular
development and on oocyte viability and DNA methylation. Oocytes were obtained
from pre-ovulatory follicles after individual follicle culture from the pre-antral stage;
gonadotrophin or steroid levels were manipulated during the culture period. Oocytes
obtained from follicles grown in gonadotrophin free conditions were able to fertilize
and develop to the blastocyst stage despite their impaired follicle development. There
was no effect of LH or steroids on follicular growth. Altering the steroidal
environment did however, affect oocyte development. Raising androgen and
oestrogen levels lowered fertilisation rates while increasing the level of global DNA
methylation. This study demonstrates that gonadotrophins and steroids influence the
acquisition of developmental competence of the oocyte and suggests that optimal




The roles that follicle stimulating hormone (FSH) and luteinizing hormone
(LH) play in ovarian development have been extensively studied for a number of
years. Until the recent availability of recombinant forms of both gonadotrophins it
was difficult to define the precise and individual roles that FSH and LH played in
follicular growth and development. From the growing number of reports that have
now utilized these recombinant gonadotrophins it is clear that FSH on its own is
capable of promoting follicular growth and development, while LH augments
steroidogenesis and plays a critical role in the ovulatory process (Chappel and
Howies 1991, Hillier 1994). Recombinant FSH alone has been used in both clinical
and animal studies: results have indicated that inclusion of LH in ovarian stimulation
protocols is required for adequate steroidogenesis and that inadequate oestrogen
synthesis is detrimental to embryo viability and endometrial development (Balasch et
al., 1995, Spears et al., 1998, Balasch etal, 2001 Shoham, 2002). The concentration
of LH required to optimize stimulation protocols has been the subject of many
debates. It has been suggested that follicular maturation is optimal when LH levels
do not rise above a 'ceiling' which, when exceeded, leads to an arrest of follicular
development (Loumaye et al, 2003). Elevation of LH levels above basal rates during
ovarian stimulation protocols has also been proposed to impact directly on oocyte
quality (Balasch et ai, 2001, Shoham, 2002). Other studies, however, have failed to
confirm any correlation between elevated LH levels and pregnancy rates
(Westergaard et al., 1996). From these conflicting reports it is still unclear what
effect LH has on oocyte development within the follicle prior to ovulation and how
this affects the quality of the resulting embryo after fertilisation.
4
Gonadotrophin levels will directly affect ovarian steroidogenesis, LH
stimulating the thecal cells of the follicle to produce androgens which are
subsequently aromatized to oestrogens within the FSH-responsive granulosa cells.
Androgens and oestrogens have been proposed as paracrine/autocrine regulators of
follicular development, but, as with LH, there is controversy over their roles in the
ovary. Apart from serving as substrates for oestrogen synthesis, androgens have been
implicated in promoting follicular development (Murray et al., 1998, Vendola et al.,
1998), and in up-regulating FSH receptor expression and enhancing FSH-stimulated
follicular differentiation (Tetsuka and Hillier, 1997, Weil et al., 1999). However,
excess androgen levels have also been associated with inducing follicular atresia,
while high androgemoestrogen ratios in follicular fluid have been correlated with
poor fertilization and development rates (Andreisz and Trounson, 1995, Xia and
Younglai, 2000). Oestrogens have been shown to inhibit follicular atresia and to
facilitate the proliferation of granulosa cells, the actions of gonadotrophins, gap
junction formation and steroidogenesis (Merck etal, 1972, Roberts and Skinner,
1990, Billig et al., 1993, Dorrington etal., 1993, Bley etal., 1997). Other studies
have indicated that oestrogen is not obligatory for follicular development (Spears et
al., 1998, Balasch et al., 1995). As both androgen and oestrogen receptors have been
reported on the oocyte, it is possible that steroids may also exert a direct effect
(Szlotys et al., 2003, Gill etal., 2004).
Recently the phenomenon of genomic imprinting has received much attention,
with maternal epigenetic imprints established during the oocyte growth period
(Obata et al., 1998). Alterations to the mechanisms involved in imprinting can result
in early embryonic lethality, but may become evident only during the later life of the
organism. One of the most researched aspects of genomic imprinting is the role of
DNA methylation in controlling gene transcription, with imprinted genes in the
paternal and maternal genomes differentially methylated (Simon et al., 1999,
Lucifiro et al., 2002). The signals that mark certain genes for imprinting either via
methylation or by other means has yet to be elucidated, however paracrine signals
arising from gonadotrophin or steroidal actions within the follicle are possible
candidates.
It has been proposed that the oocyte needs to be exposed to the correct
sequence and pattern of steroids in order to acquire the molecular programming
required for fertilisation and further development (Moor et al., 1998). Alterations to
the normal follicular sequence of FSH- and LH-stimulation, such as occurs during
ovulation stimulation, will inevitably perturb the pattern of steroid exposure which
may in turn have an effect on oocyte competence. This study aims to investigate the
effects of varying gonadotrophin and steroidal treatments on follicular development,
oocyte viability and DNA methylation, using an in vitro system that permits the
development of individual follicles from the pre-antral to the Graafian stage. This
system is highly physiological in that it closely mimics follicular development in
vivo. While mechanical isolation of follicles is labour-intensive and imposes some
restrictions, it does ensure that individual follicles, at a similar developmental stage




F1 (C57BL/6J x CBA background) and hypogonadal (hpg) mutant mice were
housed in an environmentally controlled room on a 12h light: 12h dark photoperiod.
Food and water were available ad libitum. Hpg mutant animals were generated by
breeding heterozygous paio (hpg+/~). Offspring were genotyped by extracting DNA
from an ear clipping which was then analyzed by polymerase chain reaction (Lang,
1991). All animals were maintained and treated according to UK Home Office
requirements and the study received local ethics committee approval.
Culture Supplements
In order to accommodate for batch to batch variation in recombinant human
follicle stimulating hormone (rhFSH) potency, batches were titrated to ensure that
each batch was used at the minimum concentration that allowed follicles to reach
sizes of >400 pm over a 5-6 day period (doses are described for individual
experiments).
The use of serum in the culture media could potentially introduce additional
gonadotrophins and/or steroids that could influence the results. In earlier
experiments, serum was obtained from hpg mutant adult mice (which have no or
very low levels of circulating gonadotrophins). Briefly, blood was withdrawn from
anaesthetized adult animals via cardiac puncture, allowed to clot for a minimum of
10 minutes then centrifuged at 13K rpm for 10 minutes. Serum from each batch of
animals was pooled before being aliquoted and stored at -70°C. As hpg serum proved
erratic in its ability to support fertilization, charcoal-stripped fetal bovine serum
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(CSS) was used in later experiments. The use of activated charcoal to remove
steroids has been previously described (Huot and Shain, 1988). Due to the slower
maturation of follicles in this serum, the culture period prior to oocyte collection for
in vitro fertilisation (IVF) was extended to 5 days.
Culture Medium and Chemicals
All chemicals were supplied by the Sigma Chemical Company (St Louis,
USA) with the exception of those noted here. Epidermal Growth Factor (EGF) was
from Roche (Lewes, UK) and silicone fluid was from Merck (Lutterworth, UK).
Arimidex was a gift from Astra Zeneca (Macclesfield, UK). Recombinant
gonadotrophins (rhFSH and rhLH) were supplied by Serono (Geneva, Switzerland).
Liebovitz L-15 and cc-minimal essential medium (a-MEM) were supplied by
Invitrogen (Renfrew, UK). Fetal bovine serum was supplied by Labtech (Uckfield,
UK). 5-methyl cytosine antibody was supplied by Eurogentec (Seraing, Belgium).
TRIT-C conjugated secondary antibody was supplied by Jackson ImmunoResearch
(Pennsylvania, USA). Vectashield was supplied by Vector Labs. (Peterborough,
UK).
Standard Follicle Culture
21-25 day old F1 female animals were sacrificed by cervical dislocation, their
ovaries removed and placed in watch glasses containing Leibovitz L-15 medium
supplemented with 3mg/mr' BSA (dissection medium). Individual pre-antral
follicles (175 ± 15 |um) were dissected and cultured as previously described (Murray
et al., 1998). On average 25-30 follicles were obtained from each mouse and these
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were randomly allocated across all treatment groups. Follicles were incubated for
periods of between 4-6 days in a humidified 5% CO2,95% air incubator at 37°C.
Media were supplemented with 5% serum and gonadotrophins or steroids as detailed
for each experiment.
Follicular growth, morphology and steroid production
Follicles were examined daily; antral formation was noted and follicles were
measured using an ocular micrometer. At the end of the culture period, spent culture
media were frozen at -20°C until analyzed for steroids. Samples of fresh medium
containing all supplements were also frozen and analyzed for steroids. The various
media from the follicle cultures were then analyzed for the presence of oestradiol and
androstenedione. Oestradiol was measured by ELISA as previously described
(Murray et al., 1998). Androstenedione was measured by radioimmunoassay as
previously described (Hillier et al., 1991).
Oocyte Maturation and In Vitro Fertilisation
Oocytes from uncultured pre-antral follicles or cumulus-oocyte complexes
(COCs) from cultured follicles were dissected and transferred to a-MEM medium
supplemented with 20ng ml"1 EGF, 5% serum and rhFSH. The serum type was the
same as that used in the follicle culture. The COCs were then incubated for 18hr
before being transferred into droplets of T6 medium to await fertilisation (Quinn et
al., 1982). Spermatozoa suspensions were prepared from F1 males as described
previously and allowed to capacitate for 2hr (Spears et al., 1994). Spermatozoa were
added to the droplets of T6 medium containing the oocytes. After 4-5 hours
incubation the oocytes were transferred into droplets of glutamine-free KSOM
medium supplemented with lmg/mf1 fatty acid free BSA (Devreker and Hardy,
1997). As a control for the IVF system, oocytes were obtained from 6-week old F1
females that had been superovulated as described previously (Spears etai, 1994):
oocyte-cumulus complexes were recovered from the oviducts, transferred into
droplets of T6 medium and treated in the same manner as experimental oocytes. All
oocytes were examined the following day and the number of 2-cell embryos counted.
These were transferred to fresh drops of KSOM medium at a ratio of 1 embryo to 2|il
of medium. A maximum of ten x 2-cell embryos were transferred to a 20pl drop of
medium. Where appropriate more than one 20pl droplet of medium was set up and if
necessary the droplet volume was adjusted for the number of 2-cell embryos found.
All droplets were covered with silicone fluid and incubations were in an environment
of 5% CO2 in air, at 37°C. These were then incubated until the blastocyst stage of
development. The number of oocytes fertilising and reaching the blastocyst stage of
development was noted.
Methylation Iinmunohistochemistry
At the end of the culture period, COCs were isolated by rupturing the follicles
with fine needles. Oocytes were then denuded by repeated pipetting. Oocytes were
fixed overnight in paraformaldehyde (4% in PBS) at 4°C before being permeabilised
in Triton-X 100 (0.5% in PBS) for 30 minutes and then denatured with 4N HC1 at
37°C for 1 hour. Non-specific binding was blocked using BSA (2% in PBS) for 1
hour. Oocytes were then incubated with a primary 5-methyl cytosine antibody (1:50
in PBS/BSA) for 1 hour at 37°C, washed and stained with aFITC-C conjugated
secondary antibody (1:200 in PBS/BSA) for 1 hour. After a final wash (Tween20,
0.05% in PBS), the oocytes were mounted on positively charged slides using
vectashield.
Confocal Microscopy
At the end of experiments examining follicular growth, representative
follicles from each of the groups were labeled to detect apoptotic cells using the
Terminal Transferase-mediated dUTP Nick End labeling (TUNEL) technique and
counterstained using propidium iodide ( Baker et al., 2001). Follicles were examined
using the Leica TCSNT Confocal microscope (Leica Microsystems, Milton Keynes,
UK) using a 63X water-corrected PL APO lens. Simultaneous scans at 488 and
568nm were taken to produce an amalgamated, true color RGB image.
Oocytes from experiments to examine methylation were serially scanned at
3pm intervals through the stained region, using a 40X lens. The average threshold of
the images was calculated using Imaris imaging software. Using this information,
global DNA methylation levels were assessed with the Scion Image Software
package. Specificity of staining was checked by examination of oocytes exposed
only to secondary antibody. To allow comparisons between experimental runs, all




Hormone assays were analyzed by ANOVA followed by Tukey-Kramer multiple
comparison tests where appropriate. 1VF results were analyzed by chi-square.




Experiment 1; The effects ofaltered gonadotrophin regimes on follicular growth,
development and subsequent oocyte developmental competence
Experiment 1A: Follicular Growth and Development.
Follicles were allocated to control medium supplemented with 5% hpg serum
either without gonadotrophin supplements (Gn free) or into the following treatment
groups: FSH alone (control medium + 5 IU ml"1 rhFSH); FSH + low LH (control
medium + 5 IU rhFSH + 0.01 IU rhLH ml"1); FSH + high LH (control medium + 5
IU rhFSH + 0.05 IU rhLH ml"1). Follicles were moved into fresh wells daily and
cultured for 6 days. The experiment was performed twice, with 30-40 follicles
cultured per treatment. Damaged follicles were discarded within the first two days of
the culture period.
FSH alone was capable of inducing follicular growth and development: the
addition of low or high LH had no effect on the development of the follicles, with
follicles reaching the same size and antral formation occurring at the same time and
to the same extent in all gonadotrophin groups (Fig. 1). Gn free follicles initially
began to grow, although growth was significantly restricted by day three of culture
when compared to all other group (p<0.001). These follicles then began to regress
from day 4 onwards and no follicles with antral cavities were seen in this treatment
(Fig. 1).
Representative follicles from all groups were labeled for apoptosis using
TUNEL labeling and examined by confocal microscopy (Fig. 2). The only group of
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follicles that exhibited any high degree of apoptotic labeling were those in the Gn
free group, with most granulosa cells near the basement membrane showing TUNEL
labeling (Fig. 2A). In follicles from all other groups, any TUNEL labeled cells were
almost always situated around the antral cavity; this is likely to indicate a healthy
follicle: as the antral cavity enlarges, granulosa cells nearest to the cavity become
apoptotic and release their contents into the antral fluid (Baker et al, 2001).
Spent culture media from days 4 and 5 of culture were analyzed for the
presence of oestradiol and androstenedione. Gonadotrophin treatment altered the
production of androstenedione and oestradiol during follicular growth (Fig. 3).
Neither steroid was detectable in unincubated culture medium or in that from the Gn
free group (data not shown). Follicles from both the FSH + low LH and the FSH +
high LH groups were producing androstenedione on day 4 of culture, whereas no
steroid was detected in the medium until day 5 of culture when follicles were treated
with FSH alone (p<0.05, Fig. 3A). This was reflected in the oestradiol results, as
both the FSH + low LH and the FSH + high LH groups produced significantly higher
concentrations of oestradiol compared to the FSH alone group (p<0.05, Fig. 3B).
While androstenedione production increased significantly in the FSH alone, FSH +
low LH and the FSH + high LH groups by day 5, there was a marked increase in the
production of this steroid by follicles cultured with FSH + low LH when compared to
either the FSH alone or the FSH + high LH group (Fig. 3A). Similar levels of
oestradiol were produced at this time point irrespective of treatment (Fig. 3B).
Experiment IB: In Vitro Fertilisation.
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Follicles were allocated to treatment groups as described above in
Experiment 1A (i.e. Gn free, FSH alone, FSH + low LH and FSH + high LH). These
were cultured for 4 days, after which the COCs were placed in maturation medium
prior to IVF. Maturation medium was supplemented with 1IU ml"1 rhFSFl. Four
experimental runs were performed with a total of 160 follicles cultured in each
treatment. The number of oocytes available for IVF at the end of the culture period
was as follows: Gn free -114; FSF1 alone -123; FSH + low LH -128 and FSH + high
LH - 98. A further group of 30 follicles were dissected between 200-300pm (the
same size as that attained by the Gn free group at the end of the culture period).
These follicles were not cultured: instead the oocytes from these follicles were
removed immediately and placed into maturation medium before undergoing IVF.
There was little difference in fertilisation rate amongst the culture groups regardless
of treatment (Fig. 4A). In contrast, later embryo development was more variable. The
percentage of two-cell embryos developing to the blastocyst stage was similar in the
FSH alone and FSH + low LH group but there was a substantially lower rate of two-
cell embryos derived from the FSH + high LH group that developed into blastocysts
(Fig. 4B). This low percentage was similar to the percentage of blastocysts derived
from the Gn free group. The differences between all groups did not, however, reach
significance (P = 0.08). In comparison to the 20% fertilisation rate and 23.5%
blastocyst rate obtained from the Gn free group oocytes, 29 out of 30 of the oocytes
from the uncultured late preantral follicles did not fertilise, while the remaining
oocyte did not proceed past the 2-cell stage even though both groups of oocytes were
obtained from similar sized follicles. It appears, therefore, that the oocytes from the
Gn free group had undergone a degree of maturation during the culture period
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despite the fact that they were from atretic looking follicles. Results from
superovulated F1 mice (198 oocytes) are given for comparison.
Experiment 2: Effect ofalteration in steroid regime during follicular growth in
vitro on subsequent oocyte developmental competence
Experiment 2A Follicular Growth and Development.
The gonadotrophin treatment received by the follicles resulted in an alteration
to the concentration and production of steroids during the culture period. In order to
investigate the effects of this alteration more directly, culture medium was
supplemented with an oestrogen agonist, an aromatase inhibitor or both compounds.
To elevate oestrogen levels, diethylstilboestrol (DES) was added to culture medium.
This compound is structurally related to 17-(3-oestradiol and has been used
extensively to study reproductive function. In order to elevate androgen levels and
lower oestrogen levels, an aromatase inhibitor, Arimidex (Zeneca ZD 1033), was
used. This compound selectively blocks the aromatase reaction without inhibiting
other steroidal enzymes and without having any direct steroidal actions (Lonning et
ai, 1998). To elevate levels of both steroids, culture medium was supplemented with
both DES and Arimidex. As both DES and Arimidex were solubilised in ethanol
before addition to culture medium, control medium was supplemented with the same
concentration of ethanol. Control follicles were allocated to control medium
supplemented with 5% hpg serum and 2IU ml"1 FSH. Treatment groups were High
A (control medium + 0.1 pm Arimidex); High E (control medium + 0.004 nmol
DES); High A + E (control medium + 0.1 pm Arimidex + 0.004 nmol DES).
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Follicles were moved daily into fresh wells of medium and cultured for 6 days. At
the end of the culture period, representative follicles were labeled for apoptosis using
TUNEL. Spent media from all groups were analyzed for steroids.
Elevating oestrogen, androgen or both steroids had no effect on follicular
growth or rate of antral development, with all follicles growing well and developing
large antral cavities during the culture period, irrespective of treatment (Fig. 5).
Similarly, differing steroid treatments had no effect on the degree of apoptotic cell
labeling within the follicles (data not shown as these follicles were very similar to
those shown in Fig.2, B-D).
In order to check that treatments had successfully altered the level of steroids
to which the follicles had been exposed, media samples from day 6 of culture were
analyzed for androstenedione and oestradiol. Comparison of the levels of
androstenedione in the media showed that the concentration of Arimidex used
successfully inhibited aromatase activity. In the High A and High A+E groups,
androstenedione levels were significantly raised when compared to the control group
or High E group (p<0.01, Fig. 6) As expected, inclusion of Arimidex (High A group)
also significantly reduced the level of 17-(3-oestradiol production by the follicles
compared with the mean and s.e.m. of the control group (73.0 ± 19.0 pmol/ml,
compared to 229.1 ± 31.7 for the control group; p<0.001). We were unable to
measure the increase in total oestrogen levels in response to the addition of DES (in
both the High E and the High A + E groups), as the oestrogen assay used is highly
specific for 17-P-oestradiol and does not cross react significantly with any other
oestrogen. There were no detectable steroids in the unincubated culture medium.
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Experiment 2B: In Vitro Fertilisation.
In order to minimize any influence of steroids found in serum, CSS was used
for these cultures. As the majority of follicles could not maintain their basement
membranes on the final two days of culture in CSS, the culture system was modified;
on days 1 and 2 of culture, follicles were transferred into wells of fresh medium and
damaged or atretic follicles discarded. On day 3 of culture they were then transferred
into 60|J.l of medium overlaid with 75(xl of silicone fluid.
Follicles were isolated, placed in the control medium and treatment groups as
described in Experiment 2A (i.e. Control, High A, High E and High A + E) and
cultured for five days after which COCs were removed from the follicular masses
and placed in maturation medium prior to IVF. In all cases medium was
supplemented with 1IU ml"1 rhFSH. Three experimental runs were performed with a
total of 120 follicles placed in culture for each treatment. The number of available
oocytes taken for IVF at the end of the culture period was as follows: Control - 57;
High A - 49; High E - 51 and high A + E - 51. As in Experiment IB, oocytes (50)
from superovulated F1 mice were included as a control for the IVF system. Steroid
treatment significantly altered the rate of fertilisation (p< 0.01). The presence of
DES, whether in the High E or the High A + E group, yielded fewer oocytes capable
of fertilization when compared to the control group (where steroid production could
be expected to follow a more physiological pattern), whereas elevating androgen
levels during the culture period yielded a greater percentage of oocytes capable of
fertilisation than the control group (Fig. 7). The percentage of two-cell embryos able
to complete development to the blastocyst stage was similar irrespective of steroid
treatment.
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Experiment 3: Effect ofalteration in steroid regime during follicular growth in
vitro on the global DNA methylation levels of the oocyte.
Experiment 3A: DNA methylation during culture.
Follicles were cultured in medium supplemented with CSS and 1IU ml"1
rhFSH for either 0, 2, 4 or 6 days before they were ruptured and the oocytes collected
and fixed. After immunohistochemistry, the DNA methylation pattern and level
could be seen to increase with time in culture (Fig. 8): the level of DNA methylation
showed a large increase between the start and end of culture, with the staining around
the edge of the nucleolus becoming more defined.
Experiment 3B: Global DNA methylation levels after exposure to altered steroidal
regime in culture.
Follicles were isolated, placed in the control and steroid treatment groups as
described in Experiment 2A (i.e. Control, High A, High E and High A + E) and
cultured for 5 days. At the end of the culture period, COCs were removed, oocytes
mechanically denuded and used for immunohistochemistry. The experiment was
performed a minimum of three times. Differences in global DNA methylation level
were evident after steroid treatment (Fig. 9). High A resulted in a significantly
lowered methylation level when compared to the controls (p<0.001). Whereas when




The results presented here confirm that FSH alone can drive follicular growth
and development with the addition of LH having no effect. Other in vitro studies
have reported that the inclusion of LH in culture medium accelerates the formation of
the antral cavity (Cortvrindt et al., 1998). We found no evidence to support this, as
antral formation was similar in all treatment groups, perhaps due to the difference in
culture technique. As could be expected, the inclusion of LH in the culture medium
augmented the production of androstenedione and oestradiol at an earlier time point
in follicular development. Interestingly, FSH alone supported the production of
androstenedione, and hence oestradiol, by the follicles, albeit at a later time-point
than when LH was also present. We have previously found that under the conditions
used in this culture system, follicles exposed to FSH alone produce inhibin
(unpublished data) which has been shown to augment androgen synthesis during
preovulatory follicle growth (Smyth et al., 1994); this pathway could explain the
production of androstenedione (and hence oestradiol) in follicles exposed to FSH
alone. Some reports have suggested that high levels of androgens and oestrogens can
induce atresia in developing follicles (Billig et al., 1993, Dierschte et al. 1994) while
others have shown that these steroids promote follicular development and health
(Murray et al., 1998, Vendola et al., 1998). By employing an oestrogen agonist
and/or an aromatase inhibitor to alter levels of oestrogens, androgens or both steroids
throughout the pre-antral to antral growth phase of follicles, we found that there was
no effect on follicular growth, development or health.
While follicular growth and health were unaffected by the different
gonadotrophin regimes or steroidal environments used in these experiments, there
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was an effect on oocyte developmental competence. There has been some
controversy over whether the actions of LH are necessary during follicular
development in order to optimize oocyte maturation (Balen et al., 1993, Shoham et
al., 1993, Homburg, 1998). Transgenic mice over-expressing LH appear to be fertile
and give rise to offspring (Mann et al., 1999). Conversely other studies have
indicated that high intra-follicular LH permits the premature resumption of meiosis
resulting in 'aged' oocytes (Homburg, 1998) and promotes spontaneous germinal
vesicle breakdown (Cortvrindt et al., 1998). The addition of high levels of LH to the
culture medium in these experiments did not confer any immediate advantage to the
oocyte, as similar fertilisation rates were seen in all the treatment groups. There was,
however, a trend suggesting that fertilised oocytes from the high LH group may be
less able to proceed to the blastocyst stage (p=0.08).
Surprisingly, it was found that around 20% of oocytes obtained from follicles
grown in Gn free conditions could fertilise and complete pre-implantation
development even though the oocytes were obtained from follicles that had ceased
growing by day 3 and exhibited extensive apoptosis in their granulosa cell layers.
This low rate of embryo development was similar to that of oocytes from follicles
cultured in high levels of LH, despite the fact that the high LH follicles grew well
throughout the culture period, with no increased level of atresia. In marked contrast
to the oocytes from the Gn free group, oocytes from uncultured follicles of the same
starting size were unable to fertilise, demonstrating that even oocytes from the Gn-
free group acquired further developmental competence during the culture period.
Furthermore, these oocytes must have been relatively unaffected by the level of
apoptosis in the somatic cells of the follicles. It was noticeable that the granulosa
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cells immediately surrounding the oocytes in the Gn free group tended to be non-
apoptotic, perhaps benefiting from the close proximity of the healthy oocyte or
perhaps helping to maintain the healthy status of the oocyte.
Under normal physiological conditions, levels of androgen are higher earlier in
follicular development while higher oestrogen levels become more prevalent as
follicles progress towards ovulation (Moor et al, 1998). Disruption of this pattern
has been correlated with poor fertilisation and development rates (Andriesz and
Trounson, 1995, Xia and Younglai, 2000). We have shown here that altering the
concentration of steroids in vitro affected the percentage of oocytes undergoing
fertilisation and cleavage to the two-cell stage, with fewer oocytes developing to the
two-cell stage under conditions of high levels of oestrogen in the form of DES. DES
is structurally related to 17-(3-oestradiol and is equally (if not more) potent, with a
longer half life. In addition, it has been shown to bind to both oestrogen receptors
with a higher potency than oestradiol (Guttendorf and Westendorf, 2001). While high
levels of LH stimulated steroid production earlier in the culture period, the effect was
relatively minor and probably not comparable to adding DES throughout the culture
period. This might explain why the LH treatment did not significantly affect
fertilisation or embryo development. There is little information on the effects of
elevated oestrogen concentrations during follicular development on subsequent
oocyte developmental competence. Studies from clinical situations, where
supraphysiological oestrogen levels often result as a consequence of ovarian
hyperstimulation, are difficult to interpret as any effects seen may be a result of poor
oocyte quality or the effects of elevated oestrogen on other areas of the reproductive
tract. By using an individual follicle culture system, this current study has
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demonstrated for the first time that elevation of oestrogen during the pre-antral to
antral growth phase of the follicle is detrimental to the ability of the oocyte to
undergo fertilisation.
Oestrogen has been implicated in increasing free calcium stores within oocytes
(Tesarik and Mendoza, 1995) and ensuring genomic integrity of oocytes before
ovulation (Murdoch and Van Kirk, 2001). In primates, including humans, it has been
suggested that lack of oestrogen results in oocytes less able to undergo fertilisation
(Balasch et al., 1995) and it has been demonstrated that the addition of steroids
during in vitro maturation can aid oocyte developmental competence (Zheng et al.,
2003). In contrast, studies from transgenic mouse models that lack either of the
oestrogen receptors or that lack the aromatase gene have indicated that oestrogen is
not obligatory for follicular development or oocyte maturation (Couse et al., 1999,
Huynh et al., 2004). It is also perhaps relevant that the higher fertilisation rate of
oocytes obtained from Arimidex-treated follicles described here was the result not
only of high levels of androgen but also of lowered oestrogen levels, showing that
decreased oestrogen levels cannot have been detrimental. A recent study utilizing
Arimidex to inhibit aromatase activity in vivo concluded that rising oestrogen levels
were not a requirement for either follicular development or oocyte maturation (Guo
et al., 2004).
We have shown that oocytes lay down increased levels of DNA methylation
during the culture period. Similar increases in global DNA methylation levels over
the equivalent stages of follicle growth in vivo have been observed (unpublished
observations, Swales & Spears) and increases in the methylation level of specific
sequences have been shown to occur over oocyte growth in vivo (Lucifero et al.,
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2004). The steroidal environment affected oocyte global DNA methylation levels:
the oocytes of follicles cultured in high levels of androgens and oestrogens had raised
DNA methylation levels, while those from follicles cultured in high levels of
androgen alone had reduced DNA methylation levels. DNA methylation of oocytes
thus showed an inverse correlation to the fertilisation data obtained: oocytes from the
high A group, which had lowered DNA methylation levels, had the best fertilisation
rate while those from the high A + E group, with increased DNA methylation levels,
had a significantly reduced fertilisation rate, compared to that of controls. It is
possible that inappropriate DNA methylation is one of the causes of poor fertilisation
rates. DNA methylation is part of the mechanism involved in controlling normal
expression patterns of imprinted genes: the correct establishment of genomic
imprinting during oocyte growth and maturation is vital if normal fertilisation and
embryo development are to occur (Obata et al., 1998). Additionally, DNA
methylation is implicated in preventing the movement of retro-transposons and p53-
dependent apoptosis (Dean et al., 2001, Jackson-Grusby et al., 2001). It cannot be
determined from the experiment described here whether the changes in DNA
methylation are due to alterations in levels of imprinted genes, other regions of the
genome or a combination of both. As the observed alterations in DNA methylation
were quite large, it is probably unlikely that these changes would be due only to
changes in imprinted genes, as the DNA methylation associated with these imprinted
genes is relatively small when compared to that of the non-imprinted genomic
regions. Alterations to global DNA methylation levels are associated with failure of
cloned embryos (Dean et al., 2001), while errors in the DNA methylation of specific
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imprinted genes can result in disorders or disease in subsequent offspring (Mizuno et
al.} 2001, Young etai, 2001)
Manipulating the ovary, such as through the administration of exogenous
gonadotropins, can alter the steroidal environment within those follicles and
subsequently have an effect on the developmental competence of the oocyte. While
the idea that steroids influence oocyte competence is not new, these present studies
have shown for the first time that inappropriate exposure of the oocyte to steroids
during follicle maturation may be detrimental to oocyte developmental competence
and impact upon DNA methylation of the genome.
Acknowledgements
The authors wish to thank Vivian Allison for expert assistance with the follicle
cultures and Martha Urquhart for performing the androstenedione assays. Dr
Vlastimil Srsen kindly carried out the TUNEL staining of the follicles and Linda
Wilson performed the confocal microscopy. Dr Nathalie Beaujean kindly advised on
the methylation immunohistochemistry protocols.
Grant Support. Supported by MRC grant G9901514. AKES supported by BBSRC.
26
References.
Anderiesz C, Trounson AO. (1995) The effect of testosterone on the maturation and
developmental capacity of murine oocytes in vitro. Hum Reprod 10: 2377-2381.
Baker SJ, Srsen V, Lapping R, Spears N. (2001) Combined Effect of Follicle-Follicle
Interactions and Declining Follicle-Stimulating Hormone on Murine Follicle Health
In Vitro. Biol Reprod 65: 1304-1310.
Balasch J, Miro F, Burzaco I. (1995) The role of LH in human follicle development
and oocyte fertility; evidence from IVF in a woman with long-standing
hypogonadotrophic hypogonadism and using rhFSH. Hum Reprod 10: 1678-1683.
Balasch J, Creus M, Fabregues F, Civico S, Carmona F, Puerto B, Casamitjana R,
Vanrell JA. (2001) The effect of exogenous luteinizing hormone (LH) on oocyte
viability: evidence from a comparative study using recombinant human follicle-
stimulating hormone (FSH) alone or in combination with recombinant LH for
ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction.
J Assist Reprod Genet 18: 250-6.
Balen AH, Tan SL, Jacobs HS. (1993) Hypersecretion of luteinizing hormone: a
significant cause of infertility and miscarriage. Br J Obstet Gynaecol 100: 1082-
1089.
Billig H, Furuta I, Hsueh AJ. (1993) Oestrogens inhibit and androgens enhance
ovarian granulosa cell apoptosis. Endocrinol 133: 2204-2212.
27
Bley MA, Saragueta PE, Baranao JL. (1997) Concerted stimulation of rat granulosa
cell deoxyribonucleic acid synthesis by sex steroids and follicle-stimulating
hormone. J Steroid Biochem Mol Biol 62: 11-19.
Chappel SC, Howies C. (1991) Reevaluation of the roles of LH and FSH in the
ovulatory process (review). Hum Reprod 6: 1206-1212.
Cortvrindt RG, Hu Y, Liu J, Smitz JE. (1998) Timed analysis of the nuclear
maturation of oocytes in early preantral mouse follicle culture supplemented with
recombinant gonadotrophin. Fert Steril 70: 1114-1125.
Couse JF, Bunch DO, Lindzey J, Schomberg DW, Korach KS. (1999) Prevention of
the polycystic ovarian phenotype and characterization of ovulatory capacity in the
oestrogen receptor- alpha knockout mouse. Endocrinol 140: 5855-5865.
Dean W, Santos F, Stojkovic M, Zakhartchenko V, Walter J, Wolf E, Reik W. (2001)
Conservation of methylation reprogramming in mammalian development: aberrant
reprogramming in cloned embryos. Proc Natl Acad Sci USA 98: 13734-13738.
Devreker F, Hardy K. (1997) Effects of glutamine and taurine on preimplantation
development and cleavage of mouse embryos in vitro. Biol Reprod 57: 921-928.
Dierschte DJ, Chaffin CL, Hute RJ. (1994) Role and site of oestrogen action in
follicular atresia. Trends Endocrinol. Metab 5: 215-219.
Dorrington JH, Bendell JJ, Khan SA. (1993) Interactions between FSH, estradiol-17
beta and transforming growth factor-beta regulate growth and differentiation in the
rat gonad. J. Steroid Biochem Mol Biol 44: 441-447.
28
Gill A, Jamnongjit M, Hammes SR. (2004) Androgens promote maturation and
signaling in mouse oocytes independent of transcription: a release of inhibition
model for mammalian oocyte meiosis. Mol Endocrinol 18: 97-104.
Guo Y, Guo KJ, Huang L, Tong XG, Li X. (2004) Effect of oestrogen deprivation on
follicle/oocyte maturation and embryo development in mice. Chin Med J (Engl) 117:
498-502.
Gutendorf B, Westendorf J.(2001) Comparison of an array of in vitro assays for the
assessment of the oestrogenic potential of natural and synthetic oestrogens,
phytoestrogens and xenoestrogens. Toxicology 166: 79-89
Hillier SG, Yong EL, Iilingworth PJ, Baird DT, Schwall RH, Mason AJ. (1991)
Effect of recombinant activin on androgen synthesis in cultured human thecal cells.
J. Clin Endocrinol Metab 72: 1206-1211.
Hillier SG. (1994) Current concepts of the roles of follicle stimulating hormone and
luteinizing hormone in folliculogenesis. Hum Reprod 9: 188-191.
Homburg R. Adverse effects of luteinizing hormone on fertility: fact or fantasy.
(1998) Baillieres. Clin Obstet Gynaecol 12: 555-563.
Huot RI, Shain SA. Differential metabolism of dehydroepiandrosterone sulfate and
oestrogen conjugates by normal or malignant AXC/SSh rat prostate cells and effects
of these steroid conjugates on cancer cell proliferation in vitro.(1988) J Steroid
Biochem 29: 617-621.
29
Huynh K, Jones G, Thouas G, Britt KL, Simpson ER, Jones ME. (2004) Oestrogen is
not directly required for oocyte developmental competence. Biol Reprod 70: 1263-
1269.
Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G,
Dausman J, Lee P, Wilson C, Lander E, Jaenisch R. (2001) Loss of genomic
methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet
27: 31-39.
Lang J. (1991) Assay for deletion in Gnrh (hpg) locus using PCR. Mouse Genome
89: 857.
Lonning PE, Geisler J, Dowsett M. Pharmacological and clinical profile of
anastrozole. (1998) Breast Cancer Res Treat 49 Suppl 1: S53-S57.
Loumaye E, Engrand P, Shoham Z, Hillier SG, Baird DT. (2003) Clinical evidence
for an LH ceiling? Hum Reprod 18: 2719-20.
Lucifero D, Mertineit C, Clarke HJ, Bestor TH, Trasler JM. (2002) Methylation
dynamics of imprinted genes in mouse germ cells. Genomics 79: 530-8.
Lucifero D, Mann MR, Bartolomei MS, Trasler JM. (2004) Gene-specific timing and
epigenetic memory in oocyte imprinting. Hum Mol Genet 13: 839-849.
Mann RJ, Keri RA, Nilson JH. (1999) Transgenic mice with chronically elevated
luteinizing hormone are infertile due to anovulation, defects in uterine receptivity,
and midgestation pregnancy failure. Endocrinol 140: 2592-2601.
30
Merk FB, Botticelli CR, Albright JT. (1972) An intercellular response to oestrogen
by granulosa cells in the rat ovary; an electron microscope study. Endocrinol 90:
992-1007.
Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H. (2001)
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal
hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97: 1172-
1179.
Moor RM, Dai Y, Lee C, Fulka J, Jr. (1998) Oocyte maturation and embryonic
failure. Hum Reprod Updat. 4: 223-236.
Murdoch WJ, Van Kirk EA. (2001) Oestrogenic upregulation of DNA polymerase
beta in oocytes of preovulatory ovine follicles. Mol Reprod Dev 58: 417-423.
Murray AA, Gosden RG, Allison V, Spears N. (1998) Effect of androgens on the
development of mouse follicles growing in vitro. J. Reprod Fertil 113: 27-33.
Obata Y, Kaneko-Ishino T, Koide T, Takai Y, Ueda T, Domeki I, Shiroishi T, Ishino
F, Kono T. (1998) Disruption of primary imprinting during oocyte growth leads to
the modified expression of imprinted genes during embryogenesis. Development
125: 1553-60.
Quinn P, Barros C, Whittingham DG. (1982) Preservation of hamster oocytes to
assay the fertilizing capacity of human spermatozoa. J Reprod Fertil 66: 161-168.
31
Roberts AJ, Skinner MK. (1990) Oestrogen regulation of thecal cell steroidogenesis
and differentiation: thecal cell-granulosa cell interactions. Endocrinol 127: 2918-
2929.
Shoham Z, Jacobs HS, Insler V. (1993) Luteinizing hormone: its role, mechanism of
action, and detrimental effects when hypersecreted during the follicular phase. Fertil
Steril 59: 1153-1161.
Shoham Z. (2002) The clinical therapeutic window for luteinizing hormone in
controlled ovarian stimulation. Fertil Steril 77: 1170-7.
Simon I, Tenzen T, Reubinoff BE, Hillman D, McCarrey JR, Cedar H. (1999)
Asynchronous replication of imprinted genes is established in the gametes and
maintained during development. Nature 401: 929-932.
Smyth CD, Gosden RG, McNeilly AS, Hillier SG. (1994) Effect of inhibin
immunoneutralization on steroidogenesis in rat ovarian follicles in vitro. J
Endocrinol 140: 437-43.
Spears N, Boland NI, Murray AA, Gosden RG. (1994) Mouse oocytes derived from
in vitro grown primary ovarian follicles are fertile. Hum Reprod 9: 527-532.
Spears N, Murray AA, Allison V, Boland NI, Gosden RG. (1998) Role of
gonadotropins and ovarian steroids in the development of mouse follicles in vitro. J
Reprod Fertil 113: 19-26.
Szoltys M, Slomczynska M, Tabarowski Z. (2003) Immunohistochemical
localization of androgen receptor in rat oocytes. Folia Histochem Cytobiol 41: 59-64.
32
Tesarik J, Mendoza C. (1995) Nongenomic effects of 17 beta-estradiol on maturing
human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol
Metab 80: 1438-1443.
Tetsuka M, Hillier SG. (1997) Differential regulation of aromatase and androgen
receptor in granulosa cells. J Steroid Biochem Mol Biol 61: 233-239.
Vendola KA, Zhou J, Adesanya 00, Weil SJ, Bondy CA. (1998) Androgens
stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101:
2622-2629.
Weil S, Vendola K, Zhou J, Bondy CA. (1999) Androgen and follicle-stimulating
hormone interactions in primate ovarian follicle development. J Clin Endocrinol
Metab 84: 2951-2956.
Westergaard LG, Erb K, Laursen S, Rasmussen PE, Rex S. (1996) The effect of
human menopausal gonadotrophin and highly purified, urine-derived follicle
stimulating hormone on the outcome of in-vitro fertilization in down-regulated
normogonadotrophic women. Hum Reprod 11: 1209-13.
Xia P, Younglai EV. (2000) Relationship between steroid concentrations in ovarian
follicular fluid and oocyte morphology in patients undergoing intracytoplasmic
sperm injection (ICSI) treatment. J Reprod Fertil 118: 229-233.
Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C,
Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD. (2001) Epigenetic change in
IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet 27:
153-154.
Zheng P, Si W, Bavister BD, Yang J, Ding C, Ji W. (2003) 17Beta-estradiol and
progesterone improve in-vitro cytoplasmic maturation of oocytes from unstimulated
prepupertal and adult rhesus monkeys. Hum Reprod 18: 2137-2144.
34
Figure Legends.
Figure 1. Growth rates of follicles exposed to different gonadotrophin environments.
Values are mean ± SEM (n >16 for each group). Arrow indicates the start of antral
formation iin all gonadotrophin groups.
Figure 2. Confocal micrographs after labeling with TUNEL (green) and propidium
iodide (red). Green cells indicate apoptosis. Representative follicles are shown for
(A) Gn Free, (B) FSH only, (C) low LH, (D) high LH. The follicle grown in (A) Gn
free conditions shows a high degree of apoptotic labeling. Scale bar represents 50p.m.
Figure 3. Concentration of (A) androstenedione and (B) 17-|3 -estradiol produced by
follicles treated with different gonadotrophin regimes. Media were sampled on days
4 and 5 of culture. Values are mean ± SEM (n > 9 for each group). Different
superscripts indicate significant differences. a,b refer to comparisons between
treatments on the same day of culture and x,y refer to comparisons between days
within the same treatment (p<0.05).
Figure 4. Percentage of oocytes from follicles grown in different gonadotrophin
conditions (A) fertilising and reaching the 2-cell stage and (B) 2-cell embryos
developing to the blastocyst stage. F1 controls are shown for comparison.
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Figure 5. Growth rates of follicles cultured in control medium, High A, High E and
High A + E treatment groups. Values are mean ± SEM (n >16 for each group). The
arrow indicates the start of antral formation in all groups.
Figure 6. Concentration of androstenedione produced by follicles grown in different
steroid environments. Media were sampled on day 6 of culture. Values are mean ±
SEM (n > 9 for each group). * pcO.OOl compared to control.
Figure 7. Percentage of oocytes from follicles grown in different steroid
environments (A) fertilising and reaching the 2-cell stage and (B) 2-cell embryos
developing to the blastocyst stage. F1 controls are shown for comparison.
Figure 8. Confocal images of global DNA methylation levels of oocytes removed
from culture on Days 0, 2, 4 and 6 and stained using a 5-methyl-cytosine antibody
and FIT-C secondary. Scale bars represent 10pm.
Figure 9. Normalized global DNA methylation levels for each oocyte according to
treatment group, Control, High A, High E and High A + E. Horizontal bars represent
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